| CodeSystem |
https://ncez.mzcr.cz/fhir/CodeSystem/snomed-supplement-service-type  | SNOMED CT Supplement type for registering provider |
| https://smartforms.csiro.au/ig/CodeSystem/HealthChecksSCTSupplement | SNOMED CT Supplement for Aboriginal and Torres Strait Islander Health Check |
| http://ehealth.sundhed.dk/snomed.info/sct/supplement | SNOMED CT Code System Supplement |
| https://demis.rki.de/fhir/CodeSystem/translationEvidence | Übersetzung Symptom und Manifestation |
| https://www.medizininformatik-initiative.de/fhir/core/modul-diagnose/CodeSystem/mii-cs-diagnose-lebensphase-supplement-snomed | MII_CS_Diagnose_Lebensphase_Supplement_SNOMED |
| https://www.netzwerk-universitaetsmedizin.de/fhir/CodeSystem/snomed-pce-supplement | SNOMED Supplement CodeSystem |
| http://hl7.org/fhir/us/davinci-hrex/ConceptMap/CareTeamMember-NUCCFunction | SNOMED Care Team Member Function to NUCC Map |
| http://hl7.org/fhir/us/davinci-hrex/ConceptMap/NUCC-CareTeamMemberFunction | NUCC to SNOMED Care Team Member Function Map |
| http://johnmoehrke.github.io/phr/ConceptMap/VF-VitalsDevice | Vitals Device used to SNOMED code |
| http://johnmoehrke.github.io/phr/ConceptMap/VF-VitalsLaterality | Vitals Laterality used to SNOMED code |
| http://johnmoehrke.github.io/phr/ConceptMap/VF-VitalsMethod | Vitals Method used to SNOMED code |
| http://johnmoehrke.github.io/phr/ConceptMap/VF-VitalsPosition | Vitals Position used to SNOMED code |
| http://johnmoehrke.github.io/phr/ConceptMap/VF-VitalsSite | Vitals Site used to SNOMED code |
| https://www.ehealth.fgov.be/standards/fhir/mycarenet/ConceptMap/BeCMISOToothSnomedCT | BeCMISOToothSnomedCT |
| http://hl7.org/fhir/us/vrdr/ConceptMap/CertifierTypesCM | CertifierTypes Concept Map |
| http://hl7.org/fhir/us/vrdr/ConceptMap/ContributoryTobaccoUseCM | ContributoryTobaccoUse Concept Map |
| http://hl7.org/fhir/us/vrdr/ConceptMap/MannerOfDeathCM | MannerOfDeath Concept Map |
| http://hl7.org/fhir/us/vrdr/ConceptMap/MethodOfDispositionCM | MethodOfDisposition Concept Map |
| http://hl7.org/fhir/us/vrdr/ConceptMap/PlaceOfDeathCM | PlaceOfDeath Concept Map |
| http://hl7.org/fhir/us/vrdr/ConceptMap/TransportationIncidentRoleCM | TransportationIncidentRole Concept Map |
| http://fhir.ch/ig/ch-term/ConceptMap/DocumentEntryClassCodeToDocumentEntryTypeCode | DocumentEntryClassCodeToDocumentEntryTypeCode |
| http://fhir.ch/ig/ch-term/ConceptMap/HCProfessionalHCProfessionSpecialisationMap | HCProfessionalHCProfessionSpecialisationMap |
| http://fhir.ch/ig/ch-vacd/ConceptMap/ch-vacd-targetdiseases-vaccines-cm | TargetDisease To VaccineCode Mapping |
| http://fhir.ch/ig/ch-vacd/ConceptMap/ch-vacd-vaccines-sct-sm-cm | Snomed CT VaccineCode To SwissMedic VaccineCode |
| http://fhir.ch/ig/ch-vacd/ConceptMap/ch-vacd-vaccines-sct-targetdiseases-cm | Snomed CT VaccineCode To TargetDisease Mapping |
| http://fhir.ch/ig/ch-vacd/ConceptMap/ch-vacd-vaccines-sm-sct-cm | SwissMedic VaccineCode To Snomed CT VaccineCode |
| http://fhir.ch/ig/ch-vacd/ConceptMap/ch-vacd-vaccines-targetdiseases-cm | VaccineCode To TargetDisease Mapping |
| http://fhir.ch/ig/ch-core/ConceptMap/documententry-confidentialitycode-to-fhir | DocumentEntry.confidentialityCode to FHIR mapping |
| http://hl7.org/fhir/us/vr-common-library/ConceptMap/ConceptMapBirthAttendantTitlesVitalRecords | BirthAttendantTitles Concept Map |
| http://hl7.org/fhir/us/mcode/ConceptMap/TG263CM | TG263 Concept Map |
| http://fhir.ch/ig/ch-elm/ConceptMap/ch-elm-results-geno-to-component-code | CH ELM Results To Genotying Component code ValueSet |
| http://fhir.ch/ig/ch-elm/ConceptMap/ch-elm-results-geno-to-component-interpretation-code | CH ELM Results To Genotyping Component Interpretation Code ValueSet |
| http://fhir.ch/ig/ch-elm/ConceptMap/ch-elm-results-susc-to-component-code | CH ELM Results To Susceptibility Component code ValueSet |
| http://fhir.ch/ig/ch-elm/ConceptMap/ch-elm-results-susc-to-component-interpretation-code | CH ELM Results To Susceptibility Component Interpretation Code ValueSet |
| http://fhir.ch/ig/ch-elm/ConceptMap/ch-elm-results-to-foph-patient-name-representation | CH ELM Results To FOPH Patient Name Representation |
| http://fhir.ch/ig/ch-elm/ConceptMap/ch-elm-results-to-interpretation-code | CH ELM Results To Interpretation Code |
| http://fhir.org/guides/who/anc-cds/ConceptMap/SNOMED-CT | SNOMED-CT |
| http://ehealth.sundhed.dk/ConceptMap/activitydefinition-code-to-do-missing-measurement | Activitydefinition-code to do missing measurement |
| http://ehealth.sundhed.dk/ConceptMap/activitydefinition-code-to-do-reminder | Activitydefinition-code to do reminder |
| http://ehealth.sundhed.dk/ConceptMap/activitydefinition-code-to-measurement-resource-type | Activitydefinition-code to measurement resource type |
| http://ehealth.sundhed.dk/ConceptMap/activitydefinition-code-to-perform-sharing | Activitydefinition-code-to-perform-sharing |
| http://ehealth.sundhed.dk/ConceptMap/conceptmap-device-type-to-medcom-device-type | Device type to MedCom device type |
| http://fhir.ch/ig/ch-emed-epr/ConceptMap/CHEMEDEPRAmountQuantityUnitCodeToCdTyp9 | CHEMEDEPRAmountQuantityUnitCode -> CdTyp9 |
| http://fhir.ch/ig/ch-emed-epr/ConceptMap/CdTyp9ToCHEMEDEPRAmountQuantityUnitCode | CdTyp9 -> CHEMEDEPRAmountQuantityUnitCode |
| http://hl7.org/fhir/us/ccda/ConceptMap/CF-AllergyIntoleranceCategory | CCDA to FHIR Allergy Intolerance Category |
| http://hl7.org/fhir/us/ccda/ConceptMap/CF-AllergyIntoleranceType | CCDA to FHIR Allergy Intolerance Type |
| http://hl7.org/fhir/us/ccda/ConceptMap/CF-AllergyStatus | C-CDA to FHIR Allergy Status |
| http://hl7.org/fhir/us/ccda/ConceptMap/CF-NoKnownAllergies | C-CDA to FHIR No Known Allergies |
| http://hl7.org/fhir/us/ccda/ConceptMap/CF-ProblemStatus | C-CDA Problem Status value to FHIR Condition clinicalStatus |
| http://hl7.org/fhir/us/ccda/ConceptMap/CF-Severity | C-CDA Severity to FHIR Severity |
| http://hl7.org/fhir/us/ccda/ConceptMap/FC-AllergyIntoleranceCategory | FHIR to CCDA Allergy Intolerance Category |
| http://hl7.org/fhir/us/ccda/ConceptMap/FC-AllergyIntoleranceType | FHIR Allergy Intolerance Type to CCDA value |
| http://hl7.org/fhir/us/ccda/ConceptMap/FC-AllergyStatus | FHIR to C-CDA Allergy Status |
| http://hl7.org/fhir/us/ccda/ConceptMap/FC-ImmunizationRefusal | FHIR Immunization Status Reason to C-CDA Immunization Refusal |
| http://hl7.org/fhir/us/ccda/ConceptMap/FC-ImmunizationSite | FHIR Immunization Site to C-CDA Immunization approachSiteCode |
| http://hl7.org/fhir/us/ccda/ConceptMap/FC-NoKnownAllergies | FHIR to C-CDA No Known Allergies |
| http://hl7.org/fhir/us/ccda/ConceptMap/FC-ProblemStatus | FHIR Condition clinicalStatus to C-CDA Problem Status value |
| http://hl7.org/fhir/us/ccda/ConceptMap/FC-Severity | FHIR Severity to C-CDA Severity |
| http://hl7.org/fhir/us/davinci-alerts/ConceptMap/direct-alerts | Direct ADT to Da Vinci Alerts ConceptMap |
| https://twcore.mohw.gov.tw/ig/twcore/ConceptMap/health-professional-tw | 臺灣醫事司醫事人員類別代碼對應SNOMED CT及臺灣醫事司醫事人員類別 |
| https://twcore.mohw.gov.tw/ig/twcore/ConceptMap/medical-consultation-department-nhi-tw | 臺灣健保署就醫科別代碼對應SNOMED CT |
| https://twcore.mohw.gov.tw/ig/twcore/ConceptMap/medical-treatment-department-nhi-tw | 臺灣健保署診療科別代碼對應SNOMED CT |
| https://twcore.mohw.gov.tw/ig/twcore/ConceptMap/medication-path-tw | 臺灣健保署給藥途徑代碼對應SNOMED CT |
| http://hl7.org/fhir/us/bfdr/ConceptMap/BirthAttendantTitlesCM | BirthAttendantTitles Concept Map |
| http://hl7.org/fhir/us/bfdr/ConceptMap/BirthDeliveryOccurredCM | BirthDeliveryOccurred Concept Map |
| http://hl7.org/fhir/us/bfdr/ConceptMap/DeliveryRoutesCM | DeliveryRoutes Concept Map |
| http://hl7.org/fhir/us/bfdr/ConceptMap/FetalDeathCauseOrConditionCM | FetalDeathCauseOrCondition Concept Map |
| http://hl7.org/fhir/us/bfdr/ConceptMap/FetalDeathTimePointsCM | FetalDeathTimePoints Concept Map |
| http://hl7.org/fhir/us/bfdr/ConceptMap/FetalPresentationCM | FetalPresentation Concept Map |
| http://hl7.org/fhir/us/bfdr/ConceptMap/InfectionsDuringPregnancyLiveBirthCM | InfectionsDuringPregnancyLiveBirth Concept Map |
| http://hl7.org/fhir/us/bfdr/ConceptMap/NewbornCongenitalAnomaliesCM | NewbornCongenitalAnomalies Concept Map |
| http://hl7.org/fhir/us/bfdr/ConceptMap/PerformedNotPerformedPlannedCM | PerformedNotPerformedPlanned Concept Map |
| http://moh.gov.et/fhir/hiv/ConceptMap/LOINCCodesToSNOMED | ConceptMap to and from LOINC to SNOMED |
| http://moh.gov.et/fhir/hiv/ConceptMap/SNOMEDCodesToProprietary | ConceptMap to and from SNOMED to Proprietary |
| http://fhir.hl7.nl/zorgviewer/ConceptMap/epic-rolcode | Epic Provider Type naar SNOMED-CT Mapping |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_DPE_Declaration_Type_German | Art der Erklärung |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_NFD_Implant_German | Medizinprodukt |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_NFD_Person_Institution_German | BAI_ART |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_NFD_Procedure_German | Prozedur SNOMEDCT |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_NFD_Reaction_Allergy_German | Allergie Manifestation |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_NFD_Runaway_Risk_German | Weglaufgefährdung |
| https://fhir.ee/ConceptMap/person-relationship-mpi-v3 | Mapping of MPI person relationship to legacy V3 |
| https://fhir.ee/ConceptMap/person-relationship-v3-mpi | Mapping of legacy V3 person relationship to MPI |
| https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Terminology_Complete_German | KBV_CM_Base_Terminology_Complete_German |
| https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Apgar_Score_Identifier_German | KBV_CM_Base_Apgar_Score_Identifier_German |
| https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Apgar_Score_Value_German | KBV_CM_Base_Apgar_Score_Value_German |
| https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Body_Height_Snomed_German | KBV_CM_Base_Body_Height_Snomed_German |
| https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Body_Weight_Method_Snomed_German | KBV_CM_Base_Body_Weight_Method_Snomed_German |
| https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Body_Weight_Snomed_German | KBV_CM_Base_Body_Weight_Snomed_German |
| https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Diagnosis_Severity_German | KBV_CM_Base_Diagnosis_Severity_German |
| https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Head_Circumference_BodySite_Snomed_German | KBV_CM_Base_Head_Circumference_BodySite_Snomed_German |
| https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Head_Circumference_Snomed_German | KBV_CM_Base_Head_Circumference_Snomed_German |
| https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Practitioner_Function_German | KBV_CM_Base_Practitioner_Function_German |
| https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Stage_Life_German | KBV_CM_Base_Stage_Life_German |
| https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Body_Temp_Snomed_German | KBV_CM_Base_Body_Temp_Snomed_German |
| https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Heart_Rate_German | KBV_CM_Base_Heart_Rate_German |
| http://fhir.tasmc.org.il/ConceptMap/tasmc-snomedct-specimen-type | Mapping from Sourasky local specimen types to SNOMED CT |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_LAB_ELGA_Specimen_Type_SNOMED_German | ELGA Probenart SNOMED |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_IHEXDS_AuthorSpeciality_Restricted_German | KBV_CM_MIO_Vaccination_IHEXDS_AuthorSpeciality_Restricted_German |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Lab_ImmuneReaction_Test_Presence_German | KBV_CM_MIO_Vaccination_Lab_ImmuneReaction_Test_Presence_German |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Lab_ImmuneReaction_Test_Presence_LOINC_Snomed | KBV_CM_MIO_Vaccination_Lab_ImmuneReaction_Test_Presence_LOINC_Snomed |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Lab_Titer_Immunity_German | Titer Immunität |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Prior_Disease_German | VaccinationrelevantDisease |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Prior_Disease_Snomed_ICD | KBV_CM_MIO_Vaccination_Prior_Disease_Snomed_ICD |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Source_of_Information_German | Source_of_Information |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Vaccine_ATC_Snomed | KBV_CM_MIO_Vaccination_Vaccine_ATC_Snomed |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Vaccine_German | Vaccine |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_Vaccination_Vaccine_Targetdisease | KBV_CM_MIO_Vaccination_Vaccine_Targetdisease |
| http://nictiz.nl/fhir/ConceptMap/Alcoholgebruik-to-AlcoholGebruikStatusCodelijst | Alcoholgebruik-to-AlcoholGebruikStatusCodelijst |
| http://nictiz.nl/fhir/ConceptMap/Rookgedrag-to-TabakGebruikStatusCodelijst | Rookgedrag-to-TabakGebruikStatusCodelijst |
| http://nictiz.nl/fhir/ConceptMap/WerkelijkePlaatsBaring-to-ActEncounterCode | WerkelijkePlaatsBaring-to-ActEncounterCode |
| https://twcore.mohw.gov.tw/ig/pas/ConceptMap/nhi-sct-body-site | 臺灣健保署身體部位代碼對應SNOMED CT |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_AB0_System_First_Examination_After_Childbirth_German | AB0-System des Kindes im Wochenbett |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_AB0_System_German | AB0-System |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Biometrics_II_III_German | Biometrie II und III |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Biometrics_I_German | Biometrie I |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Birth_Mode_German | Geburtsmodus |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Breastfeeding_Behavior_German | Stillverhalten der Mutter |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Catalogue_A_German | Anamneseerhebung bei Erstuntersuchung |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Child_Position_German | Kindslage |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Counselling_German | Beratung von Schwangeren |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Direct_Coombstest_German | Direkter Coombstest |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Examination_Interpretation_German | Interpretation der Messergebnisse hinsichtlich der Immunität |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Examination_Result_Qualitative_German | Qualitative Beurteilung der Messergebnisse |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Examination_Snomed_German | Laboruntersuchungen |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Findings_Required_Control_German | Kontrollbedürftige Befunde |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_General_Information_German | Allgemeine Angaben zum Fötus beim ersten Ultraschallscreening |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Heart_Sounds_Child_German | Herztöne des Kindes |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Immunization_Status_German | Nachweise der prophylaktischen Impfungen |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Localisation_Placenta_German | Lokalisation/Struktur der Plazenta |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Morphology_German | Morphologie |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Other_Ultrasound_Studies_German | Weitere Ultraschalluntersuchungen |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Practitioner_Function_German | Funktionen/Rollen des Behandelnden |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Pregnancy_Information_German | Angaben zur Schwangerschaft beim Ultraschallscreening |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Rhesus_System_Fetus_German | Rhesus-System des Fötus |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Rhesus_System_German | Rhesus-System |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_Special_Findings_German | Befundkatalog Besondere Befunde |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_oGTT_Diagnosistest_German | Oraler Glucosetoleranztest (oGTT) Diagnosetest |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_MR_oGTT_Pretest_German | Oraler Glucosetoleranztest (oGTT) Vortest |
| http://smart.who.int/ddcc/ConceptMap/lab-test-pathogen-snomed-to-icd11 | Lab Test - Result - Pathogen - Mapping SNOMED CT to ICD-11 |
| http://smart.who.int/ddcc/ConceptMap/lab-test-qual-result-snomed-to-icd11 | Lab Test - Result - Mapping SNOMED CT to ICD-11 |
| http://smart.who.int/ddcc/ConceptMap/vaccine-covid19-snomed-to-icd11 | Vaccine - COVID-19 - Mapping SNOMED to ICD-11 |
| http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-icd11-sct-agent-targeted | ConceptMap from ICD-11 to SNOMED CT for Agent Targeted |
| http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-icd11-sct-disease-targeted | ConceptMap from ICD-11 to SNOMED CT for Disease or Agent Targeted |
| http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-icd11-sct-test-result | ConceptMap from ICD-11 to SNOMED CT for Test Result |
| http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-icd11-sct-vaccines | ConceptMap from ICD-11 to SNOMED CT for Vaccines |
| http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-ichi-sct-specimen-origin | ConceptMap from ICHI to SNOMED CT for Specimen Origin |
| http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-ichi-sct-type-of-test | ConceptMap from ICHI to SNOMED CT for Type of Test |
| http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-loinc-sct-type-of-test | ConceptMap from LOINC to SNOMED CT for Type of Test |
| http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-sct-ichi-specimen-origin | ConceptMap from SNOMED CT to ICHI for Specimen Origin |
| https://fhir.hl7.org.uk/STU3/ConceptMap/CareConnect-AllergySeverity-1 | Concept Map - Allergy Severity |
| https://fhir.hl7.org.uk/STU3/ConceptMap/CareConnect-AllergyVerificationStatus-1 | Concept Map - Allergy Verification Status |
| https://fhir.hl7.org.uk/STU3/ConceptMap/CareConnect-ConditionEpisodicity-1 | Concept Map - Condition Episodicity |
| https://demis.rki.de/fhir/ConceptMap/LOINCMaterialToSNOMEDMaterial | LOINCMaterialToSNOMEDMaterial |
| https://demis.rki.de/fhir/ConceptMap/LOINCMethodToSNOMEDMethod | LOINCMethodToSNOMEDMethod |
| http://nictiz.nl/fhir/ConceptMap/AllergieCategorieCodelijst-to-AllergyIntoleranceCategory | AllergieCategorieCodelijst to AllergyIntoleranceCategory |
| http://nictiz.nl/fhir/ConceptMap/ErnstCodelijst-to-AllergyIntoleranceSeverity | ErnstCodelijst to AllergyIntoleranceSeverity |
| http://nictiz.nl/fhir/ConceptMap/InterpretatieVlaggenCodelijst-to-ObservationInterpretationCodes | InterpretatieVlaggenCodelijst to ObservationInterpretationCodes |
| http://nictiz.nl/fhir/ConceptMap/MateVanKritiekZijnCodelijst-to-AllergyIntoleranceCriticality | MateVanKritiekZijnCodelijst to AllergyIntoleranceCriticality |
| http://nictiz.nl/fhir/ConceptMap/ProbleemStatusCodelijst-to-ConditionClinicalStatusCodes | ProbleemStatusCodelijst to ConditionClinicalStatusCodes |
| http://nictiz.nl/fhir/ConceptMap/VerificatieStatusCodelijst-to-ConditionVerificationStatus | VerificatieStatusCodelijst to ConditionVerificationStatus |
| https://fhir.nhs.uk/STU3/ConceptMap/CareConnect-AllergySeverity-1 | Concept Map - Allergy Severity |
| https://fhir.nhs.uk/STU3/ConceptMap/CareConnect-AllergyVerificationStatus-1 | Concept Map - Allergy Verification Status |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-biobank/ConceptMap/SPRECFixationTypeMap | SPREC 3.0 Fixation Type Mapping |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-biobank/ConceptMap/SPRECLongTermStorageMap | SPREC 3.0 Long-Term Storage Mapping |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-biobank/ConceptMap/SPRECPrimaryContainerMap | SPREC 3.0 Primary Container Mapping |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-biobank/ConceptMap/SPRECSampleTypeMap | SPREC 3.0 Sample Type Mapping |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_ULB_Overview | KBV_CM_MIO_ULB_Overview |
| http://ig.ehealth4u.eu/fhir/ConceptMap/cyehr-cm-allergyreactionseverity-snomed2hl7fhir | Cyprus EHR Concept Map: Allergy Reaction Severity - Snomed to HL7 FHIR |
| http://ig.ehealth4u.eu/fhir/ConceptMap/cyehr-cm-allergytype-snomed2hl7fhir | Cyprus EHR Concept Map: Allergy Type - Snomed to HL7 FHIR |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Bodysite_Hip_German | Hüftlateralität |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Examination_Number_German | Untersuchungsnummer U-Heft |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Foetal_Position_German | Kindslage aus Sicht d. Kindes |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Gender_Birth_German | Geschlecht SNOMED |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Hearscreening_Method_German | Hörscreenigmethode |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Hearscreening_Result_German | Hörscreeningbefund Lokalisation |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Hip_History_German | Hüftanamnese |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Hip_Proceeding_German | Hüfte - weiteres Vorgehen |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Hip_Screening_Method_German | Hüftscreening Methode |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Newborn_Blood_Spot_Screening_Type_German | Typ der Blutabnahme |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Percentile_Body_Measure_Loinc_German | Perzentilkörpermaß LOINC |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Percentile_Body_Measure_Snomed_German | Perzentilkörpermaß SNOMED |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Practitioner_Speciality_German | Rolle des Behandelnden |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Pregnancy_History_German | Schwangerschaftsanamnese |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Pulse_Oxymetry_Screening_Data_Absent_Reason_German | Gründe zur Ablehnung des Pulsoxymetriescreenings |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_Pulse_Oxymetry_Screening_Measurement_Type_German | Typ der Pulsoxymetriemessung |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U1_Apgar_Score_Identifier_German | Apgar Score am Zeitpunkt |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U1_Apgar_Score_Value_German | Apgar-Score Wert |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U1_U3_Birthmode_German | Geburtsmodus |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U1_U3_Pulse_Oxymetry_Measurement_German | Auffälligkeit Sauerstoffsättigung |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_Consultation_German | U2 - Beratung |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_Current_Child_History_German | U2 - Aktuelle Anamnese des Kindes |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_Family_History_German | U2 - Familienanamnese |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_Physical_Exam_Head_German | U2 - Kopf |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_Physical_Exam_Mouth_Nose_German | U2 - Mundhöhle, Kiefer, Nase |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_Physical_Exam_Musculoskeletal_System_German | U2 - Bewegungsapparat |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_Physical_Exam_Skin_German | U2 - Haut |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_U3_Physical_Exam_Abdomen_Genitals_German | U2, U3 - Abdomen, Genitale |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_U3_Physical_Exam_Ears_German | U2, U3 - Ohren |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_U3_Physical_Exam_Eyes_German | U2, U3 - Augen |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_U4_Physical_Exam_Chest_Lung_Respiratory_Tract_German | U2, U3, U4 - Thorax, Lunge, Atemwege |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U2_U6_Physical_Exam_Heart_Blood_Circulation_German | U2, U3, U4, U5, U6 - Herz, Kreislauf |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U3_Consultation_German | U3 - Beratung |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U3_Current_Child_History_German | U3 - Aktuelle Anamnese des Kindes |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U3_Development_Assessment_German | U3 - Orient. Beurt. Entwicklung |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U3_Family_History_German | U3 - Familienanamnese |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U3_Physical_Exam_Head_German | U3 - Kopf |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U3_Physical_Exam_Musculoskeletal_System_German | U3 - Bewegungsapparat |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U3_U4_Physical_Exam_Mouth_Nose_German | U3, U4 - Mundhöhle, Kiefer, Nase |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U3_U4_Physical_Exam_Skin_German | U3, U4 - Haut |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U3_U9_Age_Appropriate_Development_German | altersgemäße Entwicklung |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U3_U9_Social_History_German | U3-U9 - Sozialanamnese |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U4_Consultation_German | U4 - Beratung |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U4_Current_Child_History_German | U4 - Aktuelle Anamnese des Kindes |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U4_Development_Assessment_German | U4 - Orient. Beurt. Entwicklung |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U4_Physical_Exam_Abdomen_Genitals_German | U4 - Abdomen, Genitale |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U4_Physical_Exam_Head_German | U4 - Kopf |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U4_Physical_Exam_Musculoskeletal_System_German | U4 - Bewegungsapparat |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U4_U5_Physical_Exam_Eyes_German | U4, U5 - Augen |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U5_Consultation_German | U5 - Beratung |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U5_Current_Child_History_German | U5 - Aktuelle Anamnese des Kindes |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U5_Development_Assessment_German | U5 - Orient. Beurt. Entwicklung |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U5_Physical_Exam_Chest_Lung_Respiratory_Tract_German | U5 - Thorax, Lunge, Atemwege |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U5_Physical_Exam_Mouth_Nose_German | U5 - Mundhöhle, Kiefer, Nase |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U5_Physical_Exam_Musculoskeletal_System_German | U5 - Bewegungsapparat |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U5_U6_Physical_Exam_Abdomen_Genitals_German | U5, U6 - Abdomen, Genitale |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U5_U6_Physical_Exam_Head_German | U5, U6 - Kopf |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U5_U9_Physical_Exam_Skin_German | U5, U6, U7, U7a, U8, U9 - Haut |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U6_Consultation_German | U6 - Beratung |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U6_Current_Child_History_German | U6 - Aktuelle Anamnese des Kindes |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U6_Development_Assessment_German | U6 - Orient. Beurt. Entwicklung |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U6_Physical_Exam_Eyes_German | U6 - Augen |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U6_Physical_Exam_Mouth_Nose_German | U6 - Mundhöhle, Kiefer, Nase |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U6_Physical_Exam_Musculoskeletal_System_German | U6 - Bewegungsapparat |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U6_U7_Physical_Exam_Chest_Lung_Respiratory_Tract_German | U6, U7 - Thorax, Lunge, Atemwege |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7_Consultation_German | U7 - Beratung |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7_Current_Child_History_German | U7 - Aktuelle Anamnese des Kindes |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7_Development_Assessment_German | U7 - Orient. Beurt. Entwicklung |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7_Physical_Exam_Eyes_German | U7 - Augen |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7_Physical_Exam_Mouth_Nose_German | U7 - Mundhöhle, Kiefer, Nase |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7_Physical_Exam_Musculoskeletal_System_German | U7 - Bewegungsapparat |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7_U7a_Physical_Exam_Abdomen_Genitals_German | U7, U7a - Abdomen, Genitale |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7_U9_Physical_Exam_Heart_Blood_Circulation_German | U7, U7a, U8, U9 - Herz, Kreislauf |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7a_Consultation_German | U7a - Beratung |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7a_Current_Child_History_German | U7a - Aktuelle Anamnese des Kindes |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7a_Development_Assessment_German | U7a - Orient. Beurt. Entwicklung |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7a_Physical_Exam_Mouth_Nose_German | U7a - Mundhöhle, Kiefer, Nase |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7a_U9_Physical_Exam_Eyes_German | U7a, U8, U9 - Augen |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7a_and_U9_Physical_Exam_Chest_Lung_Respiratory_Tract_German | U7a, U9 - Thorax, Lunge, Atemwege |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U7a_and_U9_Physical_Exam_Musculoskeletal_System_German | U7a, U9 - Bewegungsapparat |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U8_Consultation_German | U8 - Beratung |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U8_Current_Child_History_German | U8 - Aktuelle Anamnese des Kindes |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U8_Development_Assessment_German | U8 - Orient. Beurt. Entwicklung |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U8_Physical_Exam_Abdomen_Genitals_German | U8 - Abdomen, Genitale |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U8_Physical_Exam_Chest_Lung_Respiratory_Tract_German | U8 - Thorax, Lunge, Atemwege |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U8_Physical_Exam_Ears_German | U8 - Ohren |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U8_Physical_Exam_Musculoskeletal_System_German | U7a, U9 - Bewegungsapparat |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U8_U9_Physical_Exam_Mouth_Nose_German | U8, U9 - Mundhöhle, Kiefer, Nase |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U9_Consultation_German | U9 - Beratung |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U9_Current_Child_History_German | U9 - Aktuelle Anamnese des Kindes |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U9_Development_Assessment_German | U9 - Orient. Beurt. Entwicklung |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_CMR_U9_Physical_Exam_Abdomen_Genitals_German | U9 - Abdomen, Genitale |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_PC_PN_Examination_Number_German | Untersuchungsnummer Teilnahmekarte |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_EMP_Overview | KBV_CM_MIO_EMP_Overview |
| http://hitstdio.ntunhs.edu.tw/fhir/ConceptMap/TWCDCVaccineCodeToQRCodeSctVaccinesCovid19 | TWCDC Vaccine Code to QRCode Sct Vaccines Covid-19 |
| http://nictiz.nl/fhir/ConceptMap/DagdeelCodelijst-to-EventTiming | DagdeelCodelijst to EventTiming |
| http://nictiz.nl/fhir/ConceptMap/WeekdagCodelijst-to-DaysOfWeek | WeekdagCodelijst to DaysOfWeek |
| https://fhir.kbv.de/KBV_CM_MIO_CMR_U7a_Current_Child_History_German | U7a - Aktuelle Anamnese des Kindes |
| https://fhir.nhs.uk/ConceptMap/genomics-laterality-of-hearingloss | Genomics Laterality of Hearing Loss |
| https://fhir.nhs.uk/ConceptMap/genomics-condition-liquidtumourtype | Genomics Condition Liquid Tumour Type |
| https://fhir.nhs.uk/ConceptMap/genomics-condition-pancreatictumourtype | Genomics Condition Pancreatic Tumour Type |
| https://fhir.nhs.uk/ConceptMap/genomics-condition-pituitarytumourtype | Genomics Condition Pituitary Tumour Type |
| https://fhir.nhs.uk/ConceptMap/genomics-condition-solidtumourtype | Genomics Condition Solid Tumour Type |
| https://fhir.nhs.uk/ConceptMap/genomics-fetal-maternal-screening-genotype | Genomics Fetal Maternal Screening Genotype |
| https://fhir.nhs.uk/ConceptMap/genomics-patientpregnancytype | Genomics Patient Pregnancy Type |
| https://fhir.nhs.uk/ConceptMap/genomics-procedure-transfusiontype | Genomics Procedure Transfusion Type |
| https://fhir.nhs.uk/ConceptMap/genomics-risk-reason-for-specimen-specialhandling | Genomics Risk Reason for Specimen Special Handling |
| https://fhir.nhs.uk/ConceptMap/genomics-finalsample | Genomics Final Sample |
| https://fhir.nhs.uk/ConceptMap/genomics-primarysample | Genomics Primary Sample |
| https://fhir.nhs.uk/ConceptMap/genomics-samplepreparation | Genomics Sample Preparation |
| https://fhir.nhs.uk/ConceptMap/genomics-specimen-tumourcellularity | Genomics Specimen Tumour Cellularity |
| https://fhir.nhs.uk/ConceptMap/genomics-typeof-transplantprocedure | Genomics Type of Transplant Procedure |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ConceptMap/mii-cm-onko-allgemeiner-leistungszustand-sct | MII CM Onko Allgemeiner Leistungszustand SNOMED Mapping |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ConceptMap/mii-cm-onko-fernmetastasen-sct | Fernmetastasen Mapping |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ConceptMap/mii-cm-onko-genetische-variante-auspraegung-sct | MII CM Onko Genetische Variante Auspraegung SNOMED Mapping |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ConceptMap/mii-cm-onko-grading-sct | MII CM Onko Grading SNOMED Mapping |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ConceptMap/mii-cm-onko-intention-sct | MII CM Onko Intention SNOMED Mapping |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ConceptMap/mii-cm-onko-nebenwirkung-sct | MII CM Onko Nebenwirkung SNOMED Mapping |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ConceptMap/mii-cm-onko-operation-komplikation-sct | MII CM Onko Operation Komplikation SNOMED Mapping |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ConceptMap/mii-cm-onko-primaertumor-diagnosesicherung-sct | MII CM Onko Primaertumor Diagnosesicherung SNOMED Mapping |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ConceptMap/mii-cm-onko-seitenlokalisation-sct | MII CM Onko Seitenlokalisation SNOMED Mapping |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ConceptMap/mii-cm-onko-strahlentherapie-applikationsart-sct | MII CM Onko Strahlentherapie Applikationsart SNOMED Mapping |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ConceptMap/mii-cm-onko-strahlentherapie-boost-sct | MII CM Onko Strahlentherapie Boost SNOMED Mapping |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ConceptMap/mii-cm-onko-strahlentherapie-strahlenart-sct | MII CM Onko Strahlentherapie Strahlenart SNOMED Mapping |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ConceptMap/mii-cm-onko-strahlentherapie-strahleneinheit-sct | MII CM Onko Strahlentherapie Strahleneinheit SNOMED Mapping |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ConceptMap/mii-cm-onko-strahlentherapie-zielgebiet-sct | MII CM Onko Strahlentherapie Zielgebiet SNOMED Mapping |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ConceptMap/mii-cm-onko-studienteilnahme-sct | MII CM Onko Studienteilnahme SNOMED Mapping |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ConceptMap/mii-cm-onko-therapie-ende-sct | MII CM Onko Therapie Ende SNOMED Mapping |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ConceptMap/mii-cm-onko-therapie-stellung-sct | MII CM Onko Therapie Stellung SNOMED Mapping |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ConceptMap/mii-cm-onko-therapie-typ-sct | MII CM Onko Therapie Typ SNOMED Mapping |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ConceptMap/mii-cm-onko-therapieabweichung-sct | MII CM Onko Therapieabweichung SNOMED Mapping |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ConceptMap/mii-cm-onko-therapieplanung-sct | MII CM Onko Therapieplanung SNOMED Mapping |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ConceptMap/mii-cm-onko-tnm-uicc-sct | MII CM Onko TNM UICC SNOMED |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ConceptMap/mii-cm-onko-tod-sct | MII CM Onko Tod SNOMED Mapping |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ConceptMap/mii-cm-onko-verlauf-fernmetastasen-sct | MII CM Onko Verlauf Fernmetastasen SNOMED Mapping |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ConceptMap/mii-cm-onko-verlauf-gesamtbeurteilung-sct | MII CM Onko Verlauf Gesamtbeurteilung SNOMED Mapping |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ConceptMap/mii-cm-onko-verlauf-lymphknoten-sct | MII CM Onko Verlauf Lymphknoten SNOMED Mapping |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ConceptMap/mii-cm-onko-verlauf-primaertumor-sct | MII CM Onko Verlauf Primaertumor SNOMED Mapping |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_ZAEB_Preventive_Check_Up_German | KBV_CM_MIO_ZAEB_Preventive_Check_Up_German |
| https://fhir.healthdata.be/ConceptMap/AllergyCategory-to-AllergyIntoleranceCategory | AllergyCategory_to_AllergyIntoleranceCategory |
| https://fhir.healthdata.be/ConceptMap/AllergyStatus-to-AllergyIntoleranceClinicalStatusCodes | AllergyStatus_to_AllergyIntoleranceClinicalStatusCodes |
| https://fhir.healthdata.be/ConceptMap/ContactType-to-ActEncounterCode | ContactType to ActEncounterCode |
| https://fhir.healthdata.be/ConceptMap/CriticalExtent-to-AllergyIntoleranceCriticality | CriticalExtent_to_AllergyIntoleranceCriticality |
| https://fhir.healthdata.be/ConceptMap/CriticalExtent-to-AllergyIntoleranceSeverity | CriticalExtent_to_AllergyIntoleranceSeverity |
| https://fhir.healthdata.be/ConceptMap/Gender-to-AdministrativeGender | Gender_to_AdministrativeGender |
| https://fhir.healthdata.be/ConceptMap/MedicationAdministrationStatus-to-MedicationAdministrationStatus | MedicationAdministrationStatus_to_MedicationAdministrationStatusCodes |
| https://fhir.healthdata.be/ConceptMap/MedicationStopType-to-MedicationStatementStatus | MedicationStopType_to_MedicationStatementStatus |
| https://fhir.healthdata.be/ConceptMap/NameUsage-to-HumanNameAssemblyOrder | NameUsage_to_HumanNameAssemblyOrder |
| https://fhir.healthdata.be/ConceptMap/ProblemStatus-to-ConditionClinicalStatusCodes | ProblemStatus_to_ConditionClinicalStatusCodes |
| https://fhir.healthdata.be/ConceptMap/ResultFlags-to-ObservationInterpretationCodes | ResultFlags_to_ObservationInterpretationCodes |
| https://fhir.healthdata.be/ConceptMap/TimeOfDay-to-EventTiming | TimeOfDay_to_EventTiming |
| https://fhir.healthdata.be/ConceptMap/TreatmentDecision-to-ConsentProvisionType | TreatmentDecision to ConsentProvisionType |
| https://fhir.healthdata.be/ConceptMap/VerificationStatus-to-ConditionVerificationStatus | VerificationStatus_to_ConditionVerificationStatus |
| https://fhir.healthdata.be/ConceptMap/WeekDay-to-DaysOfWeek | WeekDay_to_DaysOfWeek |
| http://hl7.org/fhir/uv/ips/ConceptMap/absence-to-snomed-uv-ips | Absence of Information Mappings - IPS to SNOMED CT |
| http://hl7.org/fhir/uv/ips/ConceptMap/severity-snomedct-uv-ips | Severity Value Set Mappings - SNOMED CT to FHIR |
| http://fhir.ch/ig/ch-epr-term/ConceptMap/DocumentEntryClassCodeToDocumentEntryTypeCode | DocumentEntryClassCodeToDocumentEntryTypeCode |
| http://fhir.ch/ig/ch-epr-term/ConceptMap/HCProfessionalHCProfessionSpecialisationMap | HCProfessionalHCProfessionSpecialisationMap |
| http://fhir.nottinghamshire.gov.uk/conceptmap/rockwood-clinical-frailty-scale | Concept Map Rockwood Clinical Frailty Scale |
| http://nictiz.nl/fhir/ConceptMap/MateVanKritiekZijnCodelijst-to-allergy-intolerance-criticality | HCIM MateVanKritiekZijnCodelijst to allergy-intolerance-criticality |
| http://nictiz.nl/fhir/ConceptMap/ProbleemStatusCodelijst-to-Condition-Clinical-Status-Codes | HCIM ProbleemStatusCodelijst to Condition Clinical Status Codes |
| http://nictiz.nl/fhir/ConceptMap/WaarschijnlijkheidCodelijst-to-reaction-event-certainty | HCIM WaarschijnlijkheidCodelijst to reaction-event-certainty |
| http://nictiz.nl/fhir/ConceptMap/AllergieCategorieCodelijst-to-allergy-intolerance-category | HCIM AllergieCategorieCodelijst to allergy intolerance category |
| http://nictiz.nl/fhir/ConceptMap/Condition-Clinical-Status-Codes-to-ProbleemStatusCodelijst | HCIM ProbleemStatusCodelijst to Condition Clinical Status Codes |
| http://nictiz.nl/fhir/ConceptMap/InterpretatieVlaggenCodelijst-to-observation-interpretation | HCIM InterpretatieVlaggenCodelijst to Observation Interpretation Codes |
| http://nictiz.nl/fhir/ConceptMap/OrderStatusCodelijst-to-RequestStatus | HCIM OrderStatusCodelijst to RequestStatus |
| http://nictiz.nl/fhir/ConceptMap/PositieCodelijst-to-LOINC | HCIM PositieCodelijst to LOINC |
| http://nictiz.nl/fhir/ConceptMap/WeekdagCodelijst-to-days-of-week | HCIM WeekdagCodelijst-to-days-of-week |
| https://mednet.swiss/fhir/ConceptMap/mni-obs-bloodGroup-toSnomed | MedNet Interface (MNI) - Blood Group Observation SNOMED Mapping |
| http://nictiz.nl/fhir/ConceptMap/CategorieCodelijst-to-AllergyIntoleranceCategory | CategorieCodelijst to AllergyIntoleranceCategory |
| http://nictiz.nl/fhir/ConceptMap/VerwachtRisicoBijBlootstelling-to-AllergyIntoleranceCriticality | VerwachtRisicoBijBlootstelling to AllergyIntoleranceCriticality |
| http://portal.esysta.com/fhir/ConceptMap/EvaluationItem | Mapping of EvaluationItem to SNOMED CT |
| http://portal.esysta.com/fhir/ConceptMap/EvaluationItemToSnomedCM | Mapping of EvaluationItemCS to SNOMED CT |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_TELE_Clinical_Course_German | KBV_CM_MIO_TELE_Clinical_Course_German |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_TELE_Procedure_And_Recommendations_German | Weiteres Procedere und Empfehlung |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_TELE_Procedure_Category_Codes_SNOMEDCT_German | KBV_CM_MIO_TELE_Procedure_Category_Codes_SNOMEDCT_German |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_TELE_Procedure_Follow_Up_Codes_SNOMEDCT_German | KBV_CM_MIO_TELE_Procedure_Follow_Up_Codes_SNOMEDCT_German |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_TELE_Results_Type_German | KBV_CM_MIO_TELE_Results_Type_German |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_TELE_SNOMED_CT_Drug_Therapy_Status_Codes_German | KBV_CM_MIO_TELE_SNOMED_CT_Drug_Therapy_Status_Codes_German |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_TELE_Type_Of_Medical_History_German | KBV_CM_MIO_TELE_Type_Of_Medical_History_German |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_KHE_Overview | KBV_CM_MIO_KHE_Overview |
| https://fhir.kbv.de/ConceptMap/KBV_CM_MIO_DIGA_Overview | KBV_CM_MIO_DIGA_Overview |
| https://gematik.de/fhir/terminology/ConceptMap/epa-overview-cm | EPAOverviewCM |
| http://nrces.in/ndhm/fhir/r4/StructureDefinition/MedicationRequest | MedicationRequest |
| https://fhir.hl7.org.uk/STU3/StructureDefinition/CareConnect-ACVPU-Observation-1 | CareConnect-ACVPU-Observation-1 |
| https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-ITK-DM-ApplianceUseReview-Composition-1 | CareConnect-ITK-DM-ApplianceUseReview-Composition-1 |
| https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-ITK-DM-DMIRS-Composition-1 | CareConnect-ITK-DM-DMIRS-Composition-1 |
| https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-ITK-DM-EmergencySupply-Composition-1 | CareConnect-ITK-DM-EmergencySupply-Composition-1 |
| https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-ITK-DM-Immunization-Composition-1 | CareConnect-ITK-DM-Immunization-Composition-1 |
| https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-ITK-DM-MedicationReview-Composition-1 | CareConnect-ITK-DM-MedicationReview-Composition-1 |
| https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-ITK-DM-NewMedicineService-Composition-1 | CareConnect-ITK-DM-NewMedicineService-Composition-1 |
| https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-ITK-ECD-Composition-1 | Electronic Discharge Composition |
| https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-ITK-EDIS-Composition-1 | Electronic Discharge Composition |
| https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-ITK-MH-Composition-1 | Mental Health Electronic Discharge Composition |
| https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-ITK-OPL-Composition-1 | Outpatient Letter Composition |
| https://fhir.nhs.uk/STU3/StructureDefinition/CareConnect-NEWS2-Observation-1 | CareConnect-NEWS2-Observation-1 |
| https://fhir.nhs.uk/STU3/StructureDefinition/NDOP-Consent-1 | NDOP-Consent-1.xml |
| https://fhir.nhs.uk/STU3/StructureDefinition/eRS-ServiceSearchCriteria-Parameters-1 | eRS-ServiceSearchCriteria-Parameters-1 |
| http://hl7.org/fhir/StructureDefinition/patient-adoptionInfo | Patient Adoption Info |
| https://nrces.in/ndhm/fhir/r4/StructureDefinition/MedicationRequest | MedicationRequest |
| http://capable-project.eu/data/fhir/StructureDefinition/MedicationRequest_Profile | MedicationRequest_Profile |
| https://hl7chile.cl/fhir/ig/gravitycl/ValueSet/SDOHCC-ValueSetLOINCSNOMEDCT-CL | ValueSet SDOHCC LOINC-SNOMEDCT |
| https://fhir-ig.digital.health.nz/screening/ValueSet/nz-screening-programmetype-code | Codes for categorization of NZ types of screening programme |
| https://ranzcr.com/fhir/ValueSet/radiology-referral | RANZCR Radiology Referral |
| http://terminology.ehdsi.eu/ValueSet/eHDSIAdverseEventType | eHDSI Adverse Event Type |
| http://terminology.ehdsi.eu/ValueSet/eHDSIAllergenNoDrug | eHDSI Allergen No Drug |
| http://terminology.ehdsi.eu/ValueSet/eHDSIAnimalSpecies | eHDSI Animal Species |
| http://terminology.ehdsi.eu/ValueSet/eHDSIBloodGroup | eHDSI Blood Group |
| http://terminology.ehdsi.eu/ValueSet/eHDSIBodySite | eHDSI Body Site |
| http://terminology.ehdsi.eu/ValueSet/eHDSIBodySiteLaterality | eHDSI Body Site Laterality |
| http://terminology.ehdsi.eu/ValueSet/eHDSIBodyStructureLocation | eHDSI Body Structure Location Qualifier |
| http://terminology.ehdsi.eu/ValueSet/eHDSICodeProb | eHDSI Code Prob |
| http://terminology.ehdsi.eu/ValueSet/eHDSICurrentPregnancyStatus | eHDSI Current Pregnancy Status |
| http://terminology.ehdsi.eu/ValueSet/eHDSILabSpecimenType | eHDSI Laboratory Specimen Type |
| http://terminology.ehdsi.eu/ValueSet/eHDSILabTechnique | eHDSI Laboratory Technique |
| http://terminology.ehdsi.eu/ValueSet/eHDSIMedicalDevice | eHDSI Medical Device |
| http://terminology.ehdsi.eu/ValueSet/eHDSIMicroorganism | eHDSI Microorganism |
| http://terminology.ehdsi.eu/ValueSet/eHDSIMorphologicAbnormality | eHDSI Morphologic Abnormality |
| http://terminology.ehdsi.eu/ValueSet/eHDSIOutcomeOfPregnancy | eHDSI Outcome of Pregnancy |
| http://terminology.ehdsi.eu/ValueSet/eHDSIPresenceAbsence | eHDSI Presence Absence |
| http://terminology.ehdsi.eu/ValueSet/eHDSIProcedure | eHDSI Procedure |
| http://terminology.ehdsi.eu/ValueSet/eHDSIReactionAllergy | eHDSI Reaction Allergy |
| http://terminology.ehdsi.eu/ValueSet/eHDSIResolutionOutcome | eHDSI Resolution Outcome |
| http://terminology.ehdsi.eu/ValueSet/eHDSISeverity | eHDSI Severity |
| http://terminology.ehdsi.eu/ValueSet/eHDSISocialHistory | eHDSI Social History |
| http://terminology.ehdsi.eu/ValueSet/eHDSIStatusCode | eHDSI Status Code |
| http://terminology.ehdsi.eu/ValueSet/eHDSIVaccine | eHDSI Vaccine |
| http://hl7.org/fhir/us/pco/ValueSet/goal-barrier-codes | Goal Barrier Assessment Codes |
| http://hl7.org/fhir/us/pco/ValueSet/pco-goal-barrier-types-example-vs | Goal Barrier Types Example |
| http://hl7.org/fhir/us/pco/ValueSet/what-matters-codes-example | What Matters Codes Example |
| http://hl7.org/fhir/uv/lab-report/ValueSet/laterality-uv-lab | Body Structure Laterality |
| http://hl7.org/fhir/uv/lab-report/ValueSet/siteQualifier-uv-lab | Body Structure Qualifier |
| http://hl7.org/fhir/uv/lab-report/ValueSet/specialty-uv-lab | Laboratory Specialty |
| http://hl7.org/fhir/uv/lab-report/ValueSet/speciesType-uv-lab | Types of species |
| http://hl7.org/fhir/uv/lab-report/ValueSet/specimenAdditive-uv-lab | Specimen Additive |
| http://hl7.org/fhir/uv/lab-report/ValueSet/specimenContainer-uv-lab | Specimen Container |
| http://hl7.org/fhir/uv/lab-report/ValueSet/specimenType-uv-lab | Specimen Types |
| http://hl7.org/fhir/uv/lab-report/ValueSet/technique-uv-lab | Laboratory Techniques |
| http://hl7.org/cda/us/eyecare/ValueSet/AidToVisionCodes | Aid to Vision Codes |
| http://hl7.org/cda/us/eyecare/ValueSet/DiagnosticAssessmentEyeTestCodes | Diagnostic Assessment Eye Test Value Set |
| http://hl7.org/cda/us/eyecare/ValueSet/EyecareTargetSiteCodes | Eyecare Target Site Codes |
| http://hl7.org/cda/us/eyecare/ValueSet/PosteriorSegmentObservationCodes | Posterior Segment Observation Codes |
| http://hl7.org/cda/us/eyecare/ValueSet/PosteriorSegmentOrganizerCodes | Posterior Segment Organizer Codes |
| http://hl7.org/cda/us/eyecare/ValueSet/RefractionMethodCodes | Refraction Method Codes |
| http://hl7.org/cda/us/eyecare/ValueSet/RefractionObservationCodes | Refraction Observation Codes |
| http://hl7.org/cda/us/eyecare/ValueSet/VisualAcuityMethodCodes | Visual Acuity Method Codes |
| http://hl7.org/cda/us/eyecare/ValueSet/VisualAcuityObservationCodes | Visual Acuity Observation Codes |
| http://hl7.org/cda/us/eyecare/ValueSet/VisualAcuityOrganizerCodes | Visual Acuity Organizer Codes |
| https://www.ehealth.fgov.be/standards/fhir/core-clinical/ValueSet/be-vs-bodysite | Body Site |
| https://www.ehealth.fgov.be/standards/fhir/core-clinical/ValueSet/be-vs-laterality | Laterality |
| https://www.ehealth.fgov.be/standards/fhir/core-clinical/ValueSet/be-vs-reaction-manifestation-code | Reaction Manifestation Code |
| https://www.ehealth.fgov.be/standards/fhir/core-clinical/ValueSet/be-vs-score | Score Value Set |
| https://fhir.infoway-inforoute.ca/ValueSet/encountertype | Encounter Type |
| https://fhir.infoway-inforoute.ca/ValueSet/ethnicitycode | EthnicityCode |
| https://diab.iv.elga.gv.at/ValueSet/diagnose | Diagnose |
| https://diab.iv.elga.gv.at/ValueSet/fussdiagnose | Fußdiagnose |
| https://diab.iv.elga.gv.at/ValueSet/komplikationsdiagnose | Komplikationsdiagnose |
| https://diab.iv.elga.gv.at/ValueSet/nebendiagnose | Nebendiagnose |
| http://hl7.org/fhir/uv/ae-research-backport-ig/ValueSet/adverse-event-contributing-factor-vs | AdverseEvent Contributing Factor |
| http://hl7.org/fhir/uv/ae-research-backport-ig/ValueSet/adverse-event-mitigating-action-vs | AdverseEvent Mitigating Action |
| http://hl7.org/fhir/uv/ae-research-backport-ig/ValueSet/adverse-event-supporting-info | AdverseEvent Supporting Information |
| http://hl7.org/fhir/uv/ae-research-backport-ig/ValueSet/adverse-event-type-vs | AdverseEvent Type |
| http://hl7.org/fhir/uv/shc-vaccination/ValueSet/lab-result-findings | Lab result findings (SNOMED CT) |
| http://hl7.org/fhir/uv/shc-vaccination/ValueSet/specimen-collection-supervision-status | Specimen Collection Supervision Status |
| https://www.ehealth.fgov.be/standards/fhir/mycarenet/ValueSet/be-vs-basic-laterality | Basic Laterality |
| https://www.ehealth.fgov.be/standards/fhir/mycarenet/ValueSet/be-vs-toothnumber-bodysite | Tooth Number Body Site |
| https://profiles.ihe.net/ITI/Scheduling/ValueSet/sct-services | IHE ITI Scheduling Snomed CT Services |
| https://profiles.ihe.net/ITI/Scheduling/ValueSet/specialty | IHE ITI Scheduling Specialties |
| http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-certifier-types-vs | Certifier Types Value Set |
| http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-contributory-tobacco-use-vs | Contributory Tobacco Use ValueSet |
| http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-death-certification-event-max-vs | Event Code for Death Certificate Composition - Max |
| http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-death-certification-event-vs | Event Code for Death Certificate Composition |
| http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-manner-of-death-vs | Manner of Death ValueSet |
| http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-method-of-disposition-vs | Method of Disposition ValueSet |
| http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-place-of-death-vs | Place of Death ValueSet |
| http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-transportation-incident-role-vs | Transportation Incident Role ValueSet |
| https://hl7chile.cl/fhir/ig/clcore/ValueSet/VSDiagnosticosSCT | Diagnósticos SNOMED y Ausente o Desconocido |
| http://fhir.ch/ig/ch-orf/ValueSet/ch-orf-vs-consentstatus | Consent Status |
| http://fhir.ch/ig/ch-orf/ValueSet/ch-orf-vs-legalrelation | Legal Relation |
| http://fhir.ch/ig/ch-orf/ValueSet/ch-orf-vs-personalrelation | Personal Relation |
| http://ns.electronichealth.net.au/fhir/ValueSet/apgarscoretypesnomedct-1 | Apgar Score Type SNOMED CT |
| http://ns.electronichealth.net.au/fhir/ValueSet/birthcomplication-1 | Birth Complication |
| http://ns.electronichealth.net.au/fhir/ValueSet/birthmethod-1 | Birth Method |
| http://ns.electronichealth.net.au/fhir/ValueSet/birthpresentation-1 | Birth Presentation |
| http://ns.electronichealth.net.au/fhir/ValueSet/congenitalabnormality-1 | Congenital Abnormality |
| http://ns.electronichealth.net.au/fhir/ValueSet/emergency-contact-type-1 | Emergency Contact Type |
| http://ns.electronichealth.net.au/fhir/ValueSet/labourinductionmethod-1 | Labour Induction Method |
| http://ns.electronichealth.net.au/fhir/ValueSet/labouronsettype-1 | Labour Onset Type |
| https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-allergic-disposition-sct | Allergic Disposition SCT |
| https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-assessment-scales | Assessment Scales |
| https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-assessment | Assessment |
| https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-body-positioning-snomed | Body Positioning SNOMED CT |
| https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-drugs | Drugs |
| https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-observations | Observations |
| https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-procedures | Procedures |
| https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-radiologic-finding-sct | Radiologic Finding SCT |
| https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-substances-snomed | Substances SNOMED CT |
| http://fhir.ch/ig/ch-term/ValueSet/ActivePharmaceuticalIngredient | ActivePharmaceuticalIngredient |
| http://fhir.ch/ig/ch-allergyintolerance/ValueSet/CHAllergyIntoleranceConditionValueSet | CH AllergyIntolerance Condition |
| http://fhir.ch/ig/ch-allergyintolerance/ValueSet/CHAllergyIntoleranceReactionManifestationValueSet | CH AllergyIntolerance Reaction Manifestation |
| http://fhir.ch/ig/ch-allergyintolerance/ValueSet/CHAllergyIntoleranceReactionSubstanceValueSet | CH AllergyIntolerance Reaction Substance |
| http://fhir.ch/ig/ch-allergyintolerance/ValueSet/CHAllergyIntoleranceValueSet | CH AllergyIntolerance |
| http://fhir.ch/ig/ch-term/ValueSet/DocumentEntry.classCode | DocumentEntry.classCode |
| http://fhir.ch/ig/ch-term/ValueSet/DocumentEntry.confidentialityCode | DocumentEntry.confidentialityCode |
| http://fhir.ch/ig/ch-term/ValueSet/DocumentEntry.healthcareFacilityTypeCode | DocumentEntry.healthcareFacilityTypeCode |
| http://fhir.ch/ig/ch-term/ValueSet/DocumentEntry.practiceSettingCode | DocumentEntry.practiceSettingCode |
| http://fhir.ch/ig/ch-term/ValueSet/DocumentEntry.typeCode | DocumentEntry.typeCode |
| http://fhir.ch/ig/ch-term/ValueSet/HCProfessional.hcProfession | HCProfessional.hcProfession |
| http://fhir.ch/ig/ch-term/ValueSet/SubmissionSet.contentTypeCode | SubmissionSet.contentTypeCode |
| http://fhir.ch/ig/ch-term/ValueSet/UnitCode | UnitCode |
| http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-ch-vaccination-plan-immunizations-vs | CH VACD Swiss Vaccination Plan Immunizations |
| http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-recommendation-categories-vs | CH VACD Recommendation Categories for Immunizations |
| http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-targetdiseasesandillnessesundergoneforimmunization-vs | CH VACD Target disease and illnesses undergone for immunization |
| http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-vaccines-snomedct-vs | CH VACD Snomed CT for vaccine code |
| http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-vaccines-vs | CH VACD Swissmedic code for vaccine code |
| http://fhir.ch/ig/ch-term/ValueSet/treatmentreason | Treatment Reason |
| http://hl7.org/fhir/uv/cqm/ValueSet/chronic-liver-disease-legacy-example | Chronic Liver Disease Legacy Example |
| http://fhir.ch/ig/ch-lab-order/ValueSet/MicrobiolProcedures | Microbiological Procedure |
| http://fhir.ch/ig/ch-lab-order/ValueSet/clinical-focus-vitamin-d | Vitamin D all possible clinical contexts for test |
| http://fhir.ch/ig/ch-lab-order/ValueSet/normal-contexts-vitamin-d | Contexts for reimbursement of the vitamin D test |
| http://fhir.ch/ig/ch-lab-order/ValueSet/reasons-for-order | All Valid Reasons for Ordering a Lab Service |
| http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-immunization-allergyintolerances-vs | Allergies and Intolerance values for Immunization |
| http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-risks-medical-vs | Swiss Medical Risks For Immunizations |
| http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-risks-occupation-vs | Swiss Occupation Risks For Immunizations |
| http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-risks-preillness-vs | Swiss Preillness Risks For Immunizations |
| http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-risks-social-vs | Swiss Social Risks For Immunizations |
| http://hl7.org/fhir/us/vr-common-library/ValueSet/ValueSet-birth-attendant-titles-vr | Value Set - Birth Attendants Titles Vital Records |
| http://hl7.org/fhir/uv/livd/ValueSet/resultvalue-mappings-livd | Result value mappings value set for LIVD |
| http://hl7.eu/fhir/base/ValueSet/siteLaterality-eu | Body Structure Laterality |
| http://hl7.eu/fhir/base/ValueSet/siteQualifier-eu | Body Structure Qualifier |
| http://bloodpressure.oemig.de/fhir/ValueSet/BodyPosition | Body Position |
| http://bloodpressure.oemig.de/fhir/ValueSet/MeasurementSetting | Measurement Setting value set |
| https://fhir.virtually.healthcare/ValueSet/SmokingStatus | Smoking Status |
| https://fhir.virtually.healthcare/ValueSet/VHConditionCode | VH Condition Code |
| https://fhir.virtually.healthcare/ValueSet/VHImmunisationCode | VH Immunisation Code |
| https://fhir.virtually.healthcare/ValueSet/VHMedicationCode | VH Medication Code |
https://fhir.virtually.healthcare/ValueSet/VHObservationCode  http://ehealth.sundhed.dk/vs/media-codes | Media Codes |
| http://ehealth.sundhed.dk/vs/questionnaire-types | Questionnaire Types |
| http://ehealth.sundhed.dk/vs/sor-organization-type | SorOrganizationType |
| http://ehealth.sundhed.dk/vs/sor-organization-specialty | SorOrganizationSpecialty |
| https://www.hl7.it/fhir/terminology/ValueSet/additivo-campione-it | Additivo Campione |
| https://www.hl7.it/fhir/terminology/ValueSet/campione-container-lab-it | Container Campione |
| https://www.hl7.it/fhir/terminology/ValueSet/results-microorganism-snomed-ct-ips-free-set | Risultato osservazione codificato - microorganismo IPS di SNOMED CT |
| https://www.hl7.it/fhir/terminology/ValueSet/results-observation-bloodgroup | Risultato osservazione codificato - Gruppo Sanguigno IPS di SNOMED CT |
| https://www.hl7.it/fhir/terminology/ValueSet/results-presence-absence-snomed-ct-ips-free-set | Risultato osservazione codificato - presenza/assenza IPS di SNOMED CT |
| https://www.hl7.it/fhir/terminology/ValueSet/tipo-campione-lab-it | Tipo campione |
| https://www.hl7.it/fhir/terminology/ValueSet/valueset-observation-value-bloodgroup | Risultato osservazione codificato gruppo sanguigno |
| https://www.hl7.it/fhir/terminology/ValueSet/valueset-observation-value-microorganism | Risultato osservazione codificato microorganismi |
| https://www.hl7.it/fhir/terminology/ValueSet/valueset-observation-value-presence-absence | Risultato osservazione codificato presenza/assenza |
| http://canshare.co.nz/fhir/ValueSet/an-dose-adjustment-reason-vs | Dose adjustment reason |
| http://canshare.co.nz/fhir/ValueSet/an-dx-basis-vs | Basis of diagnosis |
| http://canshare.co.nz/fhir/ValueSet/an-ecog-status-vs | ECOG status |
| http://canshare.co.nz/fhir/ValueSet/an-er-status-vs | ER status |
| http://canshare.co.nz/fhir/ValueSet/an-regimen-discontinued-patient-factors-vs | Patient factors when discontinuing a regimen |
| http://canshare.co.nz/fhir/ValueSet/an-regimen-discontinued-toxicity-vs | Toxicity reasons why a regimen was discontinued |
| http://canshare.co.nz/fhir/ValueSet/an-regimen-iot-vs | Intent of treatment |
| http://canshare.co.nz/fhir/ValueSet/an-her2-status-vs | HER2 status |
| http://canshare.co.nz/fhir/ValueSet/an-pr-status-vs | ER status |
| http://canshare.co.nz/fhir/ValueSet/an-recurrence-type-vs | Type of recurrence |
| http://fhir.ch/ig/ch-emed-epr/ValueSet/ch-emed-epr-amount-quantity-unit-code | Amount Quantity Unit Codes |
| http://terminology.hl7.org/ValueSet/device-kind | FHIR Device Types |
| http://terminology.hl7.org/ValueSet/edible-substance-type | Types of Edible Substances |
| http://terminology.hl7.org/ValueSet/gender-identity | Gender Identity |
| http://terminology.hl7.org/ValueSet/snomed-intl-gps | SNOMED International Global Patient Set (GPS) |
| http://terminology.hl7.org/ValueSet/v3-AllergyStatus | Allergy Status |
| http://terminology.hl7.org/ValueSet/v3-KnowledgeSubjectObservationValue | KnowledgeSubjectObservationValue |
| http://terminology.hl7.org/ValueSet/v3-KnowledgeSubtopicObservationValue | KnowledgeSubtopicObservationValue |
| http://terminology.hl7.org/ValueSet/v3-ObservationMeasureCountableItems | ObservationMeasureCountableItems |
| http://terminology.hl7.org/ValueSet/v3-immunizationForecastStatusObservationValue | immunizationForecastStatusObservationValue |
| http://hl7.org/fhir/us/davinci-ra/ValueSet/confidence-scale | Confidence Scale Value Set |
| https://hi.iv.elga.gv.at/ValueSet/acetherapy | ACE Therapie |
| https://hi.iv.elga.gv.at/ValueSet/austritt | Austritt |
| https://hi.iv.elga.gv.at/ValueSet/comorbidities | Komorbiditäten |
| https://hi.iv.elga.gv.at/ValueSet/diagnosis | Diagnose |
| https://hi.iv.elga.gv.at/ValueSet/education | Schulung und Beratung |
| https://hi.iv.elga.gv.at/ValueSet/facilitytype | Einrichtungsart |
| https://hi.iv.elga.gv.at/ValueSet/ressourcen | Ressourcen |
| https://hi.iv.elga.gv.at/ValueSet/schulung | Schulung |
| https://hi.iv.elga.gv.at/ValueSet/symptoms | Symptomatik |
| https://hi.iv.elga.gv.at/ValueSet/targetdose | Zieldosis |
| https://hi.iv.elga.gv.at/ValueSet/therapie | Therapie |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/AxillaSurgeryVS | Axilla surgery ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ChemoTherapyTypeVS | Type of chemotherapy ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ComplicationImpactVS | Impact of complication ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ComplicationTypeVS | Type of complication ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/EducationLevelVS | Education level of patient ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/EstrogenStatusVS | Estrogen receptor status ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/GermlineMutationVS | Germline Mutation ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/GradingVS | Grading of tumor ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/HER2ReceptorStatusVS | HER2 receptor status ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/HistologicalTypeVS | Histological type of the tumor ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/HormonalTherapyTypeVS | Type of hormonal therapy ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/InvolvedMarginsReoperationTypeVS | Re-operation due to involved margins ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/LateralityNewCancerVS | Laterality of new cancer ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/LateralityVS | Laterality of breast cancer ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/LocationRadiotherapyVS | The location of radiotherapy ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/MenopausalStatusVS | Menopausal status of patient ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/PatientTreatPrefVS | Patient treatment preference ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ProgesteroneStatusVS | Progesterone receptor status ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/RecommendedTreatmentTypeVS | Recommended treatment types ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/RecurrenceMethodVS | Recurrence method ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ReoperationReasonVS | Reasoncode of the re-operation |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ReoperationTypeVS | Type of re-operation |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/SACQPatientComorbidityHistory | SACQ Patient's comorbidity history ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TNMDistantMetastasesVS | TNM Distant Metastases ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TNMPrimaryTumorVS | TNM Primary Tumor ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TNMRegionalNodesVS | TNM Regional Nodes ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TargetedAxillaSurgeryVS | Targeted axilla surgery ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TargetedTherapyVS | Type of targeted therapy ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TherapyIntentVS | Intent of therapy ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TreatmentTypeVS | Type of treatments ValueSet |
| http://hl7.org/fhir/us/dental-data-exchange/ValueSet/dental-observation-codes | Dental Observation Codes |
| http://hl7.org/fhir/us/dental-data-exchange/ValueSet/dental-reason-for-referral | DentalReasonForReferral |
| http://hl7.org/fhir/us/dental-data-exchange/ValueSet/oral-cavity-area | Oral Cavity Area |
| http://hl7.org/fhir/us/dental-data-exchange/ValueSet/tooth-identification-valueset | Tooth Identification ValueSet |
| http://healthintersections.com.au/fhir/playground/ValueSet/organ-inventory-list | Organ List (Snomed GPS) |
| http://medcomfhir.dk/ig/terminology/ValueSet/medcom-conditionlist-status-valueset | MedComConditionListStatus |
| http://hl7.org/fhir/uv/emedicinal-product-info/ValueSet/routeOfAdministration | Route Of Administration |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Active.Advance.Directive.Finding.VS | Active Advanced Healthcare Directives Findings Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Airbag.Type.VS | Airbag Type Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Airway.Device.Confirmation.Method.VS | Airway Device Confirmation Method Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Airway.Device.Type.VS | Airway Device Type Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Barrier.To.Care.VS | Barrier To Care Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Blood.Pressure.Measurement.Method.VS | Blood Pressure Measurement Method Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Cardiac.Arrest.Etiology.VS | Cardiac Arrest Etiology Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Cardiac.Arrest.Outcome.VS | Cardiac Arrest Outcome Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Cardiac.Arrest.Witness.Role.VS | Cardiac Arrest Witness Role Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Cardiac.Rhythm.Reading.VS | Cardiac Rhythm Readings Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Cardiopulmonary.Resuscitation.Type.VS | Cardiopulmonary Resuscitation Type Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/ChiefComplaint.Anatomic.Location.VS | ChiefComplaint Anatomic Location Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/ChiefComplaint.Organ.System.VS | ChiefComplaint Organ System Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Collision.Object.VS | Collision Object Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Complication.Subset.VS | Complication Subset Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Destination.Prearrival.Activation.Type.VS | Destination Prearrival Activation Type Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Device.Type.VS | ECG Device Type Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Disaster.Type.VS | Disaster Type Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/IHE.PCC.APGAR.VS | IHE PCC mPSC APGAR Assessment Type Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/IHE.PCC.Facility.Ward.VS | IHE PCC mPSC Facility Ward Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Length.Based.Weight.Class.VS | Length Based Weight Class Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Level.Of.Responsiveness.AVPU.VS | Level Of Responsiveness AVPU Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Location.In.Vehicle.VS | Location In Vehicle Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Mechanism.Of.Injury.VS | Mechanism Of Injury Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Medication.Administration.Device.VS | Medication Administration Device Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Medication.Complication.VS | Medication Complication Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/PSC.Location.Type.VS | PSC Location Type Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Paramedicine.Emergency.Event.Sub.List.VS | Paramedicine Emergency Event Sub List Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Paramedicine.Observation.Interpretation.VS | Paramedicine Observation Interpretation Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Paramedicine.Physical.Findings.of.Nervous.System.VS | Physical Finding of Nervous System Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Paramedicine.Physical.Findings.of.Respiratory.System.VS | Physical Finding of Respiratory System Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Paramedicine.Provider.Roles.VS | Paramedicine Provider Roles Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Paramedicine.Reason.For.Visit.VS | Paramedicine Reason For Visit Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Paramedicine.Vehicle.Type.VS | Paramedicine Vehicle Type Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Pathient.Transfer.to.Ambulance.Method.VS | Pathient Transfer to Ambulance_Method Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Abdomen.TargetSite.VS | Physical Finding of Abdomen Target Site Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Abdomen.VS | Physical Finding of Abdomen Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Back.TargetSite.VS | Physical Finding of Back Target Site Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Back.VS | Physical Finding of Back Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Back.and.Spine.VS | Physical Finding of Back and Spine Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Chest.TargetSite.VS | Physical Finding of Chest Target Site Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Chest.VS | Physical Finding of Chest Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Extremities.TargetSite.VS | Physical Finding of Extremities Target Site Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Extremities.VS | Physical Finding of Extremities Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Eye.TargetSite.VS | Physical Finding of Eye Target Site Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Eye.VS | Physical Finding of Eye Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Face.VS | Physical Finding of Face Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.GenitourinaryTract.VS | Physical Finding of Genitourinary Tract Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Head.VS | Physical Finding of Head Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Heart.VS | Physical Finding of Heart Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Lung.TargetSite.VS | Physical Finding of Lung Tartget Site Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Lung.VS | Physical Finding of Lung Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Neck.VS | Physical Finding of Neck Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Pelvis.VS | Physical Finding of Pelvis Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Pelvis.and.Genitourinary.VS | Physical Finding of Pelvis and Genitourinary Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Pupil.TargetSite.VS | Physical Finding of Back and Spine Target Site Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Pupil.VS | Physical Finding of Pupil Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Skin.VS | Physical Finding of Skin Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Physical.Finding.of.Spine.TargetSite.VS | Physical Finding of Spine Spine Target Site Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Protective.Equipment.VS | Protective Equipment Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Pulse.Rhythm.VS | Pulse Rhythm Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Reason.For.Visit.VS | Reason For Visit Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Respiratory.Effort.VS | Respiratory Effort Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Response.VS | Paramedicine Treatment Response Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Safety.Equipment.VS | Safety Equipment Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Stroke.Assessment.Interpretation.VS | Stroke Assessment Interpretation Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Stroke.Scale.Type.VS | Stroke Scale Type Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Substance.Use.Evidence.VS | Substance Use Evidence Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Transport.Method.VS | Transport Method Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Vehicle.Type.VS | Vehicle Type Value Set |
| https://profiles.ihe.net/PCC/mPSC/ValueSet/Weight.Estimation.Tape.Values.VS | Physical Finding of Pelvis and Genitourinary Value Set |
| http://hl7.org/fhir/us/sdoh-clinicalcare/ValueSet/SDOHCC-ValueSetLOINCSNOMEDCT | SDOHCC ValueSet LOINC SNOMEDCT |
| http://snomed.info/fhir/ValueSet/allergyintolerance-finding-code | Allergy-Intolerance Finding Code |
| http://snomed.info/fhir/ValueSet/alleryg-intolerance-detailed-type-value-set | Allergy Intolerance Detailed Type Value Set |
| http://snomed.info/fhir/ValueSet/bmi | BMI Observable entity Code |
| http://snomed.info/fhir/ValueSet/bodyheight | Body Height Observable entity Codes |
| http://snomed.info/fhir/ValueSet/bodytemp | Core body temperature Observable entity Code |
| http://snomed.info/fhir/ValueSet/bodyweight | Body weight Observable entity Code |
| http://snomed.info/fhir/ValueSet/dia-bp | Diastolic blood pressure Observable entity Code |
| http://snomed.info/fhir/ValueSet/headcircum | Head circumference Observable entity Code |
| http://snomed.info/fhir/ValueSet/heartrate | Heart rate Observable entity Code |
| http://snomed.info/fhir/ValueSet/oxygensat | Peripehral oxygen saturation Observable entity Code |
| http://snomed.info/fhir/ValueSet/resprate | Respiratory rate Observable entity Code |
| http://snomed.info/fhir/ValueSet/specimen-collection-method | Specimen Collection Method ValueSet |
| http://snomed.info/fhir/ValueSet/specimen-processing-procedure-valueset | Specimen Processing Procedure ValueSet |
| http://snomed.info/fhir/ValueSet/specimen-type | Specimen Value Set |
| http://snomed.info/fhir/ValueSet/syst-bp | Systolic blood pressure Observable entity Code |
| http://hl7.org/fhir/uv/sdc/ValueSet/species | Questionnaire Context Species |
| http://hl7.org/fhir/uv/ips/ValueSet/allergy-intolerance-uv-ips | Allergy Intolerance - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/allergy-reaction-uv-ips | Allergy Reaction - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/body-site-uv-ips | Body Site - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/current-smoking-status-uv-ips | Current Smoking Status - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/medical-devices-uv-ips | Medical Devices - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/medication-example-uv-ips | Medications - example (IPS) |
| http://hl7.org/fhir/uv/ips/ValueSet/medication-uv-ips | Medications - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/medicine-active-substances-uv-ips | Medicine Active Substances - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/pregnancy-status-uv-ips | Pregnancy Status - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/problems-uv-ips | Problems - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/procedures-uv-ips | Procedures - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/results-coded-values-laboratory-pathology-uv-ips | Results Coded Values Laboratory/Pathology - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/results-radiology-numobs-uv-ips | Results Radiology Measurement Observation - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/results-radiology-txtobs-uv-ips | Results Radiology Textual Observation - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/results-specimen-collection-method-uv-ips | Results Specimen Collection Method - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/results-specimen-type-uv-ips | Results Specimen Type - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/target-diseases-uv-ips | Vaccine Target Diseases - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/vaccines-uv-ips | Vaccines - IPS |
| http://hl7.org/fhir/us/pacio-adi/ValueSet/ADIDocumentationTypeVS | Documentation Types |
| http://fhir.ch/ig/ch-epreg/ValueSet/ch-ig-example-sct | CH IG Example SNOMED CT |
| http://hl7.org/fhir/uv/phenomics-exchange/ValueSet/Onset | Onset ValueSet |
| http://hl7.eu/fhir/laboratory/ValueSet/lab-laterality-eu-lab | Body Structure Laterality |
| http://hl7.eu/fhir/laboratory/ValueSet/lab-siteQualifier-eu-lab | Body Structure Qualifier |
| http://hl7.eu/fhir/laboratory/ValueSet/lab-specialty-eu-lab | Laboratory Specialty |
| http://hl7.eu/fhir/laboratory/ValueSet/lab-speciesType-eu-vs | Types of species |
| http://hl7.eu/fhir/laboratory/ValueSet/lab-specimenAdditive-eu-lab | Specimen Additive |
| http://hl7.eu/fhir/laboratory/ValueSet/lab-specimenContainer-eu-lab | Specimen Container |
| http://hl7.eu/fhir/laboratory/ValueSet/lab-specimenType-eu-lab | Specimen Types |
| http://hl7.eu/fhir/laboratory/ValueSet/lab-technique-eu-lab | Laboratory Techniques |
| http://hl7.org/fhir/us/central-cancer-registry-reporting/ValueSet/cancer-core-reportability-codes | Cancer Core Reportability Codes |
| https://hl7.fr/fhir/fr/medication/ValueSet/FrMedicinalProductOnly | French Medicinal Product only |
| https://hl7.fr/fhir/fr/medication/ValueSet/FrMethodOfAdministration | French Method Of Administration |
| https://hl7.fr/fhir/fr/medication/ValueSet/fr-mp-dose-form | French Medicinal product Dose form |
| https://hl7.fr/fhir/fr/medication/ValueSet/fr-mp-substance-active | French Medicinal product Active substance |
| https://hl7.fr/fhir/fr/medication/ValueSet/fr-mp-unit-of-presentation | French Medicinal product Unit of Presentation |
| https://hl7.fr/fhir/fr/medication/ValueSet/fr-route-of-administration | French Route of Administration |
| https://hl7.fr/fhir/fr/medication/ValueSet/fr-treatment-intent | French overall intention of the treatment |
| https://fhir.hl7.at/elga-austrianpatientsummary-r4/ValueSet/at-aps-immunization-vaccine-codes | AT APS Immunitzation Vaccine Codes |
| https://fhir.hl7.at/elga-austrianpatientsummary-r4/ValueSet/at-aps-problems | AT APS Problems |
| http://hl7.org/fhir/us/davinci-crd/ValueSet/serviceRequestCodes | CRD Service Request Codes Value Set |
| http://fhir.org/guides/cdc/opioid-cds/ValueSet/conditions-documenting-sleep-disordered-breathing | Sleep disordered breathing |
| http://fhir.org/guides/cdc/opioid-cds/ValueSet/conditions-documenting-substance-misuse | Conditions documenting substance misuse |
| http://fhir.org/guides/cdc/opioid-cds/ValueSet/conditions-likely-terminal-for-opioid-prescribing | Conditions likely terminal for opioid prescribing |
| http://fhir.org/guides/cdc/opioid-cds/ValueSet/hospice-disposition | Hospice Disposition |
| http://fhir.org/guides/cdc/opioid-cds/ValueSet/hospice-finding | Hospice Finding |
| http://fhir.org/guides/cdc/opioid-cds/ValueSet/hospice-procedure | Hospice Procedure |
| http://fhir.org/guides/cdc/opioid-cds/ValueSet/limited-life-expectancy-conditions | Limited life expectancy conditions |
| http://fhir.org/guides/cdc/opioid-cds/ValueSet/office-visit | Office Visit |
| http://fhir.org/guides/cdc/opioid-cds/ValueSet/opioid-counseling-procedure | Opioid counseling procedure |
| http://fhir.org/guides/cdc/opioid-cds/ValueSet/opioid-misuse-assessment-procedure | Opioid misuse assessment procedure |
| http://fhir.org/guides/cdc/opioid-cds/ValueSet/opioid-misuse-disorders | Opioid misuse disorders |
| http://fhir.org/guides/cdc/opioid-cds/ValueSet/opioid-treatment-assessment-procedure | Opioid treatment assessment procedure |
| http://fhir.org/guides/cdc/opioid-cds/ValueSet/pain-management-procedure | Pain management procedure |
| http://fhir.org/guides/cdc/opioid-cds/ValueSet/pdmp-data-reviewed-finding | PDMP data reviewed finding |
| http://fhir.org/guides/cdc/opioid-cds/ValueSet/pdmp-review-procedure | PDMP review procedure |
| http://fhir.org/guides/cdc/opioid-cds/ValueSet/sickle-cell-diseases | Sickle-cell diseases |
| http://fhir.org/guides/cdc/opioid-cds/ValueSet/substance-misuse-behavioral-counseling | Substance misuse behavioral counseling |
| http://fhir.org/guides/cdc/opioid-cds/ValueSet/therapies-indicating-end-of-life-care | Therapies indicating end of life care |
| http://who-umc.org/idmp/ValueSet/routeOfAdministration | Route Of Administration |
| http://hl7.dk/fhir/Hackathon-Sep-2022/ValueSet/ActivityCodes | ObservationCodes |
| http://hl7.dk/fhir/Hackathon-Sep-2022/ValueSet/ObservationCodesSCT | ObservationCodesSCT |
| http://terminology.ehdsi.eu/ValueSet/eHDSIAdverseEventType | Adverse Event Type |
| http://terminology.ehdsi.eu/ValueSet/eHDSIAllergenNoDrug | Allergen No Drug |
| http://terminology.ehdsi.eu/ValueSet/eHDSIBloodGroup | Blood Group |
| http://terminology.ehdsi.eu/ValueSet/eHDSIBodySite | Body Site |
| http://terminology.ehdsi.eu/ValueSet/eHDSICodeProb | Problems |
| http://terminology.ehdsi.eu/ValueSet/eHDSICurrentPregnancyStatus | Current Pregnancy Status |
| http://terminology.ehdsi.eu/ValueSet/eHDSIProcedure | Procedure |
| http://terminology.ehdsi.eu/ValueSet/eHDSIReactionAllergy | Reaction Allergy |
| http://terminology.ehdsi.eu/ValueSet/eHDSISeverity | Severity |
| http://terminology.ehdsi.eu/ValueSet/eHDSISocialHistory | eHDSI Social History |
| http://terminology.ehdsi.eu/ValueSet/eHDSIVaccine | Vaccine |
| http://jembi.org/fhir/ValueSet/art-follow-up-status-value-set | Follow Up Status |
| http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-brachytherapy-applicator-type-vs | Brachytherapy Applicator Type Value Set |
| http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-brachytherapy-device-type-vs | Brachytherapy Device Type Value Set |
| http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-disease-progression-qualifier-vs | Disease Progression Qualifier Value Set |
| http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-image-guided-radiotherapy-modality-vs | Image Guided Radiotherapy Modality Value Set |
| http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-intrafraction-verification-procedure-vs | Intrafraction Verification Procedure Value Set |
| http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-intrafraction-verification-qualifier-vs | Intrafraction Verification Procedure Qualifier Value Set |
| http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-radiotherapy-category-vs | Radiotherapy Category Code Max Value Set |
| http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-radiotherapy-free-breathing-motion-mgmt-technique-vs | Radiotherapy Free-Breathing Motion Management Technique Value Set |
| http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-radiotherapy-isotope-vs | Radiotherapy Isotope Value Set |
| http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-radiotherapy-reason-for-revision-or-adaptation-vs | Radiotherapy Reason for Revision or Adaptation Value Set |
| http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-radiotherapy-respiratory-motion-management-vs | Radiotherapy Respiratory Motion Management Value Set |
| http://fhir.ehealth.gov.vn/core/ValueSet/snomedCT-additional-dosage-instruction | ValueSet dành cho Các chỉ dẫn dùng thuốc (bổ sung) (SNOMED CT) |
| http://fhir.ehealth.gov.vn/core/ValueSet/snomedCT-anatomical-body-structure | ValueSet dành cho Vị trí cơ thể theo giải phẫu học (SNOMED CT) |
| http://fhir.ehealth.gov.vn/core/ValueSet/snomedCT-clinical-finding | ValueSet dành cho Các thông tin thăm, khám lâm sàng (SNOMED CT) |
| http://fhir.ehealth.gov.vn/core/ValueSet/snomedCT-dosage-administration-route | ValueSet dành cho Đường dùng thuốc (SNOMED CT) |
| http://fhir.ehealth.gov.vn/core/ValueSet/vaccine-code | ValueSet dành cho Vaccine Code |
| http://fhir.ehealth.gov.vn/core/ValueSet/vn-core-condition-code | ValueSet dành cho Mã bệnh tật |
| http://fhir.ehealth.gov.vn/core/ValueSet/vn-core-observation-smokingstatus | ValueSet dành cho Tình trạng hút thuốc lá (SNOMED CT) |
| http://fhir.ehealth.gov.vn/core/ValueSet/vn-core-occupation | ValueSet dành cho Thông tin nghề nghiệp |
| http://fhir.ehealth.gov.vn/core/ValueSet/vn-medication-code | ValueSet dành cho Mã dược phẩm |
| http://fhir.ehealth.gov.vn/core/ValueSet/vn-procedure-code | ValueSet dành cho Mã dịch vụ kỹ thuật |
| http://hl7.org/fhir/us/breast-radiology/ValueSet/BreastAssessmentCategoryVS | Breast Assessment Category ValueSet |
| http://hl7.org/fhir/us/breast-radiology/ValueSet/CalcificationDistributionVS | CalcificationDistribution ValueSet |
| http://hl7.org/fhir/us/breast-radiology/ValueSet/ConsistentWithVS | ConsistentWith ValueSet |
| http://hl7.org/fhir/us/breast-radiology/ValueSet/NotPreviouslySeenVS | NotPreviouslySeen ValueSet |
| http://hl7.org/fhir/us/breast-radiology/ValueSet/PreviouslyDemonstratedByVS | PreviouslyDemonstratedBy ValueSet |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-InfectPersPrecaution | IVR Infection Transport Precaution Personnel |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-actRecovAid | IVR Recovery Aid |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-actRespiOwner | IVR Owner |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-allergy | IVR Allergy |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-ambulanceType | IVR Ambulance Type |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-bedding | IVR Transport Bedding |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-deathManner | IVR Death Manner |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-diagType | IVR Diagnosis Type |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-event | IVR Event |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-eyeForm | IVR Eye Form |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-findingsAirway | IVR Findings Airway |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-formation | IVR Formation |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-gcs-augenoeffnung | IVR GCS Eye Opening |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-gcsMotoric | IVR GCS Motoric Response |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-gcsVerbal | IVR GCS Verbal Response |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-hospitalPriority | IVR Hospital Priority |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-idSource | IVR Identification Source |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-intensity | IVR Intensity |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-laterality | IVR Laterality |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-locationType | IVR Location Type |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-offender | IVR Offender |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-personRole | IVR Person Role |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-preTreatType | IVR Pretreatment Type |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-preTreatment | IVR Pretreatment |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-pressureMethod | IVR Blood Pressure Method |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-procAirType | IVR Procedure Airway Type |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-pulesResult | IVR Pulse Result |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-pulseMethod | IVR Pulse Method |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-respirationObservation | IVR Respiration Observation |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-result | IVR Result |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-size | IVR Size |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-symptom | IVR Symptom |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-teamRole | IVR Team Role |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-transDisinfection | IVR Transport Unit Disinfection |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-urgency-adequate | IVR Urgency Adequate |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-valType | IVR Valuables Type |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-ventilation | IVR Ventilation |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-violenceForm | IVR Violence Form |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-violenceResult | IVR Violence Result |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-woundTreat | IVR Wound Treatment |
| http://fhir.ch/ig/ch-ems/ValueSet/IVR-VS-yesNoUnknown | IVR Yes/No/Unknown |
| http://hl7.eu/fhir/hdr/ValueSet/TNM-M-clinical-category-vs | Clinical M |
| http://hl7.eu/fhir/hdr/ValueSet/TNM-M-pathologycal-category-vs | Pathological M |
| http://hl7.eu/fhir/hdr/ValueSet/TNM-N-clinical-category-vs | Clinical N |
| http://hl7.eu/fhir/hdr/ValueSet/TNM-N-pathological-category-vs | Pathological N |
| http://hl7.eu/fhir/hdr/ValueSet/TNM-T-clinical-category-vs | Clinical T |
| http://hl7.eu/fhir/hdr/ValueSet/TNM-T-pathological-category-vs | Clinical T |
| http://hl7.eu/fhir/hdr/ValueSet/admission-voluntary-status-vs | Encounter Voluntary Status Value Set |
| http://hl7.eu/fhir/hdr/ValueSet/allergy-intolerance-substances-eu-hdr | Allergy Intolerance |
| http://hl7.eu/fhir/hdr/ValueSet/anthropometric-observation-vs | Anthropometric Observation Value Set |
| http://hl7.eu/fhir/hdr/ValueSet/bmi-observation-vs | BMI Observation Value Set |
| http://hl7.eu/fhir/hdr/ValueSet/body-height-observation-vs | Body Height Observation Value Set |
| http://hl7.eu/fhir/hdr/ValueSet/body-weight-observation-vs | Body Weight Observation Value Set |
| http://hl7.eu/fhir/hdr/ValueSet/cancer-stage-grading-vs | Cancer Stage Grading: Snomed CT |
| http://hl7.eu/fhir/hdr/ValueSet/cancer-stageGroup-vs | Cancer Stage Group: SNOMED CT |
| http://hl7.eu/fhir/hdr/ValueSet/circumference-observation-vs | Circumference Observation Value Set |
| http://hl7.eu/fhir/hdr/ValueSet/condition-eu-hdr | Condition Value Set |
| http://hl7.eu/fhir/hdr/ValueSet/exposureAgent-eu-hdr | Exposure of transmissible agents |
| http://hl7.eu/fhir/hdr/ValueSet/hdr-encounter-type-eu-hdr | In-patient Encounter Type Value Set |
| http://hl7.eu/fhir/hdr/ValueSet/medical-devices-eu-hdr | Medical Devices (SNOMED CT) - Xpandh |
| http://hl7.eu/fhir/hdr/ValueSet/poa-indicator-eu-hdr | Condition Present on Admission (POA) Value Set |
| http://hl7.eu/fhir/hdr/ValueSet/procedure-snomed-eu-hdr | Procedure codes: Snomed CT |
| http://hl7.eu/fhir/hdr/ValueSet/sdoh-obs-snomed-loinc-eu-hdr | SDOH Observation codes |
| http://hl7.eu/fhir/hdr/ValueSet/skinfold-thickness-vs | Skinfold Thickness Value Set |
| http://hl7.eu/fhir/hdr/ValueSet/treated-problem-eu-hdr | Treatment Class Value Set |
| http://hl7.eu/fhir/hdr/ValueSet/vital-signs-observation-vs | Vital Signs Observation Value Set |
| https://www.ehealth.fgov.be/standards/fhir/core/ValueSet/be-vs-patient-relationship-type | BeVSPatientRelationshipType |
| http://hl7.org/fhir/us/birthdefectreporting/ValueSet/bdr-procedurelist | Newborn Procedure List |
| http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.10--20240802091633 | IPS Allergy or Intolerance Conditions |
| http://hl7.org/fhir/ips/ValueSet/allergy-reaction-uv-ips | IPS Allergy Reaction |
| http://hl7.org/fhir/uv/ips/ValueSet/target-site-uv-ips | IPS Body Site |
| http://hl7.org/uv/ips/fhir/ValueSet/specimen-type | IPS Specimen Type |
| http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.57--20171212192725 | Laterality (qualifier) |
| http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.58--20171212193352 | Topographical modifier (qualifier) |
| http://hl7.org/fhir/uv/ips/ValueSet/allergy-intolerance-substance-condition-uv-ips | IPS Allergy or Intolerance Substances |
| http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.66--20240802105026 | IPS Results Radiology Textual Observations |
| http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.71--20240802094107 | IPS Medications Products |
| http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.73--20240802094107 | IPS Problems |
| http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.76--20240802105320 | IPS Results Specimen Collection Method |
| http://fhir.ch/ig/ch-lab-report/ValueSet/ch-lab-bloodgroup-antibody-vs | CH LAB-Report BloodGroup Antibody Result (SNOMED CT coded substances) |
| http://fhir.ch/ig/ch-lab-report/ValueSet/ch-lab-bloodgroup-immuno-hematology-vs | CH LAB-Report BloodGroup Immunohematology Tests (SNOMED CT coded procedures) |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/AbnormalElectrocardiacAssessment | Abnormal Electrocardiac Assessment |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/ArterialAccessSite | Arterial Access Site |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/CABG | Coronary artery bypass grafting |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/CABGType | Coronary Artery Bypass Graft Type |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/CardiacArrest | Cardiac Arrest |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/CardiacCTAResults | Cardiac CTA Results |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/CardiacCatheter | SNOMED Cardiac Catheters |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/CardiacInstabilityType | Cardiac Instability Type |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/CardiacValves | Cardiac Valves |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/CerebrovascularDisease | Cerebrovascular Disease |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/ChestPainSymptomAssessment | Chest Pain Symptom Assessment |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/ChronicLungDisease | Chronic Lung Disease |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/ConcomitantProceduresPerformedType | Concomitant Procedures Performed Type |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/DiabetesMellitus | Diabetes Mellitus |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/Dyslipidemia | Dyslipidemia |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/ElectrocardiacAbnormalityType | Electrocardiac Abnormality Type |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/ElectrocardiacAssessmentMethod | Electrocardiac Assessment Method |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/ElectrocardiacAssessmentResults | Electrocardiac Assessment Results |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/FamilyPrematureCAD | Family History of Premature CAD |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/GraftVesselCABGVessel | Graft Vessel CABG Vessel |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/HeartFailure | Heart Failure codes from SNOMED |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/HemodialysisOrPeritonealDialysis | hemodialysis or peritoneal dialysis |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/Hypertension | Hypertension |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/HypothermiaInduced | Induced Hypothermia Codes |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/InterventionTypes | Intervention Types |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/IntraAndPostEvents | Cath PCI qualified list of Events |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/LesionSegmentNumber | Lesion Segment Number |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/MyocardialInfarction | Myocardial Infarction |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/NewYorkHeartAssociation | New York Heart Association Assessment Scale |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/OrganDonor | SNOMED Valueset of Organ Donor codes |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/PCIIndications | Percutaneous Coronary Intervention Indication |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/PCIOperator | PCI Operator SNOMED codes |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/PackedRedBloodCells | Packed Red Blood Ceels |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/PercutaneousCoronaryIntervention | PCI |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/PeripheralArterialOcclusiveDisease | Peripheral Arterial Occlusive Disease |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/PriorCABG | Prior History of Coronary Artery Bypass Graft |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/PriorDiagnosticCoronaryAngiographyProcedureResults | Prior Diagnostic Coronary Angiography Procedure Results |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/PriorMyocardialInfarction | Prior Myocardial Infarction |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/SmokingStatus | Smoking Status |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/StentType | CathPCI List of Stent Types |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/TIMIFlow | TIMI Flow |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/ValvularRegurgitation | Valvular Regurgitation |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/VentricularSupport | VentricularSupport |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/VentricularSupportDeviceType | Ventricular Support Device Type |
| http://hl7.org/fhir/us/registry-protocols/ValueSet/YesNo | Yes or No |
| http://fhir.ch/ig/ch-rad-order/ValueSet/ch-rad-order-caveat-condition | Caveat Condition |
| http://fhir.ch/ig/ch-rad-order/ValueSet/ch-rad-order-caveat-device | Caveat Device |
| http://fhir.ch/ig/ch-rad-order/ValueSet/ch-rad-order-caveat-qualifier-value | Qualifier Value |
| http://fhir.ch/ig/ch-rad-order/ValueSet/ch-rad-order-caveat-type | Type of Caveat |
| http://hl7.org/fhir/us/hai/ValueSet/nhsn-pathogen-ranking | NHSNPathogenRanking |
| http://hl7.org/fhir/us/cardx-htn/ValueSet/MeasSettingVS | Measurement Setting value set |
| http://hl7.org/fhir/us/cardx-htn/ValueSet/bodyPositionVS | Body Position value set |
| http://hl7.org/fhir/us/cardx-htn/ValueSet/bpMeasMethodVS | Blood Pressure Measurement Method value set |
| http://hl7.org/fhir/us/cardx-htn/ValueSet/bpmeasbodylocationprecoord | Blood Pressure Measurement Body Location Precoordinated value set |
| http://hl7.org/fhir/us/cardx-htn/ValueSet/exertionPhaseVS | Exertion Phase value set |
| http://hl7.org/fhir/us/cardx-htn/ValueSet/heartRateMeasBodyLocationPrecoordVS | Heart Rate Measurement Body Location Precoordinated value set |
| http://hl7.org/fhir/us/cardx-htn/ValueSet/heartRateMeasDeviceVS | Heart Rate Measurement Device value set |
| http://hl7.org/fhir/us/cardx-htn/ValueSet/heartRateMeasMethodVS | Heart Rate Measurement Method value set |
| http://hl7.org/fhir/us/cardx-htn/ValueSet/sleepStatusVS | Sleep Status value set |
| https://twcore.mohw.gov.tw/ig/twcore/ValueSet/condition-code-sct-tw | SNOMED CT診斷代碼值集 |
| https://twcore.mohw.gov.tw/ig/twcore/ValueSet/health-professional-sct-tw | SNOMED CT + 臺灣醫事司醫事人員類別值集 |
| https://twcore.mohw.gov.tw/ig/twcore/ValueSet/medical-department-sct-tw | 對應至 SNOMED CT之就醫科別 + 診療科別值集 |
| https://twcore.mohw.gov.tw/ig/twcore/ValueSet/medication-path-sct-tw | SNOMED CT + 臺灣健保署給藥途徑值集 |
| https://twcore.mohw.gov.tw/ig/twcore/ValueSet/serviceRequest-category | 臺灣衛福部資訊處ServiceRequest類型值集 |
| https://twcore.mohw.gov.tw/ig/twcore/ValueSet/smoking-status-comprehensive-code | SNOMED CT 吸菸狀態綜合評估值集 |
| https://twcore.mohw.gov.tw/ig/twcore/ValueSet/smoking-status-type-code | SNOMED CT + LOINC 吸菸狀態種類向值集 |
| https://twcore.mohw.gov.tw/ig/twcore/ValueSet/snomed-pregnancy-status-code | SNOMED CT + HL7 NullFlavor妊娠狀態值集 |
| https://twcore.mohw.gov.tw/ig/twcore/ValueSet/snomed-sexual-orientation-code | SNOMED CT + HL7 NullFlavor 性傾向值集 |
| https://fhir.north-west.england.nhs.uk/ValueSet/document-entry-class | Document Entry Class |
| https://fhir.north-west.england.nhs.uk/ValueSet/document-entry-type | Document Entry Type |
| http://hl7.org/fhir/uv/radiation-dose-summary/ValueSet/component-radiation-dose-summary-vs | Radiation Dose Summary component type |
| http://hl7.org/fhir/uv/radiation-dose-summary/ValueSet/procedure-reported-type-rds-vs | Procedure Reported Type Value Set |
| http://hl7.org/fhir/us/mdi/ValueSet/vs-embalmed-example | ValueSet - Embalmed example |
| http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-apgar-timing | APGAR Score Timing |
| http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-birth-attendant-titles | Birth Attendants Titles |
| http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-birth-delivery-occurred | Birth Delivery Occurred |
| http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-delivery-routes | Delivery Routes |
| http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-fertility-enhancing-drug-therapy-artificial-insem | Fertility Enhancing Drug Therapy and Artificial Insemination Value Set |
| http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-fetal-death-cause-or-condition | Fetal Death Cause or Condition |
| http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-fetal-death-time-points | Fetal Death Time Points |
| http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-fetal-presentations-max | Fetal Presentations - Max |
| http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-fetal-presentations | Fetal Presentations |
| http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-fetal-remains-disposition-method | Fetal Remains Disposition Method |
| http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-infections-during-pregnancy-live-birth | Infections During Pregnancy Live Birth |
| http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-newborn-congenital-anomalies | Newborn Congenital Anomalies |
| http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-obstetric-procedure-outcome | Obstetric Procedure Outcome |
| http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-performed-not-performed-planned | Performed NotPerformed Planned |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/AxillaSurgeryVS | Axilla surgery ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ChemoTherapyTypeVS | Type of chemotherapy ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ComplicationImpactVS | Impact of complication ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ComplicationTypeVS | Type of complication ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/EducationLevelVS | Education level of patient ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/EstrogenStatusVS | Estrogen receptor status ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/GermlineMutationVS | Germline Mutation ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/GradingVS | Grading of tumor ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/HER2ReceptorStatusVS | HER2 receptor status ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/HistologicalTypeVS | Histological type of the tumor ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/HormonalTherapyTypeVS | Type of hormonal therapy ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/InvolvedMarginsReoperationTypeVS | Re-operation due to involved margins ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/LateralityNewCancerVS | Laterality of new cancer ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/LateralityVS | Laterality of breast cancer ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/LocationRadiotherapyVS | The location of radiotherapy ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/MenopausalStatusVS | Menopausal status of patient ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/PatientTreatPrefVS | Patient treatment preference ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ProgesteroneStatusVS | Progesterone receptor status ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/RecommendedTreatmentTypeVS | Recommended treatment types ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/RecurrenceMethodVS | Recurrence method ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ReoperationReasonVS | Reasoncode of the re-operation |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ReoperationTypeVS | Type of re-operation |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/SACQPatientComorbidityHistory | SACQ Patient's comorbidity history ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TNMDistantMetastasesVS | TNM Distant Metastases ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TNMPrimaryTumorVS | TNM Primary Tumor ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TNMRegionalNodesVS | TNM Regional Nodes ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TargetedAxillaSurgeryVS | Targeted axilla surgery ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TargetedTherapyVS | Type of targeted therapy ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TherapyIntentVS | Intent of therapy ValueSet |
| http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TreatmentTypeVS | Type of treatments ValueSet |
| http://hl7.org/fhir/us/qicore/ValueSet/qicore-medication-dose-type | QICore SNOMED CT Dosage Codes |
| http://hl7.org/fhir/us/qicore/ValueSet/qicore-observation-body-position | QICore Observation Body Position |
| https://hl7.pt/fhir/NoticiaNascimento/ValueSet/document-type-vs | Tipo de documento ValueSet |
| https://hl7.pt/fhir/NoticiaNascimento/ValueSet/newborn-congenital-anomalies-vs | Tipos de doença congénita ValueSet |
| https://hl7.pt/fhir/NoticiaNascimento/ValueSet/newbornriskassessment-vs | Tipos de risco para avaliação de recém-nascidos ValueSet |
| https://hl7.pt/fhir/NoticiaNascimento/ValueSet/puerperium-vs | Tipos de outcome de puerpério ValueSet |
| https://hl7.pt/fhir/NoticiaNascimento/ValueSet/risco-gravidez-vs | Risco de gravidez ValueSet |
| https://hl7.pt/fhir/NoticiaNascimento/ValueSet/tipo-gravidez-vs | Tipo de gravidez ValueSet |
| https://hl7.pt/fhir/NoticiaNascimento/ValueSet/tipo-parto-vs | Tipos de parto ValueSet |
| https://hl7.pt/fhir/NoticiaNascimento/ValueSet/transport-type-vs | Tipos de transporte de recém-nascido ValueSet |
| https://hl7.pt/fhir/NoticiaNascimento/ValueSet/vacinas-infancia-vs | Vacinas ValueSet |
| http://hl7.org/fhir/us/core/ValueSet/us-core-condition-code | US Core Condition Codes |
| http://hl7.org/fhir/us/core/ValueSet/us-core-goal-description | US Core Goal Codes |
| http://hl7.org/fhir/us/core/ValueSet/us-core-procedure-code | US Core Procedure Codes |
| http://hl7.org/fhir/us/core/ValueSet/us-core-servicerequest-category | US Core ServiceRequest Category Codes |
| http://hl7.org/fhir/us/mihr/ValueSet/hypertensive-disorders-pregnancy-SNOMED | ValueSet – Hypertensive Disorders of Pregnancy SNOMED CT |
| http://moh.gov.et/fhir/hiv/ValueSet/active-tb-diagnosis-value-set | Active TB Diagnosis Codes |
| http://moh.gov.et/fhir/hiv/ValueSet/arv-adherence-value-set | ARV Adherence |
| http://moh.gov.et/fhir/hiv/ValueSet/arv-side-effects-value-set | ARV Side Effects |
| http://moh.gov.et/fhir/hiv/ValueSet/arv-treatment-value-set | ARV Drugs |
| http://moh.gov.et/fhir/hiv/ValueSet/cervical-cancer-screened-value-set | Cervical Cancer Screened |
| http://moh.gov.et/fhir/hiv/ValueSet/disclosure-stage-value-set | Disclosure Stage |
| http://moh.gov.et/fhir/hiv/ValueSet/edema-presence-value-set | Edema Codes |
| http://moh.gov.et/fhir/hiv/ValueSet/encounter-location-value-set | Encounter Locations |
| http://moh.gov.et/fhir/hiv/ValueSet/encounter-type-value-set | Encounter Type |
| http://moh.gov.et/fhir/hiv/ValueSet/hiv-prevention-plan-value-set | HIV Prevention Plan |
| http://moh.gov.et/fhir/hiv/ValueSet/month-ordinals-value-set | Month Ordinal Codes |
| http://moh.gov.et/fhir/hiv/ValueSet/nutritional-status-value-set | Nutritional Status |
| http://moh.gov.et/fhir/hiv/ValueSet/oi-value-set | Opportunistic Infections |
| http://moh.gov.et/fhir/hiv/ValueSet/partner-case-closure-status-value-set | Partner Case Closure Status |
| http://moh.gov.et/fhir/hiv/ValueSet/patient-functional-status-value-set | Patient Functional Status |
| http://moh.gov.et/fhir/hiv/ValueSet/plan-for-next-step-value-set | ART Not Started - Plan For Next Step |
| http://moh.gov.et/fhir/hiv/ValueSet/presenting-symptoms-value-set | Presenting Symptoms |
| http://moh.gov.et/fhir/hiv/ValueSet/reason-for-art-eligibility-value-set | Reasons For ART Eligibility |
| http://moh.gov.et/fhir/hiv/ValueSet/reasons-for-poor-arv-adherence-value-set | Reasons For Poor ARV Adherence |
| http://moh.gov.et/fhir/hiv/ValueSet/referral-reason-value-set | Referral Reason |
| http://moh.gov.et/fhir/hiv/ValueSet/residential-type-value-set | Residential Type |
| http://moh.gov.et/fhir/hiv/ValueSet/service-provider-value-set | Service Providers |
| http://moh.gov.et/fhir/hiv/ValueSet/target-population-category-value-set | Target Population Category |
| http://moh.gov.et/fhir/hiv/ValueSet/tpt-alternate-prophylaxis-type-value-set | Alternate TPT Prophylaxis Type Codes |
| http://moh.gov.et/fhir/hiv/ValueSet/tpt-prophylaxis-value-set | TPT Prophylaxis Codes For Medication Requests |
| http://moh.gov.et/fhir/hiv/ValueSet/tpt-reason-not-eligibile-value-set | Reason Not Eligible for TPT Codes |
| http://moh.gov.et/fhir/hiv/ValueSet/treatment-outcome-value-set | Treatment Outcome Codes |
| http://moh.gov.et/fhir/hiv/ValueSet/viral-load-status-value-set | Viral Load Status |
| http://hl7.org/fhir/us/covid19library/ValueSet/close-contact-setting-vs | Close Contact Setting Value Set |
| http://hl7.org/fhir/us/covid19library/ValueSet/covid-19-disease-severity-value-set | COVID-19 Disease Severity Value Set |
| http://hl7.org/fhir/us/covid19library/ValueSet/covid-19-severity-value-set | COVID-19 Signs and Symptoms Severity Value Set |
| http://hl7.org/fhir/us/covid19library/ValueSet/covid-19-snomed-diagnosis-vs | COVID-19 SNOMED CT Diagnosis Value Set |
| http://hl7.org/fhir/us/covid19library/ValueSet/covid19-det-notdet-eq-inc-vs | Detected, Not Detected, Inconclusive Value Set |
| http://hl7.org/fhir/us/covid19library/ValueSet/covid19-det-notdet-vs | Detected, Not-detected value set |
| http://hl7.org/fhir/us/covid19library/ValueSet/covid19-pos-neg-eqvs | Positive/Negative Value Set |
| http://hl7.org/fhir/us/covid19library/ValueSet/covid19-pos-neg-ind-vs | COVID19 Positive, Negative, Indeterminate value set |
| http://hl7.org/fhir/us/covid19library/ValueSet/covid19-pos-neg-inv-incl-vs | COVID19 Positive, Negative, Invalid, Inconclusive value set |
| http://hl7.org/fhir/us/covid19library/ValueSet/covid19-pos-neg-inv-vs | COVID19 Positive Negative Invalid value set |
| http://hl7.org/fhir/us/covid19library/ValueSet/covid19-pos-neg-susp-inv-vs | COVID19 Positive Negative Suspected Invalid value set |
| http://hl7.org/fhir/us/covid19library/ValueSet/covid19-pos-neg-vs | Positive, Negative value set |
| http://hl7.org/fhir/us/covid19library/ValueSet/covid19-react-nonreact-borderline-inv-value-set | Reactive, Non-reactive, Borderline, Invalid value set |
| http://hl7.org/fhir/us/covid19library/ValueSet/covid19-react-nonreact-inv-vs | COVID19 Reactive, Non-reactive, Invalid value set |
| http://hl7.org/fhir/us/covid19library/ValueSet/covid19-react-nonreact-vs | COVID19 Reactive Non-reactive value set |
| http://hl7.org/fhir/us/covid19library/ValueSet/covid19-reporting-priority-vs | Reporting Priorities Value Set |
| http://hl7.org/fhir/us/covid19library/ValueSet/covid19-signs-1nd-symptoms-value-set | COVID-19 Signs and Symptoms Value Set |
| http://hl7.org/fhir/us/covid19library/ValueSet/covid19-underlying-cardiovascular-condition-value-set | COVID-19 cardiovascular underlying condition reference set |
| http://hl7.org/fhir/us/covid19library/ValueSet/covid19-underlying-gastrointestinal-hepatic-condition-value-set | COVID-19 gastrointestinal or hepatic underlying condition reference set |
| http://hl7.org/fhir/us/covid19library/ValueSet/covid19-underlying-immune-condition-value-set | COVID-19 immune underlying condition reference set |
| http://hl7.org/fhir/us/covid19library/ValueSet/covid19-underlying-immunocompromised-condition-value-set | COVID-19 immunocompromised underlying condition reference set |
| http://hl7.org/fhir/us/covid19library/ValueSet/covid19-underlying-medical-condition-vs | COVID-19 Underlying Medical Condition Value Set |
| http://hl7.org/fhir/us/covid19library/ValueSet/covid19-underlying-metabolic-condition-value-set | COVID-19 metabolic underlying condition reference set |
| http://hl7.org/fhir/us/covid19library/ValueSet/covid19-underlying-neurolgic-condition-value-set | COVID-19 neurologic underlying condition reference set |
| http://hl7.org/fhir/us/covid19library/ValueSet/covid19-underlying-renal-condition-value-set | COVID-19 renal underlying condition reference set |
| http://hl7.org/fhir/us/covid19library/ValueSet/covid19-underlying-respiratory-condition-value-set | COVID-19 respiratory underlying condition reference set |
| http://hl7.org/fhir/us/covid19library/ValueSet/covid19-underlying-uncategorized-condition-value-set | COVID-19 uncategorized underlying condition reference set |
| http://hl7.org/fhir/us/covid19library/ValueSet/covid91-underlying-hemoglobinopathy-condition-value-set | COVID-19 hemoglobinopathy underlying condition reference set |
| http://hl7.org/fhir/us/covid19library/ValueSet/det-notdet-equivocal-invalid-vs | Detected, Not-detected, Equivocal, Invalid value set |
| http://hl7.org/fhir/us/covid19library/ValueSet/det-notdet-inconclusive-invalid-vs | Detected, Not-detected, Inconclusive, Invalid value set |
| http://hl7.org/fhir/us/covid19library/ValueSet/detected-not-detected-value-set | Detected, Not-detected Value Set |
| http://hl7.org/fhir/us/covid19library/ValueSet/fluAB-SARSCoV2-SARSCoV-value-set | Influenza A, Influenza B, SARS CoV 2, and SARS CoV value set |
| http://hl7.org/fhir/us/covid19library/ValueSet/fluAB-SARSCoV2-value-set | Influenza A, Influenza B, and SARS CoV2 value set |
| http://hl7.org/fhir/us/covid19library/ValueSet/pregnancy-status-value-set | Pregnancy Status Value Set |
| http://hl7.org/fhir/us/covid19library/ValueSet/present-absent-unknown-vs | Present, Absent, Unknown Value Set |
| http://hl7.org/fhir/us/covid19library/ValueSet/reactive-non-reactive-value-set | Reactive - Non-reactive value set |
| http://hl7.org/fhir/us/covid19library/ValueSet/smoking-status-value-set | Smoking Status Value Set |
| http://hl7.org/fhir/us/covid19library/ValueSet/state-codes-vs | State Codes Value Set |
| http://hl7.org/fhir/us/covid19library/ValueSet/yes-no-vs | Yes/No Value Set |
| http://hl7.eu/fhir/ig/xpandh/ValueSet/eHDSIAdverseEventType | Adverse Event Type |
| http://hl7.eu/fhir/ig/xpandh/ValueSet/eHDSIAllergenNoDrug | Allergen No Drug |
| http://hl7.eu/fhir/ig/xpandh/ValueSet/eHDSIBloodGroup | Blood Group |
| http://hl7.eu/fhir/ig/xpandh/ValueSet/eHDSICodeProb | Problems |
| http://hl7.eu/fhir/ig/xpandh/ValueSet/eHDSICurrentPregnancyStatus | Current Pregnancy Status |
| http://hl7.eu/fhir/ig/xpandh/ValueSet/eHDSIProcedure | Procedure |
| http://hl7.eu/fhir/ig/xpandh/ValueSet/eHDSIReactionAllergy | Reaction Allergy |
| http://hl7.eu/fhir/ig/xpandh/ValueSet/eHDSISeverity | Severity |
| http://hl7.eu/fhir/ig/xpandh/ValueSet/eHDSISocialHistory | eHDSI Social History |
| http://hl7.eu/fhir/ig/xpandh/ValueSet/eHDSIVaccine | Vaccine |
| http://hl7.org/fhir/us/cimi-labs/ValueSet/abnml-int-numeric-nom-value-set | Abnormal Interpretation Numeric Nominal value set |
| http://hl7.org/fhir/us/cimi-labs/ValueSet/abnormal-interpretation-value-set | Abnmormal Interpretation value set |
| http://hl7.org/fhir/us/cimi-labs/ValueSet/lab-result-code-value-set | Lab Result Code value set |
| http://hl7.org/fhir/us/cimi-labs/ValueSet/null-flavor-value-set | Null Flavor value set |
| http://hl7.org/fhir/us/cimi-labs/ValueSet/ordinal-value-code-value-set | Ordinal Value Code value set |
| http://hl7.dk/fhir/core/ValueSet/dk-core-SCTBasicObservation | DK Core SNOMED CT Basic Observation |
| http://hl7.dk/fhir/core/ValueSet/dk-core-TechniquesSCTCodes | DK TechniquesSCTCodes |
| http://hl7.dk/fhir/core/ValueSet/dk-core-servicerequest-codes | DK codes for ServiceRequest |
| http://hl7.dk/fhir/core/ValueSet/sor-organization-type | DK SOR Organization Type |
| http://hl7.eu/fhir/ig/pcsp/ValueSet/grade-test-vs | Grade: follow up |
| http://hl7.eu/fhir/ig/pcsp/ValueSet/laterality-qualifier-lrub-vs | Laterality Qualifier Value Set |
| http://hl7.eu/fhir/ig/pcsp/ValueSet/mcode-body-location-qualifier-vs | Body Location Qualifier Value Set |
| http://hl7.eu/fhir/ig/pcsp/ValueSet/mcode-cancer-staging-system-vs | Cancer Staging System Value Set |
| http://hl7.eu/fhir/ig/pcsp/ValueSet/morphologicAbnormality-eu-vs | Morphologically abnormal structure |
| http://hl7.eu/fhir/ig/pcsp/ValueSet/otherInfos-condition-vs | Other Infors Condition |
| http://hl7.eu/fhir/ig/pcsp/ValueSet/relapse-type-vs | Relapse type (Local/Distant/Combined) |
| http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-Gvhd-type-eu-pcsp | Gvhd condition |
| http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-ProstheticProcedureType-eu-pcsp | Prosthetic Surgical Procedure Type |
| http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-action-eu-pcsp | Surgical Actions |
| http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-affectedOrgan-eu-pcsp | Affected Organs (surgery) |
| http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-amputationProcedureType-eu-pcsp | Amputation Surgical Procedure Type |
| http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-calcest-eu-pcsp | Calculated|Estimated |
| http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-colostomyProcedureType-eu-pcsp | Colostomy Surgical Procedure Type |
| http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-fromToPosteriorAnterior-eu-pcsp | Body Location Qualifier Value Set |
| http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-gastrostomyProcedureType-eu-pcsp | Gastrostomy Surgical Procedure Type |
| http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-hereditary-eu-pcsp | Hereditary Predispositions or Disease |
| http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-isotopes-eu-pcsp | Radiotherapy Isotopes |
| http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-radiotherapyDoseType-eu-pcsp | Radiotherapy Dose Type |
| http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-radiotherapyType-eu-pcsp | Radiotherapy Type |
| http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-sacrifiedOrgan-eu-pcsp | Sacrified Organs (surgery) |
| http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-sct-prophylaxis-cathegory-eu-pcsp | SCT Prophylaxis Cathegory |
| http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-sct-prophylaxis-type-eu-pcsp | SCT Prophylaxis Type |
| http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-sct-type-eu-pcsp | Stem Cell Transplantation type |
| https://interoperabilidad.minsal.cl/fhir/ig/rbi/ValueSet/rbi-caracteristicas-margen-quirurgico-VS | Set de Valores de Caracteristicas del Margen Quirurgico |
| https://interoperabilidad.minsal.cl/fhir/ig/rbi/ValueSet/rbi-categorias-pTNM-VS | Set de Valores para Categorias pTNM |
| https://interoperabilidad.minsal.cl/fhir/ig/rbi/ValueSet/rbi-estructuras-anatomincas-VS | Set de Valores Para los Sitios del Cuerpo |
| https://interoperabilidad.minsal.cl/fhir/ig/rbi/ValueSet/rbi-invasion-linfatica-VS | Set de Valores para Invasión Linfática y Vascular |
| https://interoperabilidad.minsal.cl/fhir/ig/rbi/ValueSet/rbi-metodos-medicion-VS | Set de Valores de los Metodos de Medición del Tumor |
| https://interoperabilidad.minsal.cl/fhir/ig/rbi/ValueSet/rbi-morfologico-VS | Set de Valores de Snomed CT para Anomalías Morfológica |
| https://interoperabilidad.minsal.cl/fhir/ig/rbi/ValueSet/rbi-observaciones-biopsia-VS | Set de Valores para Observaciones Biopsia |
| https://interoperabilidad.minsal.cl/fhir/ig/rbi/ValueSet/rbi-procedimientos-biopsias-VS | Set de Valores Para Procedimientos |
| https://interoperabilidad.minsal.cl/fhir/ig/rbi/ValueSet/rbi-reporte-biopsia-vs | Set de Valores de los Reportes de Biopsia |
| https://interoperabilidad.minsal.cl/fhir/ig/rbi/ValueSet/rbi-respuestas-infiltracion-perineural-vs | Set de Valores Para Hallazgos de Infiltración Perineural |
| https://interoperabilidad.minsal.cl/fhir/ig/rbi/ValueSet/rbi-respuestas-infiltracion-peritumoral-vs | Set de Valores Para Hallazgos de Infiltración Peritumoral |
| https://interoperabilidad.minsal.cl/fhir/ig/rbi/ValueSet/rbi-snomed-hallazgos-clinicos-VS | ValueSet de Snomed CT para Hallazgos Clínicos |
| https://interoperabilidad.minsal.cl/fhir/ig/rbi/ValueSet/rbi-tipo-procedimientos-biopsias-VS | Set de Valores Para Tipo de Procedimientos |
| https://interoperabilidad.minsal.cl/fhir/ig/rbi/ValueSet/rbi-tnm-categoria-metastasis-distante-patologico-vs | Set de Valores Categoría TNM Patológico Metastásico Distante |
| https://interoperabilidad.minsal.cl/fhir/ig/rbi/ValueSet/rbi-tnm-categoria-nodo-regional-patologico-vs | Set de Valores Categoría TNM Patológico Nodos Regional |
| https://interoperabilidad.minsal.cl/fhir/ig/rbi/ValueSet/rbi-tnm-categoria-tumor-primario-patologico-vs | Set de Valores Categoría TNM Patológico Tumor Primario |
| https://interoperabilidad.minsal.cl/fhir/ig/rbi/ValueSet/rbi-topografica-VS | Set de Valores de Snomed CT para Topografía |
| http://hl7.org/fhir/uv/termchangeset/ValueSet/case-significance-vs | Case Significance Value Set |
| http://hl7.org/fhir/uv/termchangeset/ValueSet/defining-relationship-type-vs | Defining Relationship Type Value Set |
| http://hl7.org/fhir/uv/termchangeset/ValueSet/description-acceptability-vs | Description Acceptability Value Set |
| http://hl7.org/fhir/uv/termchangeset/ValueSet/dialect-vs | Dialect Value Set |
| http://hl7.org/fhir/uv/termchangeset/ValueSet/el-profile-set-operator-vs | EL Profile Set Operator Value Set |
| http://hl7.org/fhir/ValueSet/animal-breeds | animal breeds |
| http://hl7.org/fhir/ValueSet/animal-species | animal species |
| http://hl7.org/fhir/ValueSet/barrier | Barrier |
| http://hl7.org/fhir/ValueSet/condition-cause | Condition Cause Codes |
| http://hl7.org/fhir/ValueSet/condition-course | Condition Course Codes |
| http://hl7.org/fhir/ValueSet/condition-predecessor | Condition Predecessor Codes |
| http://hl7.org/fhir/ValueSet/dataelement-sdcobjectclass | DataElement SDC Object Class |
| http://hl7.org/fhir/ValueSet/dataelement-sdcobjectclassproperty | DataElement SDC Object Class Property |
| http://hl7.org/fhir/ValueSet/feeding-device | Feeding Device Codes Value Set |
| http://hl7.org/fhir/ValueSet/focal-subject | Focal Subject Codes |
| http://hl7.org/fhir/ValueSet/protective-factor | Protective Factor |
| http://hl7.org/fhir/ValueSet/specimen-additive-substance | Specimen Additive Substance Codes |
| http://fhir.ch/ig/ch-ig/ValueSet/ch-ig-example-sct | CH IG Example SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.10 | Non essential Hypertension SNOMEDCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.124 | Alcohol Brief Intervention and Counseling |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.511 | Ambulatory Blood Pressure Monitoring (ABPM) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1104.2 | Systolic blood pressure |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.15 | Hospice care ambulatory |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.418 | Physical Activity Recommendations |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.420 | Weight Reduction Recommendations |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1195.111 | BMI Follow Up Plan SNOMEDCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.24 | Alcohol Abuse Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4012 | Hypertension |
| http://hl7.org/fhir/us/breastcancer/ValueSet/shr-core-PositiveNegativeIndeterminateVS | BC PositiveNegativeIndeterminateVS ValueSet |
| http://hl7.org/fhir/us/breastcancer/ValueSet/shr-core-PositiveNegativeVS | BC PositiveNegativeVS ValueSet |
| http://nictiz.nl/fhir/ValueSet/HCIMLegalSituationCategory | HCIM LegalSituation Category |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.14.6.4--20200901000000 | RedenVanToepassenCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.14.6.1--20200901000000 | SoortInterventieCodelijst |
| https://hl7chile.cl/fhir/ig/CoreCL/ValueSet/VSDiagnosticosSCT | Diagnósticos SNOMED y Ausente o Desconocido |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.1.2--20150401000000 | AfnameprocedureCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.8.2.2--20150401000000 | AllergieCategorieCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.9.5.5--20150401000000 | DagdeelCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.8.2.4--20150401000000 http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12209.html | EchocardiographyPulmonicValveMeasurement |
| http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12210.html | EchocardiographyPulmonaryArteryMeasurement |
| http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12211.html | EchocardiographyAorticValveMeasurement |
| http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12214.html | EchocardiographyPulmonaryVeinMeasurement |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Disability | Einschränkung Funktionen |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Disability_Degree_Presence_Status | Grad Behinderung vorhanden |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Evacuation_Bladder_Content | Art der Harnableitung |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Evacuation_Intestinal_Contents | Art der Stuhlableitung |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Food_Administration_Form | Kostdarreichungsform |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Food_Type | Kostform |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Health_Care_Proxy_Type | Art der Erklärung |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Information_Legal_Guardian | Information gesetzliche Betreuung |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Information_Medication | Information Einnahme Medikamente |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Interventions_ICNP | Pflegerische Maßnahmen ICNP |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Isolation_Necessity | Isolation Notwendig |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Isolation_Type | Isolation Art |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Living_Condition | Wohnverhältnis |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Medical_Device | Medizinprodukt |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Medical_Product_Information | Information Medizinprodukt |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Nutrition | Ernährung |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Nutritional_Information | Hinweis Ernährung |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Orientation_Person | Orientierung Person |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Orientation_Place | Orientierung Ort |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Orientation_Situation | Orientierung Situation |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Orientation_Time | Orientierung Zeit |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Pain_Symptom | Schmerzsymptomatik |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Payment_Exemption | Zuzahlungsbefreiung |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Presence_Respiratory_Support | Vorliegen Atmungsunterstützung |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Problem_Presence | Vorliegen Problem |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Relatives_Involvement | Pflege durch Angehörige |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Relatives_Notification_Status | Benachrichtigung von An- und Zugehörigen |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Respiratory_Access | Art der Luftleitung |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Result_Qualitative | Ergebnis Qualitativ |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Risk | Risiko |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Risk_Presence | Vorliegen von Risiken |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ULB_Type_Of_Facility | Typ der Einrichtung |
| http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-cypdisunitintakeresult | Cyprus EHR Value Set: CYPDIS Unit Intake Result |
| http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-ehdsiadverseeventtype | Cyprus EHR Value Set: eHDSI Adverse Event Type |
| http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-ehdsiallergennodrug | Cyprus EHR Value Set: eHDSI Allergen No Drug |
| http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-ehdsibloodgroup | Cyprus EHR Value Set: eHDSI Blood Group |
| http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-ehdsicodeprob | Cyprus EHR Value Set: eHDSI Code Prob |
| http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-ehdsimedicaldevice | Cyprus EHR Value Set: eHDSI Medical Device |
| http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-ehdsiprocedure | Cyprus EHR Value Set: eHDSI Procedure |
| http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-ehdsireactionallergy | Cyprus EHR Value Set: eHDSI Reaction Allergy |
| http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-ehdsiresolutionoutcome | Cyprus EHR Value Set: eHDSI Resolution Outcome |
| http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-ehdsiseverity | Cyprus EHR Value Set: eHDSI Severity |
| http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-ehdsisocialhistory | Cyprus EHR Value Set: eHDSI Social History |
| http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-ehdsistatuscode | Cyprus EHR Value Set: eHDSI Status Code |
| http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-ehdsivaccine | Cyprys EHR Value Set: eHDSI Vaccine |
| http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-nursingcategories | Cyprus EHR Value Set: Nursing Categories |
| http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-contactpersonlevel | Cyprus EHR Value Set: Contact Person Level |
| http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-diet | Cyprus EHR Value Set: Diet |
| http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-drugormedicationtype | Cyprus EHR Value Set: Drug Or Medication Type |
| http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-drugusestatus | Cyprus EHR Value Set: Drug Use Status |
| http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-findingrelatedtosleep | Cyprus EHR Value Set: Finding Related To Sleep |
| http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-respiratoryrhythm | Cyprus EHR Value Set: Respiratory Rhythm |
| http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-tobaccotype | Cyprus EHR Value Set: Tobacco Type |
| http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-heartrhythm | Cyprus EHR Value Set: Heart Rhythm |
| http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-alcoholstatus | Cyprus EHR Value Set: Alcohol Status |
| http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-alcoholtypes | Cyprus EHR Value Set: Alcohol Types |
| https://fhir.nhs.uk/STU3/ValueSet/CareConnect-AllergyManifestation-1 | Care Connect Allergy Manifestation |
| http://terminology.hl7.org/ValueSet/device-kind | FHIR Device Types |
| http://terminology.hl7.org/ValueSet/edible-substance-type | Types of Edible Substances |
| http://terminology.hl7.org/ValueSet/gender-identity | Gender Identity |
| http://terminology.hl7.org/ValueSet/snomed-intl-gps | SNOMED International Global Patient Set (GPS) |
| http://terminology.hl7.org/ValueSet/v3-AllergyStatus | Allergy Status |
| http://terminology.hl7.org/ValueSet/v3-KnowledgeSubjectObservationValue | KnowledgeSubjectObservationValue |
| http://terminology.hl7.org/ValueSet/v3-KnowledgeSubtopicObservationValue | KnowledgeSubtopicObservationValue |
| http://terminology.hl7.org/ValueSet/v3-ObservationMeasureCountableItems | ObservationMeasureCountableItems |
| http://terminology.hl7.org/ValueSet/v3-immunizationForecastStatusObservationValue | immunizationForecastStatusObservationValue |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.10 | Seizure or Serious Neurologic Dysfunction (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.100 | Third Degree Perineal Laceration (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.101 | Fourth Degree Perineal Laceration (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.102 | Ruptured Uterus (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.103 | Unplanned Hysterectomy (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.105 | Unplanned Operation (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.106 | Attempted Forceps Procedure (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.107 | Attempted Vacuum Procedure (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.108 | Fetal Presentation at Birth- Breech (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.109 | Fetal Presentation at Birth- Cephalic (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.11 | Newborn Given Surfactant Replacement (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.110 | Fetal Presentation at Birth- Other (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.111 | Route and Method of Delivery - Spontaneous (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.112 | Route and Method of Delivery - Forceps (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.113 | Route and Method of Delivery - Vacuum (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.114 | Route and Method of Delivery - Cesarean (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.115 | Route Method of Delivery - Trial of Labor (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.116 | Route and Method of Delivery - Scheduled C (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.119 | Problem Status Active (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.125 | Cervical Cerclage (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.127 | External Cephalic Version (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.128 | Tocolysis (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.129 | Premature Rupture (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.130 | Precipitous Labor (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.131 | Prolonged Labor (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.136 | Prepregnancy Diabetes (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.137 | Gestational Diabetes (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.138 | Prepregnancy Hypertension (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.139 | Gestational Hypertension (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.14 | Delivery (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.140 | Eclampsia (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.141 | Preterm Birth (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.142 | Poor Pregnancy Outcome History (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.143 | Infertility Treatment (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.145 | Artificial or Intrauterine Insemination (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.146 | Assistive Reproductive Technology (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.147 | Listeria (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.149 | Neonatal Death (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.15 | Physician (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.150 | Hysterotomy Hysterectomy (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.153 | Fetal Autopsy (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.154 | Karyotype Determination (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.16 | Doctor of Osteopathic Medicine (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.166 | Group B Streptococcus (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.167 | Cytomegalovirus (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.168 | Parvovirus (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.169 | Toxoplasmosis (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.176 | Transferred for Maternal Medical or Fetal Indicat |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.178 | Antibiotic Administration Procedure (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.188 | ICU Care (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.189 | Cleft Palate Alone (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.190 | Transfer to Facility (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.192 | Birth Place Hospital (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.193 | Birth Place Home Intended (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.194 | Birth Place Home Unintended (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.196 | Birth Place Freestanding Birthing Center (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.197 | Birth Place Clinic Office (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.198 | NICU Care (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.22 | Augmentation of Labor - Procedure (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.24 | Chorioamnionitis During Labor (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.25 | Fever Greater Than 100.4 (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.27 | Epidural Anesthesia - Procedure (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.29 | Spinal Anesthesia - Procedure (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.30 | Fetal Intolerance of Labor (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.31 | In-utero Resuscitation (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.32 | Further Fetal Assessment (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.33 | Operative Delivery (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.34 | Induction of Labor (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.35 | Spontaneous Onset of Labor (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.36 | Meconium Staining (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.37 | Non-vertex presentation in active phase of (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.39 | Immature Fetus (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.40 | Inflammation Indication (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.41 | Breastfed Infant (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.53 | Anencephaly of the Newborn (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.54 | Cyanotic Congenital Heart Disease (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.55 | Congenital Diaphragmatic Hernia (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.56 | Karyotype Confirmed (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.57 | Suspected Chromosomal Disorder (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.58 | Cleft Lip with or without Cleft Palate (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.6 | Neonatal Sepsis (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.60 | Cleft Lip without Cleft Palate (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.61 | Down Syndrome (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.62 | Gastroschisis of the Newborn (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.63 | Hypospadias (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.65 | Meningomyelocele/Spina Bifida - Newborn (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.66 | Omphalocele of the Newborn (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.9 | Significant Birth Injury (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.93 | Chlamydia (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.95 | Pregnant (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.96 | Hepatitis B (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.97 | Hepatitis C (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.98 | Syphilis (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.99 | Transfusion Whole Blood or Packed Red Bld (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.11 | JCIH-EHDI Hearing Loss Risk Factors |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.12 | JCIH-EHDI Hearing Loss Risk Factors - Procedures |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.14 | JCIH-EHDI Newborn Hearing Loss Diagnosis |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.15 | JCIH-EHDI Reason for no Hearing Loss Diagnosis |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.16 | JCIH-EHDI Newborn Hearing Loss Referrals |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.17 | JCIH-EHDI Newborn Hearing Procedure |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.20 | JCIH-EHDI Procedure Declined |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.7 | JCIH-EHDI Reason for no Follow-up - Patient Reason |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.1 | Autopsy Performed (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.13 | Family History (HW) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.14 | Mother Breastfeeding (HW) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.19 | Associated Conditions (HW) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.2 | Autopsy Not Performed (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.6 | Death Certification (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.7 | Interventions (HW) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.8 | Dietary Behavior (HW) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.9 | Physical Activity Behavior (HW) |
| http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.33895.1.3.0.75 | Joint Commission Medical Reason |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.11222.4.11.5025 | Original Specimen Type Modifier PHLIP |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.9 | Substance Other Than Clinical Drug (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1018.98 | Route of Administration |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.20.2 | Advance Directive Type Value Set |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.1 | Amniotic Fluid Conditions (HL7) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.10 | Type of Twin (HL7) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.11 | Twin Placenta (HL7) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.12 | Umbilical Cord Complication (HL7) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.13 | Infant Fetal Complications (HL7) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.14 | Placental Measurement (HL7) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.2 | Cord Insertion Type (HL7) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.3 | Hospital Care-Setting (HL7) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.4 | Maternal Exposures (HL7) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.5 | Intended Newborn Feeding Type (HL7) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.6 | Placenta Type (HL7) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.7 | Placental Conditions (HL7) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.34 | Patient Education |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.38 | Current Smoking Status (NAACCR) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.41 | Tobacco Use |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.49 | Residence and Accommodation Type |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.60 | Priority Level (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.13.277 | Birth Defect Diagnosis |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.22 | Laterality (NAACCR) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.26 | Radiation Rx and Boost Radiation SNOMEDCT (NAACCR) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.29 | NAACCR SNOMEDCT Cancer Reportability List |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.6.2 | Allergy/Adverse Event Type Value Set |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.6.8 | Problem Severity |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.7.2 | Problem Type Value Set |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.7.4 | Problem Value Set |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.8.19 | Medication Type Value Set |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.8.9 | Body Site Value Set |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.21 | Medication Vehicle Value Set |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.60 | Social History Type Value Set |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.68 | Problem Status |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1007 | Major Site of Disease (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1009 | Microorganism |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1010 | Microscopic Exam Culture Site (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1013 | Missing Lab Result Reason |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1014 | Modifier or Qualifier |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1018 | Non Paint Lead Source |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1019 | Non-paint lead source - hobby related |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1022 | Occupation Risk Category (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1026 | Pregnancy Trimester |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1027 | Previous Vaccine History |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1032 | Rash Distribution (VZ) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1033 | Rash Location First Noted (VZ) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1035 | Reason Therapy Stopped (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1036 | Referral Status (CRA) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1037 | Risk Category |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1051 | Substance Treatment Refusal Reason |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1052 | Transmission Setting (NND) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1056 | Vaccination Location (CRA) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1057 | Vaccine Contraindications |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1060 | Abnormal Chest X-ray Condition Status |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1067 | Body Substance |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1068 | Event |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1069 | Material |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1074 | Animal |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1075 | Physical Object |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1076 | Situation with Explicit Context |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1109 | Procedure by Site (SNOMED) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3017 | Lab Test Result (PHLIP Flu) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3024 | Blood Contact Frequency (Hepatitis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3025 | Case Confirmation Method |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3026 | Case Detection Method |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3027 | Case Transmission Mode |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3028 | Contact Type (Hepatitis A) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3029 | Contact Type (Hepatitis B and C) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3033 | Number Of Sex Partners (Hepatitis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3034 | Outbreak Type (Hepatitis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3036 | Reporting Source Type |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3037 | Tattoo Obtained From (Hepatitis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3038 | Vaccine Dose Number (Hepatitis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3044 | Microbiology strain |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3045 | Microorganism (Hepatitis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3048 | Lab Test Interpretation |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3049 | Lab Test Result Qualitative |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3058 | Cancer Type |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3059 | Clinical Syndrome (Arbovirus) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3060 | Immunosuppressed Condition |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3062 | Transplant Organ |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3063 | Virus Type (Arboviral Disease) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3066 | Bat Species (Animal Rabies) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3068 | Animal Species (Animal Rabies) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3069 | Yes No Unknown Not Done |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3071 | Pregnancy Outcome (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3072 | Animal Type (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3073 | Botulinum Toxin Type (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3075 | Cholera Risk Factor (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3076 | Cholera Sequelae (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3077 | Cholera Signs Symptoms (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3078 | Cyclosporiasis Signs Symptoms (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3079 | Day Care Type (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3080 | Eosin Units (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3081 | Fetal Neonatal Infection Type (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3082 | Fetal Neonatal Specimen Type |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3085 | Fresh Berries (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3086 | Fresh Herbs (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3087 | Fresh Produce (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3088 | Information Source |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3090 | Lettuce Type (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3091 | Maternal Infection (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3092 | Meat Purchase Info (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3094 | Other Related Cases |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3095 | Outbreak Type (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3096 | Pork Type (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3097 | Present Absent Unknown Not Examined |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3098 | Recreational Water (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3099 | Seafood Purchase Info (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3101 | Skin Exposure (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3107 | Travel Mode |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3108 | Travel Purpose |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3110 | Trichinellosis Signs Symptoms (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3111 | Typhoid Signs Symptoms (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3112 | Underlying Conditions |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3113 | Water Salinity (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3116 | Notifiable Condition (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3118 | Medication Treatment (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3119 | Acute Convalescent IgG Difference (VPD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3120 | Antibiotic Received (Pertussis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3121 | Birth Attendees (VPD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3122 | Birth Location (VPD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3123 | Birth Outcome (VPD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3124 | Body Region (Tetanus) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3126 | Genotype (Measles) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3127 | Genotype (Rubella) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3128 | Immunization Information Source (CRS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3129 | Injury Occurred Environment (VPD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3130 | Injury Type (VPD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3131 | Lab Result (Pertussis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3132 | Lab Result (Rubella) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3134 | No Case Reason (CRS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3135 | Non-Live Birth Outcome (VPD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3140 | Specimen Source (CRS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3141 | Specimen Source (VPD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3142 | Test Method EIA IgM |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3143 | Tetanus Type (VPD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3144 | Treatment Outcome Tetanus (VPD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3145 | Vaccine Doses Received (Pertussis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3146 | Vaccine Doses Received (Tetanus) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3148 | PCR Specimen Source (VZ) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3149 | Lab Test Method (VZ) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3160 | Microscopic Exam Type (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3161 | Primary Reason For Evaluation (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3162 | Risk Factors (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3163 | Immigration Status |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3164 | Sputum Culture Conversion Not Documented Reason |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3167 | Therapy Extended Reason (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3203 | Treatment status |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3204 | Non-Laboratory Intervention and Procedure |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3209 | Exposure Location |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3210 | Contact Type (Hepatitis B) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3211 | Material exposure type |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3212 | Signs and Symptoms (Anthrax) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3213 | Signs and Symptoms (Acute Hepatitis B) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3214 | Signs and Symptoms (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3215 | Signs and Symptoms (Tularemia) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3220 | Disease Type (Anthrax) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3221 | Disease Type (Acute Hepatitis B) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3222 | Disease Type (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3223 | Disease Type (Tularemia) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3225 | Blood or body fluid exposure frequency |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3226 | Blood or body fluid exposure related procedure |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3228 | Sociobehavioral risk factor |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3230 | Disease Type (Hepatitis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3231 | Disease Type (STD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3232 | HIV Status (PHCR) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3240 | Flu Signs and Symptoms |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3242 | Risk Factor (Flu) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3243 | Lab Test Finding (Flu) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3246 | Specimen (Flu) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3251 | Lab Test Procedure (Flu) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3252 | Lab Test Interpretation (Flu) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3253 | Obesity Severity (Flu) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3254 | Employment Status (Flu) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3255 | Case Contact Signs and Symptoms (Flu) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3256 | Time Frame (Daily Weekly) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3257 | Surveillance Method (Novel Flu) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3258 | Change Pattern |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3259 | Age Group (Flu) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3261 | Death Location (Flu) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3262 | Lab Test Procedure (Pediatric Flu) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3263 | Lab Test Interpretation (Pediatric Flu) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3264 | Sterile Specimen (Pediatric Flu) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3265 | Positive Negative Unknown |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3266 | Microorganism (Pediatric Flu) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3267 | Non-Sterile Specimen (Pediatric Flu) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3268 | Acute Illness Complications (Pediatric Flu) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3269 | Underlying Conditions (Pediatric Flu) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3271 | Therapy Prior Illness Onset (Pediatric Flu) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3272 | Therapy After Illness Onset (Pediatric Flu) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3275 | Relationship (Flu) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3282 | Specimen Collection Method |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3285 | Anatomical Entity (Body Site) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3288 | Vaccination Contraindication (IIS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3289 | Vaccination Reaction and Adverse Event (IIS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3293 | Evidence Of Immunity (IIS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3301 | Lab Test Interpretation (VPD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3302 | Lab Test Procedure (Measles) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3303 | Specimen Source (Measles) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3304 | Parotitis Laterality (Mumps) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3305 | Type of Deafness (Mumps) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3306 | Lab Test Procedure (Mumps) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3307 | Specimen Source (Mumps) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3308 | Complications (Malaria) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3310 | Medication Missed (Malaria) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3312 | Medication Treatment (Malaria) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3313 | Species (Malaria) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3314 | Specimen Type (Malaria) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3317 | Antimicrobial Susceptibility Test Method (IPD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3318 | Bacterial Infection Syndrome (IPD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3319 | Oxacillin Interpretation (IPD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3320 | Serotype Method (IPD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3321 | Sterile Specimen (IPD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3322 | Underlying Conditions (IPD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3336 | Susceptibility Result (IPD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3359 | Evaluation Finding |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3407 | Case Class Status (NETSS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3409 | Transmission Setting (NETSS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3410 | Vaccine Not Given Reasons (NETSS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3411 | Body Region Tetanus (NETSS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3412 | Injury Occurred Environment (NETSS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3413 | Injury Type (NETSS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3414 | Birth Attendees (NETSS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3417 | Contact Type Hepatitis A (NETSS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3418 | Sexual Preference (NETSS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3419 | Lab Test Result Lyme (NETSS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3420 | Microorganism (NETSS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3421 | Bacterial Infection Syndrome (NETSS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3422 | Associated Conditions (NETSS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3425 | Geographic Region (NETSS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3432 | Serogroup (NETSS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3435 | Serotype (NETSS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3501 | Bacterial Infectious Disease |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3502 | Infectious Disease |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3503 | Pneumonia Disease |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3587 | Flu Activity Code |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3594 | Campylobacter Organism |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4000 | Lab Result (Amebiasis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4001 | Lab Result (Anaplasma) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4002 | Lab Result (Anthrax) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4003 | Lab Result (Arbovirus) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4004 | Lab Result (Arenavirus) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4005 | Lab Result (Babesiosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4006 | Lab Result (Bartonellosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4007 | Lab Result (Blastomycosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4008 | Lab Result (Botulism) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4009 | Lab Result (Brucellosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4010 | Lab Result (California serogroup virus) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4011 | Lab Result (Campylobacteriosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4012 | Lab Result (Chagas) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4013 | Lab Result (Chancroid) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4014 | Lab Result (Chlamydia trachomatis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4015 | Lab Result (Cholera) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4016 | Lab Result (Clostridium perfringens) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4017 | Lab Result (Clostridium perfringens Epsilon Toxin) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4018 | Lab Result (Coccidioidomycosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4019 | Lab Result (Colorado Tick Fever) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4020 | Lab Result (Creutzfeldt-Jakob disease) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4021 | Lab Result (Cryptococcosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4022 | Lab Result (Cryptosporidiosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4023 | Lab Result (Cyclosporiasis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4024 | Lab Result (Cysticercosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4025 | Lab Result (Dengue) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4026 | Lab Result (Diphtheria) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4027 | Lab Result (Eastern equine encephalitis virus) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4028 | Lab Result (Ebolavirus) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4029 | Lab Result (E. coli STEC) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4030 | Lab Result (Ehrlichia chaffeensis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4031 | Lab Result (Ehrlichia ewingii) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4032 | Lab Result (Ehrlichiosis Anaplasmosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4033 | Lab Result (Genital Warts) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4034 | Lab Result (Giardiasis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4035 | Lab Result (Glanders) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4036 | Lab Result (Gonorrhea) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4037 | Lab Result (Granuloma Inguinale) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4038 | Lab Result (Haemophilus influenzae) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4039 | Lab Result (Hansen's Disease) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4040 | Lab Result (Hantavirus Pulmonary Syndrome) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4041 | Lab Result (Hendra virus) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4042 | Lab Result (Hepatitis A) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4043 | Lab Result (Hepatitis B) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4044 | Lab Result (Hepatitis C) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4045 | Lab Result (Hepatitis D) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4046 | Lab Result (Hepatitis E) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4047 | Lab Result (Herpes Simplex) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4048 | Lab Result (Histoplasmosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4049 | Lab Result (HIV) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4050 | Lab Result (Influenza A virus, H1N1 2009 strain) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4051 | Lab Result (Jamestown Canyon virus) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4052 | Lab Result (Legionellosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4053 | Lab Result (Leptospirosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4054 | Lab Result (Listeriosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4055 | Lab Result (Lyme disease) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4056 | Lab Result (Lymphogranuloma Venereum) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4057 | Lab Result (Malaria) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4058 | Lab Result (Marburgvirus) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4059 | Lab Result (Measles) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4060 | Lab Result (Melioidosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4061 | Lab Result (Meningococcal Disease) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4062 | Lab Result (Monkeypox Orthopox) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4063 | Lab Result (MRSA) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4064 | Lab Result (Mumps) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4065 | Lab Result (Nipah Virus) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4066 | Lab Result (Nongonococcal Urethritis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4067 | Lab Result (Nontuberculous Mycobacteria) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4068 | Lab Result (Norovirus) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4069 | Lab Result RCMT (Pertussis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4070 | Lab Result (Plague) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4071 | Lab Result (Polio) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4072 | Lab Result (Powassan virus) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4073 | Lab Result (Prion Disease) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4074 | Lab Result (Psittacosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4075 | Lab Result (Q Fever) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4076 | Lab Result (Rabies) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4077 | Lab Result (Relapsing Fever) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4078 | Lab Result (Respiratory Syncytial Virus) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4079 | Lab Result (Rickettsial infection, other) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4080 | Lab Result (Rift Valley Fever) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4081 | Lab Result (Rotavirus) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4082 | Lab Result RCMT (Rubella) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4083 | Lab Result (Salmonellosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4084 | Lab Result (SARS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4085 | Lab Result (Shigella) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4086 | Lab Result (Smallpox) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4087 | Lab Result (Spotted fever rickettsiosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4088 | Lab Result (Staphylococcus aureus) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4089 | Lab Result (Staphylococcus aureus enterotoxin B) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4090 | Lab Result (Staphylococcus aureus food poisoning) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4091 | Lab Result (Staphylococcal TSS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4092 | Lab Result (St. Louis encephalitis virus) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4093 | Lab Result (Streptococcus pneumoniae) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4094 | Lab Result (Streptococcal TSS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4095 | Lab Result (Streptococcus, group A) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4096 | Lab Result (Streptococcus, group B) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4097 | Lab Result (Syphilis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4098 | Lab Result (Tetanus) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4099 | Lab Result (Toxoplasmosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4100 | Lab Result (Trichinellosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4101 | Lab Result (Tuberculosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4102 | Lab Result (Tularemia) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4103 | Lab Result (Typhoid Fever) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4104 | Lab Result (Typhus group rickettsiosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4105 | Lab Result (Vaccinia) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4106 | Lab Result (Vancomycin resistant Enterococcus) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4107 | Lab Result (Varicella) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4108 | Lab Result (Vesicular Stomatitis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4109 | Lab Result (Vibriosis, non-cholera) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4110 | Lab Result (Viral Hemorrhagic Fever) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4111 | Lab Result (VISA) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4112 | Lab Result (VRSA) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4113 | Lab Result (Western equine encephalitis virus) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4114 | Lab Result (West Nile virus) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4115 | Lab Result (Yellow Fever) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4116 | Lab Result (Yersiniosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4275 | Lab Result (Cancer Morphology) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4276 | Lab Result (Pesticide) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5001 | Specimen Type PHLIP |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5004 | Specimen Reject Reason (SCT) (PHLIP) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5013 | Suspected Agent (PHLIP Sal) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5021 | Original Specimen Source Site PHLIP (PLT212) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5022 | Original Specimen Source Site Modifier PHLIP |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5023 | Original Specimen Collection Method PHLIP |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5024 | Original Specimen Type PHLIP |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5026 | Lab Test Result PHLIP Salmonella |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5028 | Method Detail (PHLIP) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6001 | Certifier Types (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6002 | Manner of Death (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6004 | Contributory Tobacco Use (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6005 | Transportation Relationships (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6027 | Smoking Status (PI) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6054 | Lab Test Result (Reportable Conditions) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6070 | Infections During Pregnancy - Live Birth (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6071 | Gonorrhea (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6072 | Trachoma (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7103 | VPD Laboratory Coded Observation |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7104 | VPD Specimen Type |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7105 | VPD Specimen Collection Method |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7106 | VPD Specimen Source Body Site |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7108 | VPD Specimen Condition |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7110 | VPD Specimen Reject Reason |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7111 | Birth Attendant Titles (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7112 | Fetal Death Time Points (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7113 | Fetal Presentations (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7115 | Karyotype Suspected Chromosomal Disorder (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7116 | Karyotype Down Syndrome (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7117 | Labor and Delivery Characteristics (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7118 | Delivery Routes (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7119 | Maternal Morbidities (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7121 | Newborn Abnormal Conditions (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7122 | Newborn Congenital Anomalies (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7123 | Onset Labor (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7124 | Birth or Delivery Occurred (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7126 | Pregnancy Risk Factors (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7135 | Infections During Pregnancy Fetal Death (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7136 | Obstetric Procedures (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7137 | Autopsy Examination (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7138 | Histological Placental Examination (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7140 | Autopsy Planned (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7142 | Non-Vertex Presentation (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7143 | Steroids For Fetal Lung Maturation (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7153 | Estimated Time of Death No Labor Ongoing (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7154 | Fetal Presentation at Birth- Unknown (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7156 | Assisted Ventilation (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7165 | Previous Cesarean (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7167 | Case Transmission Mode (BIDS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7168 | Notifiable Event Disease Condition (BIDS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7170 | Specimen Site (BIDS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7171 | Salmonella Serogroup (BIDS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7172 | Shigella Serogroup (BIDS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7173 | Campylobacter Species (BIDS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7174 | Campylobacter Nonculture Test Type (BIDS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7175 | E. coli Culture Isolate Id Serotype (BIDS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7177 | E. coli Shiga Toxin Test Type (BIDS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7178 | E. coli Shiga Toxin (BIDS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7179 | Vibrio Culture Species (BIDS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7180 | Vibrio Serotype (BIDS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7181 | Vibrio Biotype (BIDS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7182 | Vibrio Cholera Toxin Test Type (BIDS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7183 | Listeria Culture Species (BIDS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7189 | Specimen Source (STD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7192 | HIV Status (STD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7194 | Drugs Used (STD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7195 | Clinician Observed Lesions (STD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7199 | Detection Method (STD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7200 | Lab Results (STD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7203 | Quantitative Syphilis Test Result (STD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7206 | Lab Test Result Qualitative (NND) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7212 | Certifier Titles (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7216 | Place of Death (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7217 | Lab Test Reactivity (NND) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7218 | Syphilis Clinical Stage (CS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7219 | Syphilis Surveillance Stage (CS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7220 | Pregnancy Treatment Stage (NND) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7223 | Birth Status (NND) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7224 | Darkfield DFA Result (CS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7225 | Signs Symptoms (CS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7227 | VDRL Test Result (NND) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7228 | CSF WBC Protein Result (NND) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7229 | Syphilis Treatment Infant (CS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7234 | Qual Lab Result Positive (Reportable Conditions) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7235 | Qual Lab Result Negative (Reportable Conditions) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7236 | Qual Lab Result Inconc (Reportable Conditions) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7244 | History of Disease as Evidence Of Immunity (IIS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7245 | Serological Evidence Of Immunity (IIS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7247 | Symptoms (EVD Triage) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7250 | Observation Identifiers (EVD Triage) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7256 | Morphologic Abnormalities of Neoplasms |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7257 | Abdominal Pain (CDS - EHR) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7258 | Weakness (CDS - EHR) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7259 | Fever (CDS - EHR) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7260 | Headache (CDS - EHR) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7261 | Hemorrhage (CDS - EHR) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7262 | Muscle Pain (CDS - EHR) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7263 | Vomiting (CDS - EHR) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7264 | Diarrhea (CDS - EHR) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7269 | Reason for Missing Test (NND) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7270 | Lab Test Result Interpretation (NND) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7273 | Death Pronouncement Finding (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7274 | Death Pronouncement Procedure (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7277 | Transport Mode to Hospital (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7282 | Complications (Mumps) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7283 | Signs and Symptoms (Mumps) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7284 | Signs and Symptoms (Pertussis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7285 | Complications (Pertussis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7329 | Type of Testing at CDC (NND) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7332 | Setting of Further Spread |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7333 | Timing of Maternal Treatment (NND) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7334 | Lab Test Interpretation (Pertussis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7343 | Lab Result (Chikungunya virus) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7344 | Lab Result (Crimean-Congo hemorrhagic fever) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7345 | Lab Result (Guanarito hemorrhagic fever) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7346 | Lab Result (Junin hemorrhagic fever) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7347 | Lab Result (Lassa fever) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7348 | Lab Result (Lujo virus) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7349 | Lab Result (Machupo hemorrhagic fever) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7350 | Lab Result (Sabia virus hemorrhagic fever) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7351 | Lab Test Performed Modifier (NND) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7357 | Hysterectomy (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7358 | Hysterotomy (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7359 | Point of Origin (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7361 | Disposition OPD (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7362 | Follow-up Attempt Outcome (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7365 | Priority (Type) of Admission or Visit (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7369 | Present on Admission (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7379 | Methods of Disposition (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7402 | Patient Residence (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7403 | Injury or Poisoning (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7405 | Co-morbid Conditions (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7419 | Provider ED (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7422 | Fetal Death Cause or Condition (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7423 | Pregnancy Resulting From Fertility Enhancing Drugs |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7431 | Surfactant Replacement Therapy (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7432 | Asthma (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7433 | Condition Control (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7437 | Disposition ED (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7439 | Episode of Care (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7440 | Hospital Discharge Status (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7441 | Neurological Manifestation (STD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7449 | Qualitative Lab Result (RCMT) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7450 | Vaccine Event Information Source (NND) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7451 | Type of Testing at CDC (VZ) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7453 | Body Region(s) of Rash |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7454 | Character of Lesions |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7458 | Transmission Mode (Zika) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7459 | Signs Symptoms (Zika) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7460 | Signs Symptoms (Arbovirus) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7462 | Prenatal Diagnostic Procedures |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7463 | Specimen Type (Zika) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7464 | Insect Repellant |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7465 | Vector (Zika) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7466 | Complications (Zika) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7467 | Drug Disease Interaction (Dengue) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7468 | Length of Gestation in Weeks |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7469 | Microcephaly Causes |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7470 | Head Circumference Findings |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7473 | Diagnostic Lab Test Findings (NND) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7474 | Type of Complication (VZ) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7476 | Positive Negative Equivocal Not Done |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7477 | Positive Negative 4 Fold Rise Not Done |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7478 | Serotype (Dengue) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7479 | Lab Result (Zika virus) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7481 | Signs Symptoms (Dengue) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7482 | Signs Symptoms (Chikungunya) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7487 | Reason for Hospitalization (VZ) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7488 | Specimen Type (Arbovirus) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7489 | Transmission Mode (Arbovirus) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7490 | Clinical Syndrome - Secondary (Arbovirus) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7491 | Pregnancy Complications (Arbovirus) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7492 | Newborn Complications (Arbovirus) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7494 | Pregnancy Outcome |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7495 | Serotype (Arbovirus) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7516 | Data Elements (NND Hep A Acute) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7517 | Data Elements (NND Hep B Acute) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7519 | Data Elements (NND Hep B Chronic) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7520 | Data Elements (NND Hep C Acute) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7521 | Data Elements (NND Hep C Chronic) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7523 | Data Elements (NND Pertussis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7524 | Data Elements (NND STD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7526 | Method of Delivery VaginalSpon Finding (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7527 | Method of Delivery Cesarean Finding (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7528 | Method of Delivery Vaginal Forceps Finding (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7529 | Method of Delivery Vaginal Vacuum Finding (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7530 | Scheduled Cesarean Finding (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7531 | Induction of Labor Finding (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7532 | Augmentation of Labor Finding (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7538 | Type of Complication (Babesiosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7540 | Blood Product |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7541 | Clinical Manifestations (Babesiosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7543 | Lab Result (Hantavirus Infection) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7544 | Outdoor Activities |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7551 | Test Result Coded Qualitative |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7552 | Organism Identified AST (STD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7553 | Specimen Type AST (STD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7554 | Specimen Collection Site AST (STD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7556 | Susceptibility Test Method (STD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7557 | Susceptibility Test Interpretation (STD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.756 | Gender Identity |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7563 | Sexual Orientation |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7585 | Fetal Remains Disposition Method (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7596 | Adverse Event Severity (Malaria) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7604 | Route Method of Delivery SpontaneousProcedure (NCHS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7607 | Type of Testing at CDC |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7608 | Type Of Complication (CRS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7609 | Sexual Orientation (STD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7610 | Gender Identity (STD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7614 | Case Appraisal (CRS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7615 | Pre-Pregnancy SerologicalTestInterp (CRS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7616 | Specimen From Mother Or Infant (CRS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7617 | Organism (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7621 | Signs and Symptoms (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7622 | Positive Negative Not Done |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7626 | Test Result (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7627 | Specimen Collection Source (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7633 | Day Care Setting (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7636 | Medical History (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7643 | Vibrio Species (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7644 | Vibrio Cholera Serotype (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7645 | Vibrio Cholera Biotype (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7647 | Typhoid Paratyphoid Serotype (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7648 | Yes No Not Tested (NND) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7649 | Signs and Symptoms (Rubella) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7650 | Type Of Complication (Rubella) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7651 | Previous Case Diagnosed By (Rubella) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7653 | Specimen Type (CRS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7655 | PCR Specimen Source (CRS) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7656 | Specimen Source (Rubella) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7657 | Specimen Type (Rubella) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7659 | Type of Testing at CDC(Rubella) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7660 | Type of Complication (Measles) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7662 | Signs and Symptoms (Measles) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7663 | Data Elements (NND Malaria) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7664 | Data Elements (NND Babesiosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7665 | Data Elements (NND Varicella) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7666 | Signs and Symptoms (Trich) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7670 | Meat Purchase Info (Trich) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7674 | Lab Test Interpretation (Trich) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7675 | Specimen type (Trich) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7676 | Strain Type (Trich) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7677 | Form Status (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7678 | Discharge Location (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7679 | Pregnancy Status (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7680 | Fetal Outcome (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7681 | Underlying Condition (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7682 | Smoking Status (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7683 | Substance Abuse (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7684 | Mode of Delivery (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7686 | Microorganism (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7689 | Vaccination Information Source (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7690 | GAS Risk Factor (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7692 | Rehab Type (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7693 | Antibiotic Received (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7695 | Antibiotic Reason (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7696 | Detection Method (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7697 | Birth Location (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7698 | Gestational Age Determination (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7699 | Susceptibility Data NA (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7700 | AR Agent (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7701 | AR Test Method (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7702 | ATI Method (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7703 | MIC Operator (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7704 | Susceptibility Interpretation (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7706 | Sequelae (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7707 | Blood Type (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7708 | Rupture Type (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7709 | Delivery Type (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7710 | Medication Pre-Treatment (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7711 | Contact Type (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7714 | Legionella Diagnosis (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7715 | Legionella Exposure (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7716 | Definitely Possibly No (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7717 | Legionella Exposure Setting (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7718 | Healthcare Exposure Type (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7720 | Water Source (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7723 | Signs and Symptoms (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7724 | Personal Protective Equipment (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7725 | Respiratory Protective Equipment (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7726 | Glove Material (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7727 | Titer Test Method (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7728 | Bird Type (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7729 | Establishment Type (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7730 | Residence Location (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7731 | Insurance Type (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7732 | Infection Type (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7734 | Lab Test Interpretation (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7735 | SPN/IPD Serotype (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7736 | Serotype Method (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7737 | Legionellosis Serogroup (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7738 | Isolate Not Available (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7744 | Lab Test Interpretation (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7745 | Type of Radiology Study |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7746 | Result of Radiology Study (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7747 | Diabetes Status |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7748 | Epidemiological Risk Factors (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7749 | Smoking Status |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7750 | Diagnosis Type (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7752 | Strength of Link (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7753 | Directionality of Link (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7754 | Treatment Administration Type (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7756 | Reason LTBI Not Started (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7757 | Reason LTBI Treatment Stopped (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7758 | Adverse Event Severity (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7761 | Susceptibility Test Interpretation (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7762 | Susceptibility Test Method (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7764 | Molecular Test Results (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7765 | Molecular Indel (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7767 | Reason Not Treated with RIPE (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7769 | Final Treatment Outcome (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7770 | Length of Time Drug Taken (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7772 | Side Effect of Treatment (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7773 | Serogroup Method (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7774 | Specimen Type (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7778 | Specimen Site (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7779 | Condition Status (FDD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7782 | Deli Meats (Listeria) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7783 | Deli Salads (Listeria) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7784 | Diet Type (Listeria) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7786 | Food (Listeria) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7787 | Food Allergy (Listeria) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7788 | Food Freshness (Listeria) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7789 | Fruit (Listeria) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7792 | Illness (Listeria) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7795 | Medical History (Listeria) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7797 | Birth Location (Listeria) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7798 | Pregnancy Outcome (Listeria) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7801 | Signs and Symptoms (Listeria) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7802 | Specimen Type (Listeria) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7804 | Patient Outcome (Listeria) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7805 | Yes No None (Listeria) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7806 | Assisted Living Exposure Type (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7808 | N. meningitidis Serogroup (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7809 | H. influenzae Serotype (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7810 | Provider Information Source (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7813 | Specimen Source (CP-CRE) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7814 | Genotypic Test Result (CP-CRE) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7816 | Data Elements (Rubella) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7817 | Type of Dairy Product (Listeria) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7818 | General Condition Status (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7820 | Born in the United States (Listeria) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7823 | Lab Test Interpretation (Legionellosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7825 | Gene Name (CP-CRE) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7826 | Specimen Source Site (VPD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7832 | Clinical Manifestation (TBRD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7833 | Complications (TBRD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7836 | Organism (TBRD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7837 | Coinfection Type (TBRD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7838 | Specimen Type (TBRD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7840 | Clinical Manifestations (Lyme) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7841 | Specimen Type (Lyme) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7843 | Organism (Lyme) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7845 | Serotype Master (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7846 | Lab Test Interpretation Master (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7848 | Exposure Setting Master (RIBD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7849 | Usual Occupation and Industry (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7850 | Organism (CP-CRE) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7862 | Test Result (CP-CRE) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7864 | Specimen Source (C. auris) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7866 | Lab Test Method (MDRO) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7867 | Test Result (C. auris) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7869 | Specimen Collection Setting Type (C. auris) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7870 | Type of Co-infection (C. auris) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7874 | Poison Control Center Record (CO) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7876 | Intent of Exposure (CO) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7877 | Extreme Weather Type (CO) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7878 | Exposure Source (CO) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7879 | Treatment Type (CO) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7884 | Exposure Site Category (CO) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7885 | Public Site of Exposure (CO) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7886 | Treatment Location (CO) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7887 | Underlying Conditions (CO) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7888 | Signs and Symptoms (CO) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7891 | Data Reporting Source (CO) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7892 | Lab Result (Candida auris) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7895 | Lab Result Carbapenem Resistant Enterobacteriace |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7896 | Residential Site of Exposure (CO) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7902 | GC specimen quality (ARLN) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7903 | GC beta-lactamase result (ARLN) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7911 | Clinical sample or isolate (ARLN) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7912 | Candida auris culture result (ARLN) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7913 | Candida auris PCR result (ARLN) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7914 | Acinetobacter culture result (ARLN) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7915 | Carbapenemase phenotypic result (ARLN) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7916 | CPO phenotypic method (ARLN) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7917 | CPO PCR method (ARLN) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7918 | CPO AST method (ARLN) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7919 | CPO PCR result (ARLN) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7921 | Specimen type (ARLN) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7922 | Microorganism (ARLN) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7923 | Medication Treatment (STD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7924 | Mother Infant Indicator (NND) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7925 | Type of Complication (STD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7926 | Number of Cigarettes Smoked per Day (CO) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7927 | Dose Unit (STD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7928 | Lab Test Result Qualitative (Syphilis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7929 | Medication Route (STD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7930 | Route of Administration (STD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7931 | Medication Frequency Unit (STD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7934 | Microorganism (STD) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7936 | Contact Type (COVID-19) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7939 | Residence Type (COVID-19) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7940 | Healthcare Occupation (COVID-19) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7941 | Job Setting (COVID-19) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7942 | Exposure Setting (COVID-19) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7944 | Signs and Symptoms (COVID-19) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7945 | Clinical Finding (COVID-19) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7946 | Animal Type (COVID-19) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7947 | Risk Factor (COVID-19) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7949 | Treatment Type (COVID-19) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7951 | Reason for Test (COVID-19) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7953 | Critical Infrastructure Sector (NND) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7955 | Location of Initial Diagnosis (Hansen) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7956 | Type of Leprosy (Hansen) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7958 | Hospital Procedure (Leptospirosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7959 | Underlying Condition(s) (Leptospirosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7960 | Disease Outcome Type (Leptospirosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7961 | Medication (Leptospirosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7962 | Contact Type (Brucellosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7963 | Medication Administered (Anthrax) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7965 | Sick Animal Type (Leptospirosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7966 | Rodent Type (Leptospirosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7967 | Animal Type (Leptospirosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7968 | Clinical Manifestations (Leptospirosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7969 | Specimen Type (Brucellosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7970 | Disease Stage (Brucellosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7971 | Animal Type (Brucellosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7973 | Diagnostic Test Finding (Anthrax) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7974 | Specimen Type (Leptospirosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7975 | Specimen Source Site (Leptospirosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7976 | Test Titer Type (Brucellosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7977 | Brucella Exposure (Brucellosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7978 | Exposure Risk (Brucellosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7980 | Patient Case Status (Hansen) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7981 | Animal Ownership (Brucellosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7982 | Vaccine Exposure (Brucellosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7983 | Time of Day (Anthrax) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7984 | Hospital Procedure (Anthrax) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7985 | Actual Route of Administration (Anthrax) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7987 | Country of Product Acquisition (Brucellosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7988 | Location Type (Leptospirosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7989 | Clinical Outcome (Anthrax) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7990 | Specimen Type (Anthrax) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7991 | Procedure Type (Anthrax) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7992 | Public TransportationType (Anthrax) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7995 | Diet Type (Anthrax) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7996 | Post-exposure or Treatment (NND) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7997 | Treatment Type (Anthrax) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7998 | Severe Weather Type (Leptospirosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7999 | Animal Type (Anthrax) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8000 | Test Results Anthrax |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8001 | Time of Day (CDC) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8002 | Reason Medication Not Completed (BSP) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8003 | Smoking Status (Anthrax) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8004 | Test Results (Brucellosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8005 | Antimicrobials (Anthrax) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8006 | Contact Type (Anthrax) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8007 | Clinical Manifestations (Brucellosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8008 | Clinical Manifestations (Anthrax) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8009 | Exposure Location (Brucellosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8010 | Organism Name (Brucellosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8011 | Activity Type (Leptospirosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8012 | Activity Type (Brucellosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8013 | Exposure Source (Anthrax) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8015 | Food Product Consumed (Brucellosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8016 | Fresh Water or Mud Type (Leptospirosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8017 | Exposure Source (Brucellosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8019 | Alcohol Use Frequency (Anthrax) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8020 | Anthrax Vaccine Exposure (Anthrax) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8021 | Total Doses of Vaccine (Anthrax) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8030 | Lab Test (Hansen) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8035 | Subject of Medication Received (Hansen) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8037 | Test Type (Brucellosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8038 | Specimen Source Site (Brucellosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8039 | Test Results (Leptospirosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8040 | Pregnancy Outcome (Leptospirosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8041 | Lab Test Type (Leptospirosis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8042 | Test Result (Hepatitis A) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8043 | HBeAg Test Result (Hepatitis B Perinatal) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8044 | Infant Nucleic Acid Test Result (Hepatitis C) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8045 | Infant HCV Antigen Test Result (Hepatitis C) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8046 | Mother Nucleic Acid Test Result (Perinatal Hep) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8047 | Common-Source Outbreak (Hepatitis A) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8048 | Common-Source Outbreak (Hepatitis B) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8049 | Common-Source Outbreak (Hepatitis C) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8050 | Other Case Hepatitides (Hepatitis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8051 | Patient Epidemiological Risk Factors (Hepatitis A) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8052 | Patient Epidemiological Risk Factors (Hepatitis B) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8053 | Patient Epidemiological Risk Factors (Hepatitis C) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8055 | Source of Laboratory Test (Hepatitis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8056 | HBsAg Test Result (Hepatitis B Perinatal) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8057 | Infant Anti-HCVTest Result (Hepatitis C Perinatal) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8059 | Signs and Symptoms (Hepatitis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8060 | Test Result (Hepatitis) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8061 | HBV DNA Test Result (Hepatitis B Perinatal) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8062 | Gender Identity (USCDI) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8063 | Sexual Orientation (USCDI) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8064 | Travel Purpose (CDC) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.834 | Allergen |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.909 | Disease |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.928 | True False (TF) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.929 | Positive Negative Unknown Not Done |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.930 | Chest XRay Result |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.931 | Vaccine Not Given Reason |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.941 | Susceptibility Result |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.946 | Specimen |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.950 | Passed Failed Unknown |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.959 | Additional Site of Disease (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.967 | Body site |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.968 | Case Classification Status |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.969 | Case investigation closure reason |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.970 | Case Investigation Status |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.972 | Case Verification (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.981 | Diagnosed Pneumonia By (VZ) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.982 | Directly Observed Therapy (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.984 | Dwelling Type |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.985 | Employment Status |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.988 | Countermeasure Encounter Purpose |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.991 | Environmental Investigation Reason |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.994 | General Condition Status |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.995 | Health Care Practice Type (TB) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.996 | History Source (CRA) |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.997 | HIV Diagnosis Based On |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.998 | HIV Status |
| http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.3.20 | Specimen Source Site (Anthrax) |
| http://phinvads.cdc.gov/fhir/ValueSet/6.1.4.1.19376.1.7.3.1.1.13.8.64 | Limb Reduction Defect (NCHS) |
| https://gematik.de/fhir/isik/v3/Medikation/ValueSet/SctRouteOfAdministration | SctRouteOfAdministration |
| http://hl7.org/fhir/ValueSet/condition-severity | Condition/Diagnosis Severity |
| http://hl7.org/fhir/ValueSet/device-action | Procedure Device Action Codes |
| http://hl7.org/fhir/ValueSet/device-kind | FHIR Device Types |
| http://hl7.org/fhir/ValueSet/c80-facilitycodes | Facility Type Code Value Set |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.32 | Gender Identity |
| http://hl7.org/fhir/ValueSet/performer-role | Procedure Performer Role Codes |
| http://hl7.org/fhir/ValueSet/procedure-category | Procedure Category Codes (SNOMED CT) |
| http://hl7.org/fhir/ValueSet/procedure-followup | Procedure Follow up Codes (SNOMED CT) |
| http://hl7.org/fhir/ValueSet/procedure-not-performed-reason | Procedure Not Performed Reason (SNOMED-CT) |
| http://hl7.org/fhir/ValueSet/procedure-outcome | Procedure Outcome Codes (SNOMED CT) |
| http://hl7.org/fhir/ValueSet/referencerange-appliesto | Observation Reference Range Applies To Codes |
| http://hl7.org/fhir/ValueSet/servicerequest-orderdetail | Service Request Order Details Codes |
| http://hl7.org/fhir/us/core/ValueSet/us-core-encounter-type | US Core Encounter Type |
| http://hl7.org/fhir/us/core/ValueSet/us-core-servicerequest-category | US Core ServiceRequest Category Codes |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Bodysite_Hip | Hüftlateralität |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Examination_Number | Untersuchungsnummer U-Heft |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Foetal_Position | Kindslage aus Sicht d. Kindes |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Gender_Birth | Geschlecht |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Hearscreening_Method | Hörscreenigmethode |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Hearscreening_Result | Hörscreeningbefund Lokalisation |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Hip_History | Hüftanamnese |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Hip_Proceeding | Hüfte - weiteres Vorgehen |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Hip_Screening_Method | Hüftscreening Methode |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Newborn_Blood_Spot_Screening_Type | Typ der Blutabnahme |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Percentile_Body_Measure_Snomed | Perzentilkörpermaß SNOMED |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Practitioner_Speciality | Rolle des Behandelnden |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Pregnancy_History | Schwangerschaftsanamnese |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Pulse_Oxymetry_Screening_Data_Absent_Reason | Gründe zur Ablehnung des Pulsoxymetriescreenings |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_Pulse_Oxymetry_Screening_Measurement_Type | Typ der Pulsoxymetriemessung |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U1_Apgar_Score_Identifier | Apgar Score am Zeitpunkt |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U1_Apgar_Score_Value | Apgar-Score Wert |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U1_U3_Birthmode | Geburtsmodus |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U1_U3_Pulse_Oxymetry_Measurement | Auffälligkeit Sauerstoffsättigung |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_Consultation | U2 - Beratung |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_Current_Child_History | U2 - Aktuelle Anamnese des Kindes |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_Family_History | U2 - Familienanamnese |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_Physical_Exam_Head | U2 - Kopf |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_Physical_Exam_Mouth_Nose | U2 - Mundhöhle, Kiefer, Nase |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_Physical_Exam_Musculoskeletal_System | U2 - Bewegungsapparat |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_Physical_Exam_Skin | U2 - Haut |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_U3_Physical_Exam_Abdomen_Genitals | U2, U3 - Abdomen, Genitale |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_U3_Physical_Exam_Ears | U2, U3 - Ohren |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_U3_Physical_Exam_Eyes | U2, U3 - Augen |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_U4_Physical_Exam_Chest_Lung_Respiratory_Tract | U2, U3, U4 - Thorax, Lunge, Atemwege |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U2_U6_Physical_Exam_Heart_Blood_Circulation | U2, U3, U4, U5, U6 - Herz, Kreislauf |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U3_Consultation | U3 - Beratung |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U3_Current_Child_History | U3 - Aktuelle Anamnese des Kindes |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U3_Development_Assessment | U3 - Orient. Beurt. Entwicklung |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U3_Family_History | U3 - Familienanamnese |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U3_Physical_Exam_Head | U3 - Kopf |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U3_Physical_Exam_Musculoskeletal_System | U3 - Bewegungsapparat |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U3_U4_Physical_Exam_Mouth_Nose | U3, U4 - Mundhöhle, Kiefer, Nase |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U3_U4_Physical_Exam_Skin | U3, U4 - Haut |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U3_U9_Age_Appropriate_Development | Altersgemäße Entwicklung |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U3_U9_Social_History | U3-U9 - Sozialanamnese |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U4_Consultation | U4 - Beratung |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U4_Current_Child_History | U4 - Aktuelle Anamnese des Kindes |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U4_Development_Assessment | U4 - Orient. Beurt. Entwicklung |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U4_Physical_Exam_Abdomen_Genitals | U4 - Abdomen, Genitale |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U4_Physical_Exam_Head | U4 - Kopf |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U4_Physical_Exam_Musculoskeletal_System | U4 - Bewegungsapparat |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U4_U5_Physical_Exam_Eyes | U4, U5 - Augen |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U5_Consultation | U5 - Beratung |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U5_Current_Child_History | U5 - Aktuelle Anamnese des Kindes |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U5_Development_Assessment | U5 - Orient. Beurt. Entwicklung |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U5_Physical_Exam_Chest_Lung_Respiratory_Tract | U5 - Thorax, Lunge, Atemwege |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U5_Physical_Exam_Mouth_Nose | U5 - Mundhöhle, Kiefer, Nase |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U5_Physical_Exam_Musculoskeletal_System | U5 - Bewegungsapparat |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U5_U6_Physical_Exam_Abdomen_Genitals | U5, U6 - Abdomen, Genitale |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U5_U6_Physical_Exam_Head | U5, U6 - Kopf |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U5_U9_Physical_Exam_Skin | U5, U6, U7, U7a, U8, U9 - Haut |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U6_Consultation | U6 - Beratung |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U6_Current_Child_History | U6 - Aktuelle Anamnese des Kindes |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U6_Development_Assessment | U6 - Orient. Beurt. Entwicklung |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U6_Physical_Exam_Eyes | U6 - Augen |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U6_Physical_Exam_Mouth_Nose | U6 - Mundhöhle, Kiefer, Nase |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U6_Physical_Exam_Musculoskeletal_System | U6 - Bewegungsapparat |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U6_U7_Physical_Exam_Chest_Lung_Respiratory_Tract | U6, U7 - Thorax, Lunge, Atemwege |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7_Consultation | U7 - Beratung |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7_Current_Child_History | U7 - Aktuelle Anamnese des Kindes |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7_Development_Assessment | U7 - Orient. Beurt. Entwicklung |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7_Physical_Exam_Eyes | U7 - Augen |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7_Physical_Exam_Mouth_Nose | U7 - Mundhöhle, Kiefer, Nase |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7_Physical_Exam_Musculoskeletal_System | U7 - Bewegungsapparat |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7_U7a_Physical_Exam_Abdomen_Genitals | U7, U7a - Abdomen, Genitale |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7_U9_Physical_Exam_Heart_Blood_Circulation | U7, U7a, U8, U9 - Herz, Kreislauf |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7a_Consultation | U7a - Beratung |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7a_Current_Child_History | U7a - Aktuelle Anamnese des Kindes |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7a_Development_Assessment | U7a - Orient. Beurt. Entwicklung |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7a_Physical_Exam_Mouth_Nose | U7a - Mundhöhle, Kiefer, Nase |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7a_U9_Physical_Exam_Eyes | U7a, U8, U9 - Augen |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7a_and_U9_Physical_Exam_Chest_Lung_Respiratory_Tract | U7a, U9 - Thorax, Lunge, Atemwege |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U7a_and_U9_Physical_Exam_Musculoskeletal_System | U7a, U9 - Bewegungsapparat |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U8_Consultation | U8 - Beratung |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U8_Current_Child_History | U8 - Aktuelle Anamnese des Kindes |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U8_Development_Assessment | U8 - Orient. Beurt. Entwicklung |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U8_Physical_Exam_Abdomen_Genitals | U8 - Abdomen, Genitale |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U8_Physical_Exam_Chest_Lung_Respiratory_Tract | U8 - Thorax, Lunge, Atemwege |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U8_Physical_Exam_Ears | U8 - Ohren |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U8_Physical_Exam_Musculoskeletal_System | U8 - Bewegungsapparat |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U8_U9_Physical_Exam_Mouth_Nose | U8, U9 - Mundhöhle, Kiefer, Nase |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U9_Consultation | U9 - Beratung |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U9_Current_Child_History | U9 - Aktuelle Anamnese des Kindes |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U9_Development_Assessment | U9 - Orient. Beurt. Entwicklung |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_CMR_U9_Physical_Exam_Abdomen_Genitals | U9 - Abdomen, Genitale |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_PC_PN_Examination_Number | Untersuchungsnummer Teilnahmekarte |
| https://tgateway.infoway-inforoute.ca/vs/practitionerspecialty | PractitionerSpecialtywithFrench |
| https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ClasseAsa | ClasseAsa |
| https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ClassificationDeParis | ClassificationDeParis |
| https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/Complications | Complications |
| https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ConsentementReponse | ConsentementReponse |
| https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/EchelleBostonScore | EchelleBostonScore |
| https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/InaptConsentementPar | InaptConsentementPar |
| https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/IndicationsEndoscopie | IndicationEndoscopie |
| https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/InstrumentsUtilises | InstrumentsUtilises |
| https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/IntervenantEndoscopiste | IntervenantEndoscopiste |
| https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/IntervenantProcedure | IntervenantProcedure |
| https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/IntervenantResident | IntervenantResident |
| https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/LienUsagerEndo | LienUsagerEndo |
| https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ListeMedicamentsEndo | ListeMedicamentsEndo |
| https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/MethodesAdministration | MethodesAdministration |
| https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/Observations | Observations |
| https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/PrecisionProvenanceExterne | PrecisionProvenanceExterne |
| https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/PreparationColiqueLaxatifs | PreparationColiqueLaxatifs |
| https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ProceduresEffectuees | ProceduresEffectuees |
| https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ProceduresType | ProceduresType |
| https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ProceduresTypeSpecimentEnvoye | ProceduresTypeSpecimenEnvoye |
| https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/Recommandations | Recommandations |
| https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/RetroflexionEffectuee | RetroflexionEffectuee |
| https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/StatutObservation | StatutObservation |
| https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/StructuresCorporelles | StructuresCorporelles |
| https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/SuiviPriseCharge | SuiviPriseCharge |
| https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/TaillesPolype | TaillesPolype |
| https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/TypeObservation | TypeObservation |
| http://hl7.org/fhir/uv/ips/ValueSet/allergy-intolerance-substance-condition-gps-uv-ips | Allergy intolerance substance condition (GPS) - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/allergy-reaction-gps-uv-ips | Allergy Reaction (GPS) - IPS |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_EMP_Dose_Form_SNOMED_CT | Darreichungsform SNOMED CT® |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_EMP_Drug_Therapy_Status_SNOMED_CT | Medikation Statusgrund |
| http://hitstdio.ntunhs.edu.tw/fhir/ValueSet/covid-19-diseases | COVID-19 Diseases |
| http://hitstdio.ntunhs.edu.tw/fhir/ValueSet/covid-19-lab-result | COVID-19 Lab Result |
| http://hitstdio.ntunhs.edu.tw/fhir/ValueSet/covid-19-sample-origin | COVID-19 Sample Origin |
| http://hitstdio.ntunhs.edu.tw/fhir/ValueSet/sct-vaccines-covid-19 | SNOMED CT Vaccine List (COVID-19) |
| http://hitstdio.ntunhs.edu.tw/fhir/ValueSet/vaccines-covid-19 | Vaccine List (COVID-19) |
| https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-diagnosis-use | Diagnosis Use |
| https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-diagnostic-report-type | Diagnostic Report Type |
| https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-medicine-codes | Medicine Codes |
| https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-practitioner-role | Practitioner Role |
| https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-route-of-administration | Route Of Administration |
| https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-specimen-types | Specimen Types |
| https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-vaccine-codes | Vaccine Codes |
| https://www.ehealth.fgov.be/standards/fhir/allergy/ValueSet/be-causativeagent | BeCausativeAgent |
| https://www.ehealth.fgov.be/standards/fhir/allergy/ValueSet/be-exposureroute | BeExposureRoute |
| https://www.ehealth.fgov.be/standards/fhir/allergy/ValueSet/be-noallergy | BeNoAllergy |
| https://www.ehealth.fgov.be/standards/fhir/allergy/ValueSet/be-riskmanifestation | BeRiskManifestation |
| https://www.ehealth.fgov.be/standards/fhir/allergy/ValueSet/be-vs-allergyintolerance-type | BeVSAllergyIntoleranceType |
| https://gematik.de/fhir/isik/ValueSet/ISiKTerminPriority | ISiKTerminPriority |
| https://standards.digital.health.nz/fhir/ValueSet/cancer-type-code | Cancer type |
| https://standards.digital.health.nz/fhir/ValueSet/sact-administration-site-code | Administration location |
| https://standards.digital.health.nz/fhir/ValueSet/sact-location-medication-collection-code | Medication collection location |
| https://standards.digital.health.nz/fhir/ValueSet/sact-support-factor-code | Support Factors |
| https://standards.digital.health.nz/fhir/ValueSet/sact-support-factor-value-code | Possible values for Support Factors |
| https://standards.digital.health.nz/fhir/ValueSet/sact-treatment-intent-code | Treatment intent |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.9.12.3--20200901000000 | DagdeelCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.47--20240131165054 | MedicatieToedieningRedenVanAfwijkenCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.55--20230119145802 | MedicatiegebruikStopTypeCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.53--20220323181942 | PrikPlakLocatieCodeLijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.42--20221114132525 | RedenWijzigen-StakenCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.54--20221114181621 | RedenWijzigen-StakenWDSCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.43--20221115122002 | RedenWijzigen-StoppenGebruikCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.50--20221216102010 | StopTypeCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.49--20221115120643 | Toedieningsafspraak-RedenWijzigen-StakenCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.9.12.2--20200901000000 | WeekdagCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.48--20230112155455 | WisselendDoseerschemaStopTypeCodelijst |
| https://www.ehealth.fgov.be/standards/fhir/vaccination/ValueSet/be-vs-vaccination-bodysite | BeVSVaccinationBodySite |
| https://www.ehealth.fgov.be/standards/fhir/vaccination/ValueSet/be-vs-vaccination-reason-code | BeVSVaccinationReasonCode |
| https://www.ehealth.fgov.be/standards/fhir/vaccination/ValueSet/be-vs-vaccine-code | BeVSVaccineCode |
| http://fhir.org/guides/argonaut/ValueSet/device-kind | Argonaut Device Types |
| http://fhir.org/guides/argonaut/ValueSet/observation-ccdasmokingstatus | Smoking Status |
| http://fhir.org/guides/argonaut/ValueSet/observation-value-codes | Observation Value Codes (SNOMED-CT) |
| http://fhir.org/guides/argonaut/ValueSet/procedure-type | Argonaut ProcedureType |
| http://fhir.org/guides/argonaut/ValueSet/provider-role | Care Team Provider Roles |
| http://fhir.org/guides/argonaut/ValueSet/substance-sct | DAF SNOMED CT Substances Other Than Clinical Drugs |
| http://fhir.org/guides/argonaut/ValueSet/substance | Argonaut Substance-Reactant for Intolerance and Negation Codes |
| https://www.ehealth.fgov.be/standards/fhir/ValueSet/be-causativeagent | BeCausativeAgent |
| https://www.ehealth.fgov.be/standards/fhir/ValueSet/be-exposureroute | BeExposureRoute |
| https://www.ehealth.fgov.be/standards/fhir/ValueSet/be-noallergy | BeNoAllergy |
| https://www.ehealth.fgov.be/standards/fhir/ValueSet/be-riskmanifestation | BeRiskManifestation |
| https://www.ehealth.fgov.be/standards/fhir/ValueSet/be-vs-score | Score Value Set |
| https://plsp.dk/fhir/ValueSet/Laterality2 | Health Hub Dk Core Laterality |
| http://fhir.infoway-inforoute.ca/io/CA-CSD/ValueSet/delivery-method | Delivery Method |
| http://ontariohealth.ca/fhir/ValueSet/mi-category-type | Medical Imaging Category Type |
| http://ontariohealth.ca/fhir/ValueSet/mi-procedure-bodypart-sct | Medical Imaging Procedure Body Part. |
| http://ontariohealth.ca/fhir/ValueSet/mi-procedure-contrast-used | Medical Imaging Procedure Contrast Used |
| http://ontariohealth.ca/fhir/ValueSet/mi-procedure-laterality-sct | Medical Imaging Procedure Laterality - SNOMED CT |
| http://ontariohealth.ca/fhir/ValueSet/mi-procedure-specialty | Medical Imaging Procedure Specialty |
| http://aehrc.github.io/genclipr-fhir-ig/ValueSet/AbnormalClinicalFindings | Abnormal Clinical Findings Value Set |
| http://aehrc.github.io/genclipr-fhir-ig/ValueSet/BiologicalSexes | Biological Sexes Value Set |
| http://aehrc.github.io/genclipr-fhir-ig/ValueSet/Lateralities | Lateralities Value Set |
| http://aehrc.github.io/genclipr-fhir-ig/ValueSet/PresenceValues | Presence Value Set |
| http://aehrc.github.io/genclipr-fhir-ig/ValueSet/Severities | Severity Value Set |
| http://aehrc.github.io/genclipr-fhir-ig/ValueSet/TestInterpretationValues | Test Interpretation Value Set |
| https://demis.rki.de/fhir/ars/ValueSet/abnahmeortSNOMED | Abnahmeort |
| https://demis.rki.de/fhir/ars/ValueSet/anforderungChlamydienSentinelSNOMED | Untersuchungsanlass Chlamydien-Sentinel |
| https://demis.rki.de/fhir/ars/ValueSet/anforderungMasernSentinelSNOMED | Untersuchungsanlass Masern-Sentinel |
| https://demis.rki.de/fhir/ars/ValueSet/anforderungSNOMED | Untersuchungsanlass Diagnose oder Screening |
| https://demis.rki.de/fhir/ars/ValueSet/antwortGeneSNOMED | Ergebnis der Laboruntersuchung Gene |
| https://demis.rki.de/fhir/ars/ValueSet/antwortMreSNOMED | Ergebnis der Laboruntersuchung MRE |
| https://demis.rki.de/fhir/ars/ValueSet/antwortOrdinalSNOMED | Ergebnis der Laboruntersuchung Ordinal |
| https://demis.rki.de/fhir/ars/ValueSet/antwortPathogenBakSNOMED | Ergebnis der Laboruntersuchung BAK |
| https://demis.rki.de/fhir/ars/ValueSet/antwortPathogenMykSNOMED | Ergebnis der Laboruntersuchung MYK |
| https://demis.rki.de/fhir/ars/ValueSet/antwortPathogenParSNOMED | Ergebnis der Laboruntersuchung PAR |
| https://demis.rki.de/fhir/ars/ValueSet/antwortPathogenVirSNOMED | Ergebnis der Laboruntersuchung VIR |
| https://demis.rki.de/fhir/ars/ValueSet/antwortSemiquantitativeErgebnisseSNOMED | Ergebnis der Laboruntersuchung Semiquantitative Ergebnisse |
| https://demis.rki.de/fhir/ars/ValueSet/interpretationSNOMED | Angabe der Interpretation mit SNOMED CT qualifier values |
| https://demis.rki.de/fhir/ars/ValueSet/materialSNOMED | Probenmaterial |
| https://demis.rki.de/fhir/ars/ValueSet/methodeSNOMED | Testmethoden |
| http://www.egde.no/ValueSet/care-team-role-vs | Care Team role |
| http://www.egde.no/ValueSet/consent-vs | Consent codes from Loinc and Snomed-ct |
| http://www.egde.no/ValueSet/organization-type-vs | Organization type |
| http://capable-project.eu/data/fhir/ValueSet/body-parts | Body parts |
| http://capable-project.eu/data/fhir/ValueSet/ctcae-symptom-grades | CTCAE symptom grades |
| http://capable-project.eu/data/fhir/ValueSet/capsules | Capsule list |
| http://capable-project.eu/data/fhir/ValueSet/hobbies | Hobbies |
| http://capable-project.eu/data/fhir/ValueSet/list-codes | List codes |
| http://capable-project.eu/data/fhir/ValueSet/medication-performer-type | Medication performer types |
| http://capable-project.eu/data/fhir/ValueSet/melanoma-types | Types of melanoma |
| http://capable-project.eu/data/fhir/ValueSet/patient-goals | Patient goals |
| http://capable-project.eu/data/fhir/ValueSet/prescription-type | Prescription types |
| http://capable-project.eu/data/fhir/ValueSet/symptom-codes | Symptom codes |
| http://capable-project.eu/data/fhir/ValueSet/visit-types | Visit types |
| http://capable-project.eu/data/fhir/ValueSet/who-score | WHO score |
| https://fhir.infoway-inforoute.ca/ValueSet/allergicconditioncode | Allergic Condition Code |
| https://fhir.infoway-inforoute.ca/ValueSet/allergyintolerancestatuscode | Allergy/Intolerance Status Code |
| https://fhir.infoway-inforoute.ca/ValueSet/procedurecode | Procedure Code |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-tnm-klassifikation-typ | MII VS Onkologie TNM Klassifikation Typ |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-tnm-m-kategorie | MII VS Onkologie TNM M Kategorie |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-tnm-n-kategorie | MII VS Onkologie TNM N Kategorie |
| https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-tnm-t-kategorie | MII VS Onkologie TNM T Kategorie |
| http://fhir.ch/ig/swissnoso/ValueSet/swissnoso-germ | Swissnoso Germ |
| https://terms.sil-th.org/core/ValueSet/vs-43file-refer-care-procedure | 43File: รหัสแสดงการให้การดูแลหรือปฐมพยาบาลผู้ป่วยขณะส่งต่อผู้ป่วย |
| https://terms.sil-th.org/core/ValueSet/vs-meta-child-development-observations | Metadata: รหัสการตรวจหรือบริการซึ่งเกี่ยวกับพัฒนาการเด็ก |
| https://terms.sil-th.org/core/ValueSet/vs-meta-lab-observations | Metadata: รหัสการตรวจทางห้องปฏิบัติการบางส่วน |
| https://terms.sil-th.org/core/ValueSet/vs-meta-ncd-observations | Metadata: รหัสการตรวจหรือบริการคัดกรองโรค NCD |
| https://terms.sil-th.org/core/ValueSet/vs-meta-neonate-observations | Metadata: รหัสการตรวจหรือบริการซึ่งเกี่ยวกับทารกแรกคลอด |
| https://terms.sil-th.org/core/ValueSet/vs-meta-physical-observations | Metadata: รหัสการตรวจร่างกาย |
| https://terms.sil-th.org/core/ValueSet/vs-meta-pregnancy-observations | Metadata: รหัสการตรวจหรือบริการซึ่งเกี่ยวกับการตั้งครรภ์ |
| https://terms.sil-th.org/core/ValueSet/vs-snomed-blood-abo | SNOMED CT Blood Group - ABO |
| https://terms.sil-th.org/core/ValueSet/vs-snomed-blood-rh | SNOMED CT Blood Group - Rh |
| https://terms.sil-th.org/core/ValueSet/vs-snomed-bloodgroup | SNOMED CT Blood Group |
| https://terms.sil-th.org/core/ValueSet/vs-snomed-int | SNOMED-CT International Release |
| http://roche.com/fhir/iop/ValueSet/device-kind | device-kind |
| http://roche.com/fhir/iop/ValueSet/device-settings-codes | device-settings-codes |
| http://roche.com/fhir/iop/ValueSet/observation-codes | observation-codes |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_ZAEB_Preventive_Check_Up_Type | KBV_VS_MIO_ZAEB_Preventive_Check_Up_Type |
| https://fhir.healthdata.be/ValueSet/AdministrationAgreementStopType | AdministrationAgreementStopType |
| https://fhir.healthdata.be/ValueSet/AdministrationDevice | AdministrationDevice |
| https://fhir.healthdata.be/ValueSet/AlcoholUseStatus | AlcoholUseStatus |
| https://fhir.healthdata.be/ValueSet/AlertName | AlertName |
| https://fhir.healthdata.be/ValueSet/AllergyCategory | AllergyCategory |
| https://fhir.healthdata.be/ValueSet/AllergyStatus | AllergyStatus |
| https://fhir.healthdata.be/ValueSet/AsNeededCriterium | AsNeededCriterium |
| https://fhir.healthdata.be/ValueSet/BathingOneself | BathingOneself |
| https://fhir.healthdata.be/ValueSet/BodyPartToBeBathed | BodyPartToBeBathed |
| https://fhir.healthdata.be/ValueSet/BodyPartToBeDressed | BodyPartToBeDressed |
| https://fhir.healthdata.be/ValueSet/BurnwoundDepth | BurnwoundDepth |
| https://fhir.healthdata.be/ValueSet/BurnwoundLaterality | BurnwoundLaterality |
| https://fhir.healthdata.be/ValueSet/CausativeAgent | CausativeAgent |
| https://fhir.healthdata.be/ValueSet/ChangingPosition | ChangingPosition |
| https://fhir.healthdata.be/ValueSet/ClimbingStairs | ClimbingStairs |
| https://fhir.healthdata.be/ValueSet/Clothing | Clothing |
| https://fhir.healthdata.be/ValueSet/CollectionMethod | CollectionMethod |
| https://fhir.healthdata.be/ValueSet/CommunicationDetails | CommunicationDetails |
| https://fhir.healthdata.be/ValueSet/ConditionsDuringMeasurement | ConditionsDuringMeasurement |
| https://fhir.healthdata.be/ValueSet/ContactType | ContactType |
| https://fhir.healthdata.be/ValueSet/ContainerType | ContainerType |
| https://fhir.healthdata.be/ValueSet/CriticalExtent | CriticalExtent |
| https://fhir.healthdata.be/ValueSet/CuffType | CuffType |
| https://fhir.healthdata.be/ValueSet/DASMethod | DASMethod |
| https://fhir.healthdata.be/ValueSet/DeathIndicator | DeathIndicator |
| https://fhir.healthdata.be/ValueSet/DecubitusCategory | DecubitusCategory |
| https://fhir.healthdata.be/ValueSet/DefecationColor | DefecationColor |
| https://fhir.healthdata.be/ValueSet/DentalHygiene | DentalHygiene |
| https://fhir.healthdata.be/ValueSet/DepartmentSpecialty | DepartmentSpecialty |
| https://fhir.healthdata.be/ValueSet/Depth | Depth |
| https://fhir.healthdata.be/ValueSet/Destination | Destination |
| https://fhir.healthdata.be/ValueSet/DevelopmentCognition | DevelopmentCognition |
| https://fhir.healthdata.be/ValueSet/DevelopmentLinguistics | DevelopmentLinguistics |
| https://fhir.healthdata.be/ValueSet/DevelopmentLocomotion | DevelopmentLocomotion |
| https://fhir.healthdata.be/ValueSet/DevelopmentSocialChild | DevelopmentSocialChild |
| https://fhir.healthdata.be/ValueSet/DeviatingBreathingPattern | DeviatingBreathingPattern |
| https://fhir.healthdata.be/ValueSet/DeviceAnatomicalLocation | DeviceAnatomicalLocation |
| https://fhir.healthdata.be/ValueSet/DiastolicEndpoint | DiastolicEndpoint |
| https://fhir.healthdata.be/ValueSet/DressingOneself | DressingOneself |
| https://fhir.healthdata.be/ValueSet/Drinking | Drinking |
| https://fhir.healthdata.be/ValueSet/DrinkingLimitations | DrinkingLimitations |
| https://fhir.healthdata.be/ValueSet/DrugUseStatus | DrugUseStatus |
| https://fhir.healthdata.be/ValueSet/Eating | Eating |
| https://fhir.healthdata.be/ValueSet/EatingLimitations | EatingLimitations |
| https://fhir.healthdata.be/ValueSet/EstimatingMethod | EstimatingMethod |
| https://fhir.healthdata.be/ValueSet/FamilyComposition | FamilyComposition |
| https://fhir.healthdata.be/ValueSet/FamilyCompositionChild | FamilyCompositionChild |
| https://fhir.healthdata.be/ValueSet/FecalContinence | FecalContinence |
| https://fhir.healthdata.be/ValueSet/FeedingMethod | FeedingMethod |
| https://fhir.healthdata.be/ValueSet/FeedingTubeType | FeedingTubeType |
| https://fhir.healthdata.be/ValueSet/FeedingType | FeedingType |
| https://fhir.healthdata.be/ValueSet/FrequencyQualifier | FrequencyQualifier |
| https://fhir.healthdata.be/ValueSet/Gender | Gender |
| https://fhir.healthdata.be/ValueSet/Grooming | Grooming |
| https://fhir.healthdata.be/ValueSet/HeadCircumferenceMeasuringMethod | HeadCircumferenceMeasuringMethod |
| https://fhir.healthdata.be/ValueSet/HealthProfessionalRole | HealthProfessionalRole |
| https://fhir.healthdata.be/ValueSet/HearingAidType | HearingAidType |
| https://fhir.healthdata.be/ValueSet/HearingFunction | HearingFunction |
| https://fhir.healthdata.be/ValueSet/HeartRateMeasurementMethod | HeartRateMeasurementMethod |
| https://fhir.healthdata.be/ValueSet/HeartbeatRegularity | HeartbeatRegularity |
| https://fhir.healthdata.be/ValueSet/HomeAccessibility | HomeAccessibility |
| https://fhir.healthdata.be/ValueSet/HomeAdaption | HomeAdaption |
| https://fhir.healthdata.be/ValueSet/IndependentMedicationUse | IndependentMedicationUse |
| https://fhir.healthdata.be/ValueSet/InfusionCatheterType | InfusionCatheterType |
| https://fhir.healthdata.be/ValueSet/InterpretationHeartRate | InterpretationHeartRate |
| https://fhir.healthdata.be/ValueSet/InterpretationMethod | InterpretationMethod |
| https://fhir.healthdata.be/ValueSet/Intervention | Intervention |
| https://fhir.healthdata.be/ValueSet/Laterality | Laterality |
| https://fhir.healthdata.be/ValueSet/LifeStance | LifeStance |
| https://fhir.healthdata.be/ValueSet/Location | Location |
| https://fhir.healthdata.be/ValueSet/LumenLocation | LumenLocation |
| https://fhir.healthdata.be/ValueSet/MaintainingPosition | MaintainingPosition |
| https://fhir.healthdata.be/ValueSet/MaritalStatus | MaritalStatus |
| https://fhir.healthdata.be/ValueSet/MeasuringLocation | MeasuringLocation |
| https://fhir.healthdata.be/ValueSet/MeasuringMethod | MeasuringMethod |
| https://fhir.healthdata.be/ValueSet/MeasuringPosition | MeasuringPosition |
| https://fhir.healthdata.be/ValueSet/MedicationAdministrationReasonForDeviation | MedicationAdministrationReasonForDeviation |
| https://fhir.healthdata.be/ValueSet/MedicationAdministrationStatus | MedicationAdministrationStatus |
| https://fhir.healthdata.be/ValueSet/MedicationAgreementAdditionalInformation | MedicationAgreementAdditionalInformation |
| https://fhir.healthdata.be/ValueSet/MedicationReason | MedicationReason |
| https://fhir.healthdata.be/ValueSet/MedicationStopType | MedicationStopType |
| https://fhir.healthdata.be/ValueSet/MenstrualCare | MenstrualCare |
| https://fhir.healthdata.be/ValueSet/Microorganism | Microorganism |
| https://fhir.healthdata.be/ValueSet/Morphology | Morphology |
| https://fhir.healthdata.be/ValueSet/MultipleBirthIndicator | MultipleBirthIndicator |
| https://fhir.healthdata.be/ValueSet/Municipality | Municipality |
| https://fhir.healthdata.be/ValueSet/NameUsage | NameUsage |
| https://fhir.healthdata.be/ValueSet/Origin | Origin |
| https://fhir.healthdata.be/ValueSet/PainCourse | PainCourse |
| https://fhir.healthdata.be/ValueSet/PainPattern | PainPattern |
| https://fhir.healthdata.be/ValueSet/PainType | PainType |
| https://fhir.healthdata.be/ValueSet/PerformNursingActivity | PerformNursingActivity |
| https://fhir.healthdata.be/ValueSet/PharmaceuticalForm | PharmaceuticalForm |
| https://fhir.healthdata.be/ValueSet/PlaceOfResidence | PlaceOfResidence |
| https://fhir.healthdata.be/ValueSet/Position | Position |
| https://fhir.healthdata.be/ValueSet/Postcode | Postcode |
| https://fhir.healthdata.be/ValueSet/ProblemName | ProblemName |
| https://fhir.healthdata.be/ValueSet/ProblemStatus | ProblemStatus |
| https://fhir.healthdata.be/ValueSet/ProblemType | ProblemType |
| https://fhir.healthdata.be/ValueSet/ProcedureMethod | ProcedureMethod |
| https://fhir.healthdata.be/ValueSet/ProcedureType | ProcedureType |
| https://fhir.healthdata.be/ValueSet/ProductCode | ProductCode |
| https://fhir.healthdata.be/ValueSet/ProductType | ProductType |
| https://fhir.healthdata.be/ValueSet/ProthesisType | ProthesisType |
| https://fhir.healthdata.be/ValueSet/PulseRegularity | PulseRegularity |
| https://fhir.healthdata.be/ValueSet/ReasonForUse | ReasonForUse |
| https://fhir.healthdata.be/ValueSet/RefractionMeasurementMethod | RefractionMeasurementMethod |
| https://fhir.healthdata.be/ValueSet/Relationship | Relationship |
| https://fhir.healthdata.be/ValueSet/ResultFlags | ResultFlags |
| https://fhir.healthdata.be/ValueSet/ResultType | ResultType |
| https://fhir.healthdata.be/ValueSet/Rhythm | Rhythm |
| https://fhir.healthdata.be/ValueSet/Role | Role |
| https://fhir.healthdata.be/ValueSet/RouteOfAdministration | RouteOfAdministration |
| https://fhir.healthdata.be/ValueSet/RouteOfExposure | RouteOfExposure |
| https://fhir.healthdata.be/ValueSet/RouteOfMedicationAdministration | RouteOfMedicationAdministration |
| https://fhir.healthdata.be/ValueSet/SOAPLineHeader | SOAPLineHeader |
| https://fhir.healthdata.be/ValueSet/SmokingStatus | SmokingStatus |
| https://fhir.healthdata.be/ValueSet/SpecimenMaterial | SpecimenMaterial |
| https://fhir.healthdata.be/ValueSet/SpecimenSource | SpecimenSource |
| https://fhir.healthdata.be/ValueSet/StatusName | StatusName |
| https://fhir.healthdata.be/ValueSet/StatusValue | StatusValue |
| https://fhir.healthdata.be/ValueSet/StomaType | StomaType |
| https://fhir.healthdata.be/ValueSet/SubstanceCode | SubstanceCode |
| https://fhir.healthdata.be/ValueSet/Symptom | Symptom |
| https://fhir.healthdata.be/ValueSet/TemperatureType | TemperatureType |
| https://fhir.healthdata.be/ValueSet/TestMethod | TestMethod |
| https://fhir.healthdata.be/ValueSet/TextResultType | TextResultType |
| https://fhir.healthdata.be/ValueSet/TimeOfDay | TimeOfDay |
| https://fhir.healthdata.be/ValueSet/ToiletTrainednessFeces | ToiletTrainednessFeces |
| https://fhir.healthdata.be/ValueSet/ToiletTrainednessUrine | ToiletTrainednessUrine |
| https://fhir.healthdata.be/ValueSet/ToiletUse | ToiletUse |
| https://fhir.healthdata.be/ValueSet/Transfer | Transfer |
| https://fhir.healthdata.be/ValueSet/Treatment | Treatment |
| https://fhir.healthdata.be/ValueSet/TreatmentDecision | TreatmentDecision |
| https://fhir.healthdata.be/ValueSet/TypeOfDisorder | TypeOfDisorder |
| https://fhir.healthdata.be/ValueSet/TypeOfDrugOrMedication | TypeOfDrugOrMedication |
| https://fhir.healthdata.be/ValueSet/TypeOfHelp | TypeOfHelp |
| https://fhir.healthdata.be/ValueSet/TypeOfHome | TypeOfHome |
| https://fhir.healthdata.be/ValueSet/TypeOfIntervention | TypeOfIntervention |
| https://fhir.healthdata.be/ValueSet/TypeOfLivingWill | TypeOfLivingWill |
| https://fhir.healthdata.be/ValueSet/TypeOfSmokingOrTobacco | TypeOfSmokingOrTobacco |
| https://fhir.healthdata.be/ValueSet/UrineCatheterType | UrineCatheterType |
| https://fhir.healthdata.be/ValueSet/UrineContinence | UrineContinence |
| https://fhir.healthdata.be/ValueSet/VaccineProduct | VaccineProduct |
| https://fhir.healthdata.be/ValueSet/VerificationStatus | VerificationStatus |
| https://fhir.healthdata.be/ValueSet/VisualAcuityMeasurementDevice | VisualAcuityMeasurementDevice |
| https://fhir.healthdata.be/ValueSet/VisualAcuityType | VisualAcuityType |
| https://fhir.healthdata.be/ValueSet/VisualAidType | VisualAidType |
| https://fhir.healthdata.be/ValueSet/VisualFunction | VisualFunction |
| https://fhir.healthdata.be/ValueSet/Walking | Walking |
| https://fhir.healthdata.be/ValueSet/WeekDay | WeekDay |
| https://fhir.healthdata.be/ValueSet/WoundDrainType | WoundDrainType |
| https://fhir.healthdata.be/ValueSet/WoundEdge | WoundEdge |
| https://fhir.healthdata.be/ValueSet/WoundType | WoundType |
| https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-alcohol-drinking-status | Alcohol Drinking Status |
| https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-benefit-type | Benefit Type |
| https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-benefitcategory | Benefit Category |
| https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-care-team-qualification | Care Team Qualification |
| https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-care-team-role | Care Team Role |
| https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-claim-type | Claim Type |
| https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-coverage-type | Coverage Type |
| https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-diagnostic-type | Diagnostic Type |
| https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-diet-type | Diet Type |
| https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-encounter-type | EncounterTypes |
| https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-general-assessment | General Assessment |
| https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-general-well-being | General Wellbeing |
| https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-lifestyle | Lifestyle |
| https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-mental-status | Mental Status |
| https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-productorservice | ProductorService |
| https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-tobacco-chewing-status | Tobacco Chewing Status |
| https://nrces.in/ndhm/fhir/r4/ValueSet/ndhm-tobacco-smoking-status | Tobacco Smoking Status |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/blood-gas-analysis-combined | Blood Gas Analysis Combined |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/diseases-combined | Diseases Combined |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/procedures-combined | Procedures Combined |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/apheresis-procedures | Apheresis-Procedures |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/cardiovascular-diseases | Cardiovascular-Diseases |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/chronic-kidney-diseases | Chronic Kidney Diseases |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/chronic-liver-diseases | Chronic-Liver-Diseases |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/chronic-lung-diseases | Chronic Lung Diseases |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/chronic-neurological-mental-diseases | Chronic Neurological Mental Diseases |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/complications-covid-19 | Complications of Covid-19 |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/condition-severity | Condition Severity |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/detected-not-detected-inconclusive | Detected Not-detected Inconclusive |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/diabetes-mellitus-diseases | Diabetes Mellitus Diseases |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/dialysis-procedures | Dialysis Procedures |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/discharge-disposition | Discharge Disposition |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/ethnic-groups | Ethnic Groups |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/gastrointestinal-ulcers | Gastrointestinal Ulcers |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/human-immunodeficiency-virus-infections | Human Immunodeficiency Virus Infections |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/known-exposure | Known Exposure to SARS-CoV-2 |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/malignant-neoplastic-diseases | Malignant Neoplastic Diseases |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/organs-for-transplant | Organs for Transplantation |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/pharmacological-therapy-snomed | Drug Therapy SNOMED |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/pregnancy-status | Pregnancy Status |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/radiology-findings | Radiology Findings |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/radiology-procedures | Radiology Procedures |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/respiratory-therapies-devices | Respiratory Therapy Devices |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/respiratory-therapies | Respiratory Therapies |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/resuscitation-status | Do-Not-Resuscitate-Order |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/rheumatological-immunological-diseases | Rheumatological Immunological Diseases |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/sars-cov-2-symptoms | SARS-CoV-2-Symptoms |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/stage-at-diagnosis | Stage at Diagnosis |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/therapeutic-intent | Therapeutic Intent |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/vaccines-snomed | Vaccines SNOMED |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/verification-status | ConditionVerificationStatus SNOMED |
| https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/yes-no-unknown-other-na | Yes-No-Unknown-Other-Na |
| http://fhir.dgmc.health.gov.il/ValueSet/body-site-laterlity | Body Site Laterality |
| http://fhir.kl.dk/ffinst/ValueSet/BodyTemperatureSCTObservables | TemperatureSCTObservables |
| http://fhir.kl.dk/ffinst/ValueSet/BodyheightSCTobservables | BodyheightSCTobservables |
| http://fhir.kl.dk/ffinst/ValueSet/BodyweightSCTobservables | BodyweightSCTobservables |
| http://fhir.kl.dk/ffinst/ValueSet/ConsciousnessSCTFindings | ConsciousnessSCTFindings |
| http://fhir.kl.dk/ffinst/ValueSet/DiastolicBloodPressureSCTObservables | DiastolicBloodPressureSCTObservables |
| http://fhir.kl.dk/ffinst/ValueSet/EQ5DSCTfindingsActivity | EQ5DSCTfindingsActivity |
| http://fhir.kl.dk/ffinst/ValueSet/EQ5DSCTfindingsAnxiety | EQ5DSCTfindingsAnxiety |
| http://fhir.kl.dk/ffinst/ValueSet/EQ5DSCTfindingsHygiene | EQ5DSCTfindingsHygiene |
| http://fhir.kl.dk/ffinst/ValueSet/EQ5DSCTfindingsMobility | EQ5DSCTfindingsMobility |
| http://fhir.kl.dk/ffinst/ValueSet/EQ5DSCTfindingsPain | EQ5DSCTfindingsPain |
| http://fhir.kl.dk/ffinst/ValueSet/HeartRateSCTobservables | HeartRateSCTobservables |
| http://fhir.kl.dk/ffinst/ValueSet/OxygenSaturationSCTobservables | OxygenSaturationSCTobservables |
| http://fhir.kl.dk/ffinst/ValueSet/RespirationRateSCTObservables | RespirationRateSCTObservables |
| http://fhir.kl.dk/ffinst/ValueSet/SCTUrinStix | SCTUrinStix |
| http://fhir.kl.dk/ffinst/ValueSet/SystolicBloodPressureSCTObservables | SystolicBloodPressureSCTObservables |
| http://fhir.kl.dk/ffinst/ValueSet/TechniqesSCTCodes | TechniqesSCTCodes |
| http://fhir.kl.dk/ffinst/ValueSet/VRSSCTfindingsPain | VRSSCTfindingsPain |
| http://fhir.kl.dk/ffinst/ValueSet/WHO5SCTfindingsActive3 | WHO5SCTfindingsActive3 |
| http://fhir.kl.dk/ffinst/ValueSet/WHO5SCTfindingsCalm2 | WHO5SCTfindingsCalm2 |
| http://fhir.kl.dk/ffinst/ValueSet/WHO5SCTfindingsHappy1 | WHO5SCTfindingsHappy1 |
| http://fhir.kl.dk/ffinst/ValueSet/WHO5SCTfindingsInterest5 | WHO5SCTfindingsInterest5 |
| http://fhir.kl.dk/ffinst/ValueSet/WHO5SCTfindingsRested4 | WHO5SCTfindingsRested4 |
| http://hl7.org/fhir/uv/ips/ValueSet/allergy-intolerance-substance-condition-uv-ips | Allergy intolerance substance condition - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/core-problem-finding-situation-event-gps-uv-ips | CORE Problem List Finding/Situation/Event (GPS) - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/medical-devices-uv-ips | Medical Devices - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/medication-example-uv-ips | Medications (example) - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/medication-snomed-uv-ips | Medications (SNOMED CT) - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/medicine-active-substances-uv-ips | Medicine Active Substances - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/procedures-uv-ips | Procedures - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/result-coded-value-pathology-gps-uv-ips | Results Coded Values Pathology (GPS) - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/results-laboratory-blood-abo-rh-grp-gps-uv-ips | Results Laboratory ABO+RH Group (GPS) - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/results-laboratory-presence-absence-gps-uv-ips | Results Laboratory Presence/Absence (GPS) - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/results-organism-gps-uv-ips | Results Organism (GPS) - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/results-radiology-numobs-gps-dicom-uv-ips | Results Radiology Measurement Observation (GPS-DICOM) - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/results-radiology-txtobs-gps-dicom-loinc-uv-ips | Results Radiology Textual Observations (GPS-DICOM-LOINC) - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/results-specimen-collection-method-gps-uv-ips | Results Specimen Collection Method (GPS) - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/results-specimen-type-gps-uv-ips | Results Specimen Type (GPS) - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/snomed-intl-gps | SNOMED International Global Patient Set (GPS) |
| http://hl7.org/fhir/uv/ips/ValueSet/target-site-uv-ips | Target Site - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/targetDiseases-gps-uv-ips | Vaccine Target Diseases (GPS) - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/targetDiseases-uv-ips | Vaccine Target Diseases - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/vaccines-gps-uv-ips | Vaccines (GPS) - IPS |
| https://fhir.nhs.uk/ValueSet/NHSDigital-CareSettingType | NHSDigital-CareSettingType |
| https://fhir.nhs.uk/ValueSet/NHSDigital-ImmunizationExplanationReason | NHS Digital Immunization Explanation Reason |
| https://fhir.nhs.uk/ValueSet/NHSDigital-VaccinationProcedure | Interim version of UK Core Vaccination Procedure. |
| https://fhir.nhs.uk/ValueSet/NHSDigital-MedicationDispense-Code | Digital Medicine MedicationDispense Code |
| https://fhir.nhs.uk/ValueSet/NHSDigital-MedicationRequest-Code | Digital Medicine MedicationRequest Code |
| https://fhir.nhs.uk/ValueSet/NHSDigital-MedicationCode | NHS Digital Medication Code |
| https://fhir.nhs.uk/ValueSet/NHSDigital-ReasonImmunizationNotAdministered | NHSDigital Reason Immunization Not Administered |
| https://fhir.nhs.uk/ValueSet/NHSDigital-VaccineCode | NHS Digital Vaccine Code |
| https://fhir.nhs.uk/ValueSet/NHSDigital-action-code | NHSDigital Action Code |
| https://fhir.nhs.uk/ValueSet/NHSDigital-ServiceRequest-category | ServiceRequestCategory |
| https://fhir.nhs.uk/ValueSet/DocumentCategory | NHSEnglandDocumentCategory |
| https://fhir.nhs.uk/ValueSet/Document-Type | NHSEnglandDocumentType |
| https://fhir.nhs.uk/ValueSet/covid-19-snomed-procedure-code-vs | COVID-19 SNOMED CT Procedure Code Value Set |
| https://www.medizininformatik-initiative.de/fhir/core/modul-prozedur/ValueSet/procedures-intend | MII VS Prozedur Durchführungsabsicht [SNOMED CT] |
| https://www.medizininformatik-initiative.de/fhir/core/modul-prozedur/ValueSet/procedures-category-sct | MII VS Prozedur OPS Kategorien [SNOMED CT] |
| https://www.medizininformatik-initiative.de/fhir/core/modul-prozedur/ValueSet/procedures-sct | MII VS Prozedur Prozeduren [SNOMED CT] |
| https://demis.rki.de/fhir/ValueSet/answerSetLaboratoryTest-SNOMED | SNOMED-AnswerSet für Labortest |
| https://demis.rki.de/fhir/ValueSet/answerSetNCVP | AnswerSet für Vibrio spp., humanpathogen (außer Erreger der Cholera); soweit ausschließlich eine Ohrinfektion vorliegt, nur bei Vibrio cholerae non O1/non-O139 |
| https://demis.rki.de/fhir/ValueSet/answerSetResistance-SNOMED | SNOMED-AnswerSet für Resistenz |
| https://demis.rki.de/fhir/ValueSet/answerSetWBKP | AnswerSet für Krankheitserreger unter Berücksichtigung der Art der Krankheitserreger und der Häufigkeit ihres Nachweises wenn Hinweise auf eine schwerwiegende Gefahr für die Allgemeinheit bestehen |
| https://demis.rki.de/fhir/ValueSet/materialNCVP | Material für Vibrio spp., humanpathogen (außer Erreger der Cholera); soweit ausschließlich eine Ohrinfektion vorliegt, nur bei Vibrio cholerae non O1/non-O139 |
| https://demis.rki.de/fhir/ValueSet/reasonForTesting | Untersuchungsgrund |
| http://fhir.ch/ig/ch-epr-term/ValueSet/DocumentEntry.classCode | DocumentEntry.classCode |
| http://fhir.ch/ig/ch-epr-term/ValueSet/DocumentEntry.confidentialityCode | DocumentEntry.confidentialityCode |
| http://fhir.ch/ig/ch-epr-term/ValueSet/DocumentEntry.healthcareFacilityTypeCode | DocumentEntry.healthcareFacilityTypeCode |
| http://fhir.ch/ig/ch-epr-term/ValueSet/DocumentEntry.practiceSettingCode | DocumentEntry.practiceSettingCode |
| http://fhir.ch/ig/ch-epr-term/ValueSet/DocumentEntry.typeCode | DocumentEntry.typeCode |
| http://fhir.ch/ig/ch-epr-term/ValueSet/HCProfessional.hcProfession | HCProfessional.hcProfession |
| http://fhir.ch/ig/ch-epr-term/ValueSet/SubmissionSet.contentTypeCode | SubmissionSet.contentTypeCode |
| https://sil-th-group-a.org/valueset/screening-tests | Lung Cancer Screening Tests |
| https://sil-th-group-a.org/valueset/lung-cancer-condition | lung-cancer-condition |
| http://fhir.nottinghamshire.gov.uk/valueset/preferred-place-of-death | Preferred place of death |
| http://ontariohealth.ca/fhir/ValueSet/service-category-eServices | Service Category-eServices |
| http://ontariohealth.ca/fhir/ValueSet/service-type-ocean | Service Type OCEAN |
| http://hl7.org/fhir/uv/ips/ValueSet/allergy-intolerance-substance-product-gps-uv-ips | Allergy-intolerance substance-product - GPS - IPS |
| http://hl7.org/fhir/uv/ips/ValueSet/allergy-intolerance-substance-product-snomed-extended-uv-ips | Allergy intolerance substance product - SNOMED CT extended - IPS |
| http://hl7.org/fhir/ValueSet/covid-19-cond | COVID-19 related Condition codes |
| http://terminology.hl7.org/ValueSet/snomed-intl-ips | SNOMED CT® International Patient Set (IPS) |
| https://medipee.com/fhir/uroli-export/ValueSet/HighMediumLowVS | SCT: High - Medium - Low |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.3.2--20150401000000 | AlcoholGebruikStatusCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.8.3.2--20150401000000 | AlertNaamCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.2.1--20150401000000 | BehandelingCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.4.2--20150401000000 | DiastolischEindpuntCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.4.2--20150401000000 | DrugGebruikStatusCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.4.1--20150401000000 | DrugsOfGeneesmiddelSoortCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.2.4--20150401000000 | GeverifieerdBijCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.3.2--20150401000000 | HartslagMeetMethodeCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.3.1--20150401000000 | HartslagRegelmatigheidCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.4.5--20150401000000 | HoudingCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.10.1.2--20150401000000 | HulpmiddelAnatomischeLocatieCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.4.4--20150401000000 | MeetLocatieCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.4.1--20150401000000 | MeetmethodeCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.16.1.2--20150401000000 | OrderStatusCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.16.1.2--20171231000000 | OrderStatusCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.5.1.3--20150401000000 | ProbleemNaamCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.5.1.1--20150401000000 | ProbleemTypeCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.9.6.2--20171231000000 | RedenMedicatieafspraakCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.9.11.2--20171231000000 | RedenWijzigenOfStoppenGebruikCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.2.3--20150401000000 | SoortTabakGebruikCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.26.4--20150401000000 | StatusNaamSnomedCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.26.8--20150401000000 | StatusWaardeSnomedCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.2.2--20150401000000 | TabakGebruikStatusCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.2.1--20150401000000 | TekstUitslagTypeCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.6.1--20150401000000 | TemperatuurTypeCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.14.1.1--20150401000000 | VerrichtingAnatomischeLocatieCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.1.2--20171231000000 | AfnameprocedureCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.5.3--20171231000000 | AfwijkendAdemhalingspatroonCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.3.2--20171231000000 | AlcoholGebruikStatusCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.8.3.2--20171231000000 | AlertNaamCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.8.2.2--20171231000000 | AllergieCategorieCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.2.1.1--20171231000000 | BehandelingCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.15.1.3--20171231000000 | BestemmingCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.4.2--20171231000000 | BrandwondAnatomischeLocatieCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.4.4--20171231000000 | BrandwondLateraliteitCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.4.3--20171231000000 | BrandwondSoortCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.1.9--20171231000000 | ContainerTypeCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.9.12.3--20171231000000 | DagdeelCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.1.2--20171231000000 | DecubitusAnatomischeLocatieCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.1.1--20171231000000 | DecubitusCategorieCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.1.3--20171231000000 | DecubitusWondLateraliteitCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.15.5--20171231000000 | DefecatieKleurCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.4.2--20171231000000 | DiastolischEindpuntCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.5.2--20171231000000 | DiepteCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.4.1--20171231000000 | DieptegraadCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.8.2--20171231000000 | DrinkBeperkingenCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.8.1--20171231000000 | DrinkenCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.4.2--20171231000000 | DrugsGebruikStatusCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.4.1--20171231000000 | DrugsOfGeneesmiddelSoortCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.7.2--20171231000000 | EetBeperkingenCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.8.2.6--20171231000000 | ErnstCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.7.1--20171231000000 | EtenCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.2.1.4--20171231000000 | GeverifieerdBijCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.13.1--20171231000000 | GezinssamenstellingCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.16.1--20171231000000 | GezinssamenstellingKindCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.3.2--20171231000000 | HartslagMeetMethodeCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.3.1--20171231000000 | HartslagRegelmatigheidCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.15.1.2--20171231000000 | HerkomstCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.17.1--20171231000000 | HoorFunctieCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.17.2--20171231000000 | HorenHulpmiddelTypeCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.4.5--20171231000000 | HoudingCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.3.4--20171231000000 | HoudingHandhavenCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.3.1--20171231000000 | HoudingVeranderenCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.3.2--20171231000000 | HuidAnatomischeLocatieCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.3.3--20171231000000 | HuidLateraliteitCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.10.1.2--20171231000000 | HulpmiddelAnatomischeLocatieCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.10.2.1--20171231000000 | InfuuskatheterTypeCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.1.7--20171231000000 | InterpretatieVlaggenCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.14.2.4--20171231000000 | InterventieSnomedCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.1.12--20171231000000 | LateraliteitCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.5.1--20171231000000 | LevensovertuigingCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.17.3--20171231000000 | LocatieGehoorapparaatCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.3.9--20171231000000 | LopenCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.10.2.2--20171231000000 | LumenLocatieCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.8.2.4--20171231000000 | MateVanKritiekZijnCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.10.1.4--20171231000000 | MedischHulpmiddelLateraliteitCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.4.4--20171231000000 | MeetLocatieCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.4.1--20171231000000 | MeetmethodeCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.3.4--20171231000000 | MeetmethodeCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.3.2--20171231000000 | MetingNaamCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.1.10--20171231000000 | MicroorganismeCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.1.11--20171231000000 | MonsterAnatomischeLocatieCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.1.6--20171231000000 | MonstermateriaalCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.1.13--20171231000000 | MorfologieCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.3.3--20171231000000 | OnderzoekCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.32.3--20171231000000 | OntwikkelingMotoriekCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.32.4--20171231000000 | OntwikkelingSociaalCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.32.5--20171231000000 | OntwikkelingTaalCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.32.6--20171231000000 | OntwikkelingVerstandelijkCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.9.2--20171231000000 | PijnAnatomischeLocatieCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.9.3--20171231000000 | PijnLateraliteitCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.7.1--20171231000000 | PolsRegelmatigheidCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.5.1.5--20171231000000 | ProbleemAnatomischeLocatieCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.5.1.6--20171231000000 | ProbleemLateraliteitCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.5.1.2--20171231000000 | ProbleemStatusCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.5.1.1--20171231000000 | ProbleemTypeCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.10.1.1--20171231000000 | ProductTypeCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.13.2--20171231000000 | ProtheseTypeCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.1.1--20171231000000 | ResultaatTypeCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.5.1--20171231000000 | RitmeCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.29.4--20171231000000 | SNAQrcHulpBijEtenCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.14.1--20171231000000 | SchedelomvangMeetmethodeCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.10.3.1--20171231000000 | SondeTypeCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.3.1--20171231000000 | SoortAandoeningCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.3.2.1--20171231000000 | SoortHulpCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.14.3.3--20171231000000 | SoortInterventieCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.2.3--20171231000000 | SoortTabakGebruikCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.8.2.16--20171231000000 | SpecifiekeStofAllergeneStoffenCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.26.4--20171231000000 | StatusNaamSnomedCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.26.8--20171231000000 | StatusWaardeSnomedCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.5.2.2--20171231000000 | StomaAnatomischeLocatieCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.5.2.3--20171231000000 | StomaLateraliteitCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.5.2.1--20171231000000 | StomaTypeCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.8.2.5--20171231000000 | SymptoomCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.11.2--20171231000000 | TeKledenLichaamsdeelCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.10.2--20171231000000 | TeWassenLichaamsdeelCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.2.1--20171231000000 | TekstUitslagTypeCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.6.1--20171231000000 | TemperatuurTypeCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.1.4--20171231000000 | TestmethodeCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.5.4--20171231000000 | ToedieningHulpmiddelCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.22.4--20171231000000 | ToiletgebruikCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.3.12--20171231000000 | TraplopenCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.33.1--20171231000000 | UiterlijkeVerzorgingCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.3.7--20171231000000 | UitvoerenTransferCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.14.2--20171231000000 | UrineKatheterTypeCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.5.1.4--20171231000000 | VerificatieStatusCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.8.2.17--20171231000000 | VeroorzakendeStofAllergeneStoffenCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.34.1--20171231000000 | VerrichtenVPKHandelingCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.14.1.2--20171231000000 | VerrichtingTypeCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.13.1--20171231000000 | VerzorgenTandenCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.16.1--20171231000000 | VisueleFunctieCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.31.2--20171231000000 | VoedingMethodeCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.31.1--20171231000000 | VoedingSoortCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.9.12.2--20171231000000 | WeekdagCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.8.2.12--20171231000000 | WijzeVanBlootstellingCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.2.6--20171231000000 | WondAnatomischeLocatieCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.2.7--20171231000000 | WondDrainTypeCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.2.8--20171231000000 | WondLateraliteitCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.2.4--20171231000000 | WondSoortCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.35.1--20171231000000 | ZelfstandigMedicatiegebruikCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.11.1--20171231000000 | ZichKledenCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.10.1--20171231000000 | ZichWassenCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.16.2--20171231000000 | ZienHulpmiddelTypeCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.32.2--20171231000000 | ZindelijkheidFecesCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.32.1--20171231000000 | ZindelijkheidUrineCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.22.3--20171231000000 | ZorgBijMenstruatieCodelijst |
| http://hl7.org/fhir/ValueSet/animal-breeds | animal breeds |
| http://hl7.org/fhir/ValueSet/animal-species | animal species |
| http://hl7.org/fhir/ValueSet/barrier | Barrier |
| http://hl7.org/fhir/ValueSet/condition-cause | Condition Cause Codes |
| http://hl7.org/fhir/ValueSet/condition-course | Condition Course Codes |
| http://hl7.org/fhir/ValueSet/condition-predecessor | Condition Predecessor Codes |
| http://hl7.org/fhir/ValueSet/dataelement-sdcobjectclass | DataElement SDC Object Class |
| http://hl7.org/fhir/ValueSet/dataelement-sdcobjectclassproperty | DataElement SDC Object Class Property |
| http://hl7.org/fhir/ValueSet/feeding-device | Feeding Device Codes Value Set |
| http://hl7.org/fhir/ValueSet/focal-subject | Focal Subject Codes |
| http://hl7.org/fhir/ValueSet/protective-factor | Protective Factor |
| http://hl7.org/fhir/ValueSet/specimen-additive-substance | Specimen Additive Substance Codes |
| http://medmij.nl/fhir/ValueSet/DentalCare-ASAScore | DentalCare - ASA Score |
| http://medmij.nl/fhir/ValueSet/DentalCare-OralHygieneFinding | DentalCare - Oral Hygiene Finding |
| https://mednet.swiss/fhir/ValueSet/mni-obs-bloodGroup | MedNet Interface (MNI) - Blood Group Observation ValueSet |
| https://mednet.swiss/fhir/ValueSet/mni-serviceRequestCode | MedNet Interface (MNI) - ServiceRequest Code ValueSet |
| http://hl7.org/fhir/ValueSet/body-site | SNOMED CT Body Structures |
| http://omi.de/fhir/registry/ValueSet/type-code-value-set | Type Code Value Set |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.26.11.7--20211028090253 | CategorieCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.26.11.31--20231207101023 | DiagnoseNaamCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.26.11.19--20231120131658 | ErnstCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.26.11.41--20240910090504 | StartRedenCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.26.11.34--20240501114150 | SymptoomErnstCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.26.11.35--20240501114333 | SymptoomNaamCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.26.11.16--20231120123250 | VerwachtRisicoBijBlootstellingCodelijst |
| http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.26.11.14--20231120120019 | WijzeVanVaststellenCodelijst |
| http://portal.esysta.com/fhir/ValueSet/BloodGlucoseMarkVS | BloodGlucoseMarkVS |
| http://portal.esysta.com/fhir/ValueSet/BloodGlucoseUnit | BloodGlucoseUnit |
| http://portal.esysta.com/fhir/ValueSet/CarbohydrateUnit | CarbohydrateUnit |
| http://portal.esysta.com/fhir/ValueSet/CarbohydrateUnitSettingVS | CarbohydrateUnitSettingVS |
| http://portal.esysta.com/fhir/ValueSet/CarbohydrateUnitVS | CarbohydrateUnitVS |
| http://portal.esysta.com/fhir/ValueSet/DiabetesType | DiabetesType |
| http://portal.esysta.com/fhir/ValueSet/DiabetesTypeVS | DiabetesTypeVS |
| http://portal.esysta.com/fhir/ValueSet/DiaryEventVS | DiaryEventVS |
| http://portal.esysta.com/fhir/ValueSet/EsystaEvaluationColorVS | EsystaEvaluationColorVS |
| http://portal.esysta.com/fhir/ValueSet/EvaluationColor | EvaluationColor |
| http://portal.esysta.com/fhir/ValueSet/EvaluationColorVS | EvaluationColorVS |
| http://portal.esysta.com/fhir/ValueSet/InsulinPenMarkerColor | InsulinPenMarkerColor |
| http://portal.esysta.com/fhir/ValueSet/InsulinPenMarkerColorVS | InsulinPenMarkerColorVS |
| http://portal.esysta.com/fhir/ValueSet/InsulinType | InsulinType |
| http://portal.esysta.com/fhir/ValueSet/InsulinTypeVS | InsulinTypeVS |
| http://portal.esysta.com/fhir/ValueSet/MedicalFindingStageVS | MedicalFindingStageVS |
| http://portal.esysta.com/fhir/ValueSet/MedicalFindingsVS | MedicalFindingsVS |
| https://gematik.de/fhir/terminology/ValueSet/epa-medication-snomed-ct-vs | EPAMedicationSNOMEDCTVS |
| https://gematik.de/fhir/terminology/ValueSet/epa-medication-type-pharmaceutical-product-vs | EPA Medication Type ValueSet for a EPA Pharmaceutical Product |
| https://gematik.de/fhir/terminology/ValueSet/epa-medication-type-product-vs | EPA Medication Type ValueSet for PZN-Medication |
| https://gematik.de/fhir/terminology/ValueSet/epa-medication-type-vs | EPA Medication Type ValueSet |
| https://gematik.de/fhir/terminology/ValueSet/epa-medicine-form-snomed-ct-vs | Darreichungsform SNOMED CT® |
| https://gematik.de/fhir/terminology/ValueSet/epa-substance-snomed-ct-vs | EPA Substance SNOMED-CT® ValueSet |
| https://www.ehealth.fgov.be/standards/fhir/patientwill/ValueSet/be-vs-patientwill-scope | BeVSPatientWillScope |
| http://fhir.kl.dk/children/ValueSet/BodyheightSCTobservablesChildren | HøjdeObservationskoderSCT |
| https://furore.com/data/fhir/ValueSet/EducationLevelVS | Education level of patient ValueSet |
| https://furore.com/data/fhir/ValueSet/ProcedureIntentVS | Procedure Intent Value Set |
| http://hl7.it/fhir/lab-report/ValueSet/additivo-campione-it | Additivo Campione |
| http://hl7.it/fhir/lab-report/ValueSet/campione-container-lab-it | Container Campione |
| http://hl7.it/fhir/lab-report/ValueSet/results-microorganism-snomed-ct-ips-free-set | Risultato osservazione codificato - microorganismo IPS di SNOMED CT |
| http://hl7.it/fhir/lab-report/ValueSet/results-observation-bloodgroup | Risultato osservazione codificato - Gruppo Sanguigno IPS di SNOMED CT |
| http://hl7.it/fhir/lab-report/ValueSet/results-presence-absence-snomed-ct-ips-free-set | Risultato osservazione codificato - presenza/assenza IPS di SNOMED CT |
| http://hl7.it/fhir/lab-report/ValueSet/tipo-campione-lab-it | Tipo campione |
| http://hl7.it/fhir/lab-report/ValueSet/valueset-observation-value-bloodgroup | Risultato osservazione codificato gruppo sanguigno |
| http://hl7.it/fhir/lab-report/ValueSet/valueset-observation-value-microorganism | Risultato osservazione codificato microorganismi |
| http://hl7.it/fhir/lab-report/ValueSet/valueset-observation-value-presence-absence | Risultato osservazione codificato presenza/assenza |
| https://tstifhir.azurehealthcareapis.com/ValueSet/adultcheck-code | 成人預防保健疾病史代碼集值 |
| https://tstifhir.azurehealthcareapis.com/ValueSet/adultcheck-lifecode | 成人預防保健生活史代碼集值 |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_TELE_Clinical_Course | Verlauf |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_TELE_Procedure_And_Recommendations | Weiteres Procedere und Empfehlung |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_TELE_Results_Type | Befundtyp |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_TELE_SNOMED_CT_Drug_Therapy_Status_Codes | Medikation Therapie Statuscodes SNOMED CT® |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_TELE_Type_Of_Medical_History | Art der Anamnese |
| http://fhir.data4life.care/covid-19/r4/ValueSet/chronic-condition-set | ChronicConditions |
| http://fhir.data4life.care/covid-19/r4/ValueSet/covapp-symptoms-group-1 | Symptoms |
| http://fhir.data4life.care/covid-19/r4/ValueSet/covapp-symptoms-group-2 | Symptoms |
| https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-allergic-disposition-sct | Allergic Disposition SCT |
| https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-body-positioning-snomed | Body Positioning SNOMED CT |
| https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-radiologic-finding-sct | Radiologic Finding SCT |
| https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-substances-snomed | Substances SNOMED CT |
| https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/ValueSet/vs-ventilation-observable-sct | Ventilation Observable SCT |
| https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-ACVPU-1 | Care Connect ACVPU |
| https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-AllergyCertainty-1 | Care Connect Allergy Certainty |
| https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-InspiredOxygen-1 | Care Connect Inspired Oxygen |
| https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-SaturatedOxygenSp02Scale-1 | Care Connect Saturated Oxygen Sp02 Scale |
| https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-ObservationMethod-1 | Care Connect Observation Method |
| https://fhir.hl7.org.uk/STU3/ValueSet/CareConnect-ObservationType-1 | Care Connect Observation Type |
| https://demis.rki.de/fhir/ValueSet/materialWBGP | Material für Meldepflicht für die Meldepflicht von Krankheitserregern mit Hinweise auf eine schwerwiegende Gefahr für die Allgemeinheit |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_KHE_Initiated_Services_SNOMED_CT | Veranlasste Leistungen |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_KHE_Results_Type | Befundtyp |
| https://www.medizininformatik-initiative.de/fhir/core/modul-labor/ValueSet/Laborergebnis-semiquantitativ | MII VS Labor Laborergbenis Semiquantitativ |
| https://www.medizininformatik-initiative.de/fhir/core/modul-labor/ValueSet/Laborergebnis-qualitativ | MII VS Labor Laborergebnis Qualitativ |
| https://www.medizininformatik-initiative.de/fhir/core/modul-labor/ValueSet/QuelleKlinischesBezugsdatum | MII VS Labor Quelle klinisches Bezugsdatum |
| http://hl7.org/fhir/us/immds/ValueSet/targetDisease | Vaccine Target Disease |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.1280649 | Sneezing and Itching Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.15972546 | Conditions Indicating Appropriate Sinonasal Imaging |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.16432390 | Cerumen Impaction |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.16929355 | Allergic Rhinitis Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.18316962 | Severe Asthma |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.23618223 | Hearing Aids Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.33895.1.3.0.45 | Comfort Measures |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.15.1.999.1 | Selected non pharmaceutical therapies for moderate to severe chronic pain |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.18.1.1.11.1.999.1 | pain medication action plan |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.15.7.1.1.11.1.999.1 | selected follow up visit intervals for opioid monitoring |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.4.7 | malignant neoplasms and cancer pain |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.4.9 | malignancy or cancer related pain |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.150 | Cerumen on Otoscopy |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.172 | Hearing Loss |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.175 | Tinnitus |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.14.1.999.178 | Ear Congestion |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.15.1.999.179 | Ear Pruritus |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.180 | Otalgia |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31441.1.2.999.96 | Initial Encounter with Otolaryngologist or undefined clinician |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31212.1.1.999.81 | Cerumen Impaction |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.1.999.188 | Radiotherapy |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.191 | Head and Neck Anatomic Locations |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.194 | Ear Canal Stenosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.197 | Exostoses |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.200 | Non intact Tympanic Membrane |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.11.1.999.246 | Hearing Aids |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.11.1.999.250 | DO NOT USE |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.252 | Irrigation |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31593.1.12.1.999.288 | Otoscopy performed on exam |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31663.1.1.999.291 | Otolaryngologist as a Clinician or Service |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31104.1.1.999.275 | Dermatologic Diseases of the Ear |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31108.1.1.999.20 | Keratoses Obturans |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.11.1.999.221 | Tympanoplasty |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.12.1.999.223 | Myringoplasty |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.13.1.999.225 | Mastoidectomy |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.14.1.999.227 | Ear Surgery, Other |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.336 | Sleep Apnea |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.237 | Allergic Rhinitis |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.263 | Uncontrolled or severe asthma |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.302 | Rhinosinusitis |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.305 | Nasal Polyposis |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.308 | Suspected Nasal Neoplasm |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.11.1.999.215 | Sneezing as a finding |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.12.1.999.217 | Pruritus Unspecified or Other Location |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.34920.1.1.999.290 | Clinicians who perform allergy testing |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35043.1.1.999.279 | Radiography of face, head or neck |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.318 | Eustachian Tube Dysfunction |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35607.1.11.1.999.267 | Immunotherapy that is not Identified as Subcutaneous |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35607.1.14.1.999.268 | Immunotherapy |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.657 | Clostridium difficile infection |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.724 | Ileus due to infection |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.727 | Vomiting potentially due to CDI |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.730 | Toxic Megacolon in adults |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.14.1.999.732 | Abdominal Distension |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.690 | Septic Shock due to C. Diff |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.37937.1.13.2.999.660 | History of CDI |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38112.1.1.999.661 | Consult Infectious Disease |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38827.1.1.999.691 | Abdominal Xrays for CDI |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38839.1.1.999.692 | CT of abdomen with contrast for fulminant CDI |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38904.1.1.999.693 | Surgical consult for CDI |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.39406.1.1.999.694 | Fecal microbiota transplantation |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.4.37623.1.1.999.645 | Hospitalist |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37627.1.1.999.697 | Positive result indicator |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.11.1.999.646 | Body Temperature |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.648 | Diarrhea Potentially due to CDI |
| http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.9.37637.1.1.999.652 | Inpatient Setting |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.1 | Substance Reactant for Intolerance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.2 | Clinical Substance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.9 | Substance Other Than Clinical Drug |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1018.240 | SNOMED CT CORE Problem List |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1018.98 | Route of Administration |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.101 | Gender Identity USCDI core |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.120 | Patient Sex for Quality Measurement |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.121 | CMS Sex |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.14 | Published test VS |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.33 | Sexual Orientation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.40 | MDP Test Intensional |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.56 | Medical Reason Not Done SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.120 | Phototherapy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.121 | Phototherapy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.123 | Neonatal Jaundice |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.124 | Neonatal Jaundice |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.126 | Maternal Drug Use |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.127 | Maternal Drug Use |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.129 | Fetal Conditions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.130 | Fetal Conditions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.132 | Congenital Malformations |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.133 | Congenital Malformations |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.135 | Social Indications |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.136 | Social Indications |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.138 | Severe Birth Trauma |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.139 | Severe Birth Trauma |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.141 | Severe Hypoxia or Asphyxia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.142 | Severe Hypoxia or Asphyxia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.144 | Severe Shock and Resuscitation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.145 | Severe Shock and Resuscitation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.147 | Neonatal Severe Respiratory Complications |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.148 | Neonatal Severe Respiratory Complications |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.150 | Neonatal Severe Infection |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.151 | Neonatal Severe Infection |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.153 | Neonatal Severe Neurological Complications |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.154 | Neonatal Severe Neurological Complications |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.156 | Severe Shock and Resuscitation Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.157 | Severe Shock and Resuscitation Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.159 | Neonatal Severe Respiratory Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.160 | Neonatal Severe Respiratory Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.162 | Neonatal Severe Neurological Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.163 | Neonatal Severe Neurological Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.165 | Neonatal Severe Septicemia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.166 | Neonatal Severe Septicemia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.168 | Moderate Birth Trauma |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.169 | Moderate Birth Trauma |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.171 | Moderate Respiratory Complications |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.172 | Moderate Respiratory Complications |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.174 | Moderate Respiratory Complications Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.175 | Moderate Respiratory Complications Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.177 | Moderate Birth Trauma with LOS |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.178 | Moderate Birth Trauma with LOS |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.180 | Moderate Respiratory Complications with LOS |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.181 | Moderate Respiratory Complications with LOS |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.186 | Moderate Respiratory complications with LOS Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.187 | Moderate Respiratory complications with LOS Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.189 | Single Liveborn Newborn Vaginal |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.190 | Single Liveborn Newborn Vaginal |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.192 | Single Liveborn Newborn Cesarean |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.193 | Single Liveborn Newborn Cesarean |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.196 | Moderate Infection with LOS |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.197 | Moderate Infection with LOS |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.205 | Neonatal Intensive Care Unit |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.206 | Intensive Care Unit |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.209 | Blood Transfusion Administration |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.213 | Blood Transfusion |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.24 | Blood Transfusion Administration |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.246 | Blood Transfusion |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.248 | Conversion of Cardiac Rhythm |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.250 | Hysterectomy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.252 | Tracheostomy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.254 | Ventilation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.256 | Severe Maternal Morbidity Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.357 | Conversion of Cardiac Rhythm |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.358 | Hysterectomy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.359 | Tracheostomy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.360 | Ventilation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.368 | Preadmission Observation Undelivered Mother |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.369 | ED Visit and OB Triage |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.372 | COVID 19 Confirmed |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.373 | COVID 19 Confirmed |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.375 | Respiratory Conditions Related to COVID 19 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.376 | Respiratory Conditions Related to COVID 19 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.378 | Respiratory Support Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.379 | Respiratory Support Procedures Related to COVID 19 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.67 | Other Health Care Facility |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.10 | Non essential Hypertension SNOMEDCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.102 | Suicide Attempt |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.13 | Cirrhosis SNOMEDCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.14 | Cirrhosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.151 | Polycystic Ovary Syndrome |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.230 | Gestational Diabetes SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.233 | All Results of High Risk HPV Test |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.234 | High Risk HPV Positive Results |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.248 | Suicide Attempt SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.263 | High Risk Positive HPV Results Without HPV16 or HPV18 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.264 | CDS Pregnancy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.266 | Rhabdomyolysis Intensional |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.267 | CDS Rhabdomyolysis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.268 | HPV Negative Results |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.29 | Non pharmacologic treatments for chronic pain SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.296 | SCT Findings 202209 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.302 | Test Cervical Excision Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.307 | Counseling for Physical Activity CDS |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.309 | SCT Findings 202309 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.311 | SCT Procedures 202209 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.312 | SCT Procedures 202309 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.313 | Statin Allergen Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.36 | Non pharmacologic treatments for chronic pain |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.48 | Anxiety |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.51 | Sleep disordered breathing |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.52 | Anxiety |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.53 | Sleep disordered breathing |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.79 | Behavioral Counseling for Nutrition and Activity Referral |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.85 | Impaired Glucose Tolerance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.9 | Hypertension |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.90 | Gestational Diabetes |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.96 | Dependence on dialysis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.464 | Cluster Headache |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.555 | Patient Declines Treatment for Cluster Headache (SNOMEDCT) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.641 | Neuromodulation for migraine |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.642 | No pain with headache |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.646 | Anxiety Disorders (ICD10 and SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.648 | Depression Diagnosis (ICD10 and SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.649 | Psychosis (ICD10 and SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.650 | Cluster Headache (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.660 | Acute cluster headache treatment |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.662 | Long term preventive treatment for cluster headache |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.105 | Abnormal Presentation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.15 | Intravenous Thrombolytic tPA Therapy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.16 | Intraarterial Thrombolytic tPA Therapy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.171 | Abnormal Presentation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.173 | Delivery of Singleton |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.21 | Intravenous or Intraarterial Thrombolytic tPA Therapy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.27 | Cornual Ectopic Pregnancy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.59 | Delivery Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.67 | PCI |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.69 | Endotracheal Intubation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.99 | Delivery of Singleton |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.225 | Opioid Medication Assisted Treatment (MAT) SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.243 | Opioid Use Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.279 | Triage |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.283 | Emergency Department Location |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.284 | Emergency Department Location |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.285 | Mental Health Diagnosis without Substance Use Disorders |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.286 | Decision to Transfer |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.10 | Breastfeeding |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.100 | Familial Hypercholesterolemia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.102 | Rhabdomyolysis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.12 | Liver Disease |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.13 | Rhabdomyolysis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.20 | Atherosclerosis and Peripheral Arterial Disease |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.21 | Atherosclerosis and Peripheral Arterial Disease |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.42 | Liver Disease |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.44 | Cerebrovascular Disease Stroke or TIA |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.46 | Ischemic Heart Disease or Related Diagnoses |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.47 | Stable and Unstable Angina |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.502 | Overweight or Obese |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.513 | Elevated Blood Pressure Reading |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.514 | Finding of Elevated Blood Pressure or Hypertension |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.525 | Referral (ophthalmology) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.527 | Retina visualization inadequate |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.528 | Refusal or Noncompliance with treatment |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.530 | Vitreous hemorrhage |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.553 | Uveitis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.560 | Tonometry |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.576 | Vitreous hemorrhage |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.580 | Intravitreal and Periocular Injections |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.581 | Intravitreal and Periocular Injections |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.587 | Lost to follow up |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.588 | Uveitis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.611 | 3 Mirror Goldmann exam |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.612 | Scleral depressed exam |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.615 | Physical Disability |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.616 | Financial difficulty |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.619 | Scleral depressed exam |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.69 | Stable and Unstable Angina |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.70 | Ischemic Heart Disease or Related Diagnoses |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.71 | Cerebrovascular Disease Stroke or TIA |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.73 | Breastfeeding |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.85 | Familial Hypercholesterolemia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.9 | Outpatient Encounters for Preventive Care |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.53 | Indicators of Human Immunodeficiency Virus (HIV) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.105 | conditions_heartfailure |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.110 | CKD stage4above SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.111 | CKD stage4above |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.113 | Chronic kidney disease SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.117 | DigTx Cognitive Impairment SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.120 | Diabetic ketoacidosis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.121 | Diabetic ketoacidosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.124 | DKD |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.147 | HFrEF SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.151 | History of Hypoglycemia SCD |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.17 | Atrial fibrillation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.184 | DigTx Virtual Reality Contraindications Visual Impairment |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.21 | Thoracic aorta disease |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.214 | Type 1 Diabetes Mellitus SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.244 | MRA Mineralocorticoid Receptor Antagonist Allergy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.260 | UACR SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.281 | Allergy or adverse reaction to statins |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.37 | relatedconditions_hypertension SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.440 | relatedconditions_T2DM SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.459 | Liver cancer |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.47 | ACE inhibitor allergy/intolerance codes |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.474 | Allergy to Tdap Vaccine |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.475 | Allergy to Td Vaccine |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.476 | Allergy To Vaccine Component |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.478 | Allergy to HPV Vaccine |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.48 | ACE inhibitor allergy/intolerance codes |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.492 | Inhaled Corticosteroids Allergy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.498 | Metformin AllergyIntolerance SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.5 | Delivery - Procedure |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.516 | Allergy to Herpes Zoster Vaccine SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.519 | Drug hypersensitivity SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.520 | Drug hypersensitivity |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.524 | Chronic Hepatitis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.525 | Chronic Hepatitis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.535 | Vasospastic disease SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.536 | Vasospastic disease |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.538 | Hemiplegic and basilar migraine SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.539 | Hemiplegic and basilar migraine |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.541 | Peptic ulcer disease SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.542 | Peptic ulcer disease |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.545 | Bleeding disorder SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.548 | Electronic cigarettes or Vaping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.549 | Bleeding disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.561 | conditions_migraine |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.562 | relatedconditions_migraine SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.563 | relatedconditions_migraine |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.564 | Triptan Allergy Intolerance SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.565 | Triptan Allergy Intolerance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.566 | Ischemic bowel disease SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.568 | Ischemic bowel disease |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.570 | Allergy to house dust mites SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.572 | Allergy to house dust mites |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.574 | conditions_hyperlipidemia SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.575 | conditions_hyperlipidemia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.594 | Intolerance to ARB SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.612 | Wolff Parkinson White SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.614 | Wolff Parkinson White |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.618 | relatedconditions_Asthma SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.622 | relatedconditions_Asthma |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.623 | LAMA Allergy SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.624 | LABA Allergy SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.625 | BetaBlock NonCS Secondary Allergy SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.626 | Eplerenone Allergy SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.627 | Spironolactone Allergy SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.628 | SGLT2 Inhibitors Allergy SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.630 | Angiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.631 | Pneumococcal Vaccine Allergy SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.632 | Meglitinides Allergy SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.633 | DPP4i Allergy SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.635 | Alpha_glucosidase inhibitors allergy SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.636 | Glucagon_Like Peptide 1 Receptor Agonist (GLP1RA) Allergy SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.637 | Insulins Allergy SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.638 | Thiazolidinediones Allergy SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.639 | T2DM_Medications Allergy SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.643 | T2DM_Medications Allergy SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.646 | T2DM_Medication Allergy Intolerance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.647 | Statins Allergy Intolerance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.649 | ACE Inhibitors Allergy Intolerance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.650 | ARB Allergy Intolerance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.652 | Long Acting Muscarinic Antagonists (LAMA) Allergy Intolerance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.653 | Long Acting Beta Agonists (LABA) Allergy Intolerance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.654 | BetaBlocker NonCS Secondary Allergy Intolerance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.656 | Mineralocorticoid receptor antagonists (MRA) Allergy Intolerance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.657 | Eplerenone Allergy Intolerance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.658 | Spironolactone Allergy Intolerance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.659 | SGLT2i Allergy Intolerance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.660 | Angiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy Intolerance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.661 | Tetanus, Diphtheria, Pertusis (Tdap) Vaccine Allergy Intolerance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.665 | Tetanus toxoid, diphtheria (Td) Vaccine Allergy Intolerance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.666 | Human Papillomavirus (HPV) vaccine Allergy Intolerance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.670 | Pneumococcal Vaccine Allergy Intolerance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.671 | Inhaled Corticosteroids(ICS) Allergy Intolerance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.675 | GLP1RA Allergy Intolerance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.713 | PIM_IHD_CHD_CAD_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.723 | Macrolide Allergy SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.724 | Macrolides Allergy Intolerance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.725 | Prednisone Allergy SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.727 | Tetracycline Allergy SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.728 | Tetracycline Allergy Intolerance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.729 | Fluoroquinolones Allergy SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.730 | Fluoroquinolone Allergy Intolerance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.732 | Penicillin Allergy SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.733 | Penicillin Allergy Intolerance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.737 | Pneumonia SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.738 | Pneumonia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.742 | Pulmonary Embolism SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.743 | Pulmonary Embolism |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.745 | Influenza SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.747 | Influenza |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.749 | COVID19 SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.750 | COVID19 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.753 | RSV SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.754 | RSV |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.755 | Respiratory Rate SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.757 | Respiratory Rate |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.759 | Acute Respiratory Failure SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.760 | Acute Respiratory Failure |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.761 | Dyspnea SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.763 | Dyspnea |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.765 | Confusion SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.766 | Confusion |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.767 | Drowsiness SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.769 | Drowsiness |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.771 | Cyanosis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.772 | Cyanosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.776 | Arterial oxygen saturation SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.777 | Arterial oxygen saturation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.790 | Simple Knee Pain SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.791 | Simple Knee Pain |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.792 | Simple Left Knee Pain SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.793 | Simple Right Knee Pain SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.796 | Simple Right Knee Pain |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.797 | Simple Left Knee pain |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.799 | Knee joint surgery SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.800 | Knee joint surgery |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.802 | Knee Osteoarthritis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.803 | Knee Osteoarthritis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.804 | Osteoarthritis of right knee SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.805 | Osteoarthritis of left knee SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.808 | Osteoarthritis of right knee |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.809 | Osteoarthritis of left knee |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.810 | Hip Osteoarthritis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.812 | Hip Osteoarthritis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.814 | Hip joint surgery SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.815 | Hip joint surgery |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.818 | Osteoarthritis of right hip SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.819 | Osteoarthritis of left hip SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.820 | Osteoarthritis of right hip |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.821 | Osteoarthritis of left hip |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.853 | Hyperkalemia_SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.854 | Hyperkalemia Conditions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.862 | PIM_Ambulatory_Visits_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.876 | Alpha Glucosidase AllergyIntolerance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.878 | Inflammatory bowel disease SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.879 | Inflammatory bowel disease |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.88 | DEPRECATED Diabetes |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.880 | Gastrointestinal obstruction SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.882 | Gastrointestinal obstruction |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.883 | DPP4i AllergyIntolerance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.884 | Multiple endocrine neoplasia type 2 (MEN II) SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.886 | Multiple endocrine neoplasia type 2 (MEN II) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.887 | Gastroparesis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.889 | Gastroparesis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.890 | Meglitinide AllergyIntolerance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.891 | Sulfonylurea AllergyIntolerance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.893 | Peripheral edema SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.894 | Peripheral edema |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.895 | Thiazolidinedione AllergyIntolerance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.911 | CKD stage5OrESRD SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.912 | CKD stage5OrESRD |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.915 | Anxiety_SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.916 | Anxiety |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.918 | Stress_SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.92 | ASCVD |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.920 | Stress |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.921 | PBH_Anxiety_SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.922 | PBH_Depression_SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.923 | PBH_Stress_SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.924 | PBH_Insomnia_SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.938 | Crohn disease SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.94 | Albuminuria SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.940 | Crohn disease |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.941 | Celiac disease SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.943 | Celiac disease |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.95 | Albuminuria |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.953 | OIA_DM_SNOMEDCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.954 | OIA_CAD_SNOMEDCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.955 | OIA_PVD_SNOMEDCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.956 | OIA_DM_ICD10_SNOMEDCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.957 | OIA_CAD_ICD10_SNOMEDCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.958 | OIA_PVD_ICD10_SNOMEDCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.97 | Sulfonylurea AllergyIntolerance SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.99 | BMI SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.10 | Nutrition Diagnosis SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.101 | Hospice Status |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.11 | Nutrition Focused Physical Findings SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.14 | Vitamin Mineral Supplement and Bioactive Substance Management SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.17 | Pediatric Enteral Formulas SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.18 | Modified Amino Acid Formulas SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.19 | Nutrition Counseling Approach and Strategies SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.2 | Food and Nutrient Delivery SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.20 | Enteral Nutrition Management SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.24 | Malnutrition Assessment |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.29 | Malnutrition Assessment |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.30 | Malnutrition Risk Screening |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.33 | Malnutrition Assessment |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.38 | Malnutrition Screening Finding of At Risk Result |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.40 | Malnutrition Risk Screening |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.42 | Nutrition Assessment Status Finding of Severely Malnourished |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.43 | Nutrition Assessment Status Finding of Severely Malnourished |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.44 | Nutrition Assessment Status Finding of Moderately Malnourished |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.47 | Nutrition Assessment Status Finding of Moderately Malnourished |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.48 | Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.49 | Nutrition Focused Physical Findings Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.5 | Adult Enteral Formulas SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.50 | Enteral Nutrition Composition SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.51 | Enteral Nutrition Composition Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.52 | Parenteral Nutrition Management SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.53 | Malnutrition Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.55 | Malnutrition Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.58 | Nutrition Order Item Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.59 | Diet Item Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.60 | Edible Substances |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.61 | Feeding Device SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.65 | Nutrition Recommendation Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.7 | Modular Nutrition Formulas SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.70 | Nutrition Education SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.71 | Coordination of Care by a Nutrition Professional SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.73 | Nutrition Anthropometric Measurement SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.75 | Nutrition Anthropometric Measurements Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.76 | Manage Feeding Environment |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.77 | Special Food Items and Regime/Therapy for Special Food Items SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.82 | Food and Nutrition Related History Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.84 | Food and Nutrition Related History SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.85 | Nutrition Diagnosis Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.87 | Feeding Device Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.88 | Nutrition Care Plan |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.89 | Malnutrition Screening Finding of At Risk Result |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.91 | Hospital Dietitian Referral |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.93 | Nutrition Care Plan |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.96 | Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.99 | Nutrition Diagnosis SNOMED CT (2) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.1 | Findings Related to Medication Management, Referral Source |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.100 | Recommendations Related to Medication Regimen |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.101 | Interventions Related to Medication Regimen, Initiate Medication |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.102 | Interventions Related to Medication Regimen, Change Medication |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.103 | Interventions Related to Medication Regimen, Change Medication Dose |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.104 | Interventions Related to Medication Regimen, Change Medication Dosage Form |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.105 | Interventions Related to Medication Regimen, Change Medication Course |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.106 | Interventions Related to Medication Regimen, Change Medication Dosing Interval |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.107 | Interventions Related to Medication Regimen, Discontinue Medication |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.109 | Interventions Related to Medication Regimen |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.11 | Interventions Related to Medication Management, Medication Reconciliation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.110 | Interventions Related to Education, Medications |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.111 | Interventions Related to Education, Medical Equiptment and Devices |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.112 | Interventions Related to Medication Management, Notifications |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.113 | Interventions Related to Medication Management, Refill Synchronization |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.114 | Status of Patient Condition |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.115 | Interventions Related to Education, Diseases and Disorders |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.116 | Interventions Related to Education |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.118 | Interventions Related to Medication Management |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.119 | Interventions Related to Medication Management, Targeted Medication Review |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.120 | Interventions Related to Medication Management, Discussion |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.121 | Reasons for Interventions Related to Medication Management, Cost |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.122 | Interventions Related to Education, Immunizations |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.123 | Status of Recommendations |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.124 | Interventions Related to Medication Management, Provision of Documents |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.125 | Status of Compliance Ability |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.126 | Status of Interventions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.127 | Status of Disease Control |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.128 | Status of Compliance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.129 | Occupations of Providers |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.130 | Environments of Care |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.131 | Findings Related to Medication Management, Body Mass Index |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.132 | Findings Related to Medication Management, Alcohol Use |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.133 | Findings Related to Medication Management, Caffeine Use |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.134 | Interventions Related to Education, Diet |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.136 | Findings Related to Medication Management, Exercise |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.137 | Interventions Related to Education, Behavior |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.138 | Findings Related to Medication Management, Diet |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.139 | Status of Care Goal |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.140 | Findings Related to Medication Management, Illicit Drug Use |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.141 | Interventions Related to Administration, Immunizations |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.142 | Interventions Related to Care Coordination, Communication Needs |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.144 | Findings Related to Medication Management, Life Event |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.145 | Interventions Related to Medication Management, Device or Equipment Fitting |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.146 | Findings Related to Medication Management, Immunizations |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.148 | Findings Related to Medication Management, Cultural Beliefs |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.149 | Findings Related to Medication Management, Tobacco Use |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.150 | Interventions Related to Medication Regimen, Continue Medication |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.151 | Encounter Type |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.152 | Encounter Class |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.156 | Allergy/Intolerance Severity |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.16 | Reasons for Interventions Related to Medication Management |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.160 | Allergy/Intolerance Manifestation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.162 | Allergy/Intolerance Substance & Negation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.163 | Allergy/Intolerance Negation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.165 | Interventions Related to Care Coordination, Benefit Management |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.166 | Interventions Related to Administration |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.167 | Interventions Related to Administration, Medications |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.168 | Findings Related to Medication Management, Eating Habits |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.169 | Findings Related to Medication Management, Tobacco Exposure |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.170 | Interventions Related to Care Coordination |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.176 | Interventions Related to Medication Management, Information Gathering |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.177 | Interventions Related to Medication Management, Care Planning |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.178 | Interventions Related to Medication Management, Documentation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.179 | Allergy/Intolerance Substance, Food |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.180 | Allergy/Intolerance Substance, Environmental |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.181 | PharmacyEncounterReason |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.182 | Encounter Reason |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.183 | Findings Related to Medication Management, Medication related |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.197 | PharmacyAllergies |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.198 | PharmacyInterventions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.200 | PharmacyReasonsForInterventions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.201 | PharmacyInterventionStatus |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.202 | PharmacyCareCoordination |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.203 | PharmacyReferralsTo |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.204 | PharmacyGoalStatusOutcome |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.205 | PharmacyTypeOfProfession |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.207 | PharmacyEnvironmentsOfCare |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.208 | PharmacyEncounterType |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.209 | PharmacytEncounterClass |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.212 | PharmacyAllergyIntoleranceManifestation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.213 | PharmacyReasonForMedicationChange |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.214 | PharmacyEducation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.215 | PharmacyEducationStatus |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.216 | PharmacyReferralsFrom |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.218 | Reasons for Interventions Related to Medication Management, Discontinue Medication |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.224 | Social Determinants of Health Problem Observation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.227 | Findings Related to Medication Management, Infectious Disease Symptoms |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.229 | COVID19 Related Disease, Test, or Exposure |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.230 | Maternity Health Interventions Value Set |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.231 | Social Determinants of Health Interventions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.232 | Maternity Health Findings |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.233 | Reason Medication Discontinued Lack of Indication |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.234 | Reason Medication Discontinued Lack of Effectiveness |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.235 | Reason Medication Discontinued Safety Issue Occurred |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.236 | Reason Medication Discontinued Compliance Issue other than cost |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.237 | Recommendation to Resolve Medication Therapy Problem |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.239 | Reason Medication Discontinued Patient Unable to Afford |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.3 | Findings Related to Medication Management, Transitions Between Health Care Settings |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.35 | Interventions Related to Medication Management, Comprehensive Medication Review |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.5 | Reasons for Interventions Related to Medication Management, Unnecessary Therapy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.53 | Reasons for Interventions Related to Medication Management, Adverse Events |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.55 | Reasons for Interventions Related to Medication Management, Adherence |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.56 | Findings Related to Medication Management, Multiple Providers |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.58 | Findings Related to Medication Management, Chronic Disease Present |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.59 | Findings Related to Medication Management, Taking Medication for Chronic Disease |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.6 | Reasons for Interventions Related to Medication Management, New or Additional Therapy Required |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.60 | Findings Related to Medication Management, Health Literacy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.61 | Findings Related to Medication Management |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.7 | Reasons for Interventions Related to Medication Management, Ineffective Therapy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.8 | Reasons for Interventions Related to Medication Management, Dose Too Low |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.83 | Assessments Related to Medication Management, General Assessments |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.84 | Assessments Related to Medication Management |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.85 | Assessments Related to Medication Management, Assessments Using Assessment Scales |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.86 | Interventions Related to Medication Regimen, Monitoring |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.87 | Interventions Related to Care Coordination, Consultations |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.88 | Interventions Related to Care Coordination, Referrals to Other Providers |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.89 | Interventions Related to Care Coordination, Referrals for Specific Services |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.9 | Reasons for Interventions Related to Medication Management, Dose Too High |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.90 | Recommendations Related to Medication Regimen, Continue Medication |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.91 | Recommendations Related to Medication Regimen, Initiate Medication |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.92 | Recommendations Related to Medication Regimen, Change Medication |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.93 | Recommendations Related to Medication Regimen, Change Medication Dose |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.94 | Recommendations Related to Medication Regimen, Change Medication Dosage Form |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.95 | Recommendations Related to Medication Regimen, Change Medication Course |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.97 | Recommendations Related to Medication Regimen, Change Medication Dosing Interval |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.98 | Recommendations Related to Medication Regimen, Discontinue Medication |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.99 | Recommendations Related to Medication Regimen, Monitoring |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.12 | Medication Route |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.24 | Extended Pregnancy Status |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.27 | Care Team Member Function (SNOMEDCT) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.29 | Allergy Clinical Status |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.30 | Care Team Member Function |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.35 | Arthritis Feedback Types (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.50 | Transport vehicle type |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.53 | Sex |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.54 | Specimen type |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.57 | Advance Directives Content Type |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.58 | Acute COVID 19 Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.59 | Medication Adherence SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.101 | Myocardial Infarction |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.124 | Follow Up Within 6 Months |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.125 | Follow Up Within 6 Months |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.15 | Hospice Care Ambulatory |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.175 | Office and Wellness Visits for General Screening |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.178 | Office and Wellness Visits for General Screening |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.179 | Hypertensive disorders in pregnancy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.182 | Eclampsia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.183 | Gestational Hypertension |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.184 | Preexisting Hypertension in Pregnancy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.185 | Postpartum Encounter |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.187 | Postpartum Encounter |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.188 | Preexisting Hypertension in Pregnancy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.190 | Spontaneous or Elective Abortion |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.191 | Preeclampsia or Eclampsia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.193 | Spontaneous or Elective Abortion |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.84 | Statin Associated Muscle Symptoms |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.85 | Statin Associated Muscle Symptoms |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.12 | Cornual Ectopic Pregnancy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.14 | Perforation of Uterus |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.16 | Uterine Rupture |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.18 | Transabdominal Cerclage |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.2 | Transabdominal Cerclage |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.23 | Intensive Care Unit |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.24 | Uterine Horn |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.25 | Metroplasty |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.36 | Placenta Accreta Spectrum Previa or Vasa Previa |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.37 | Placenta Accreta Spectrum Previa or Vasa Previa |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.38 | Outpatient Surgery Service |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.41 | Statin Allergen |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.42 | Statin Allergen |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.54 | Total Parenteral Nutrition |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.57 | Ischemic Stroke Thrombosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.60 | Ischemic Stroke Other |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.64 | Application of Venous Foot Pumps |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.65 | Application of Intermittent Pneumatic Compression Devices |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.66 | Application of Graduated Compression Stockings |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.67 | 20 to 42 Plus Weeks Gestation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.68 | 37 to 42 Plus Weeks Gestation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.69 | 37 to 38 Weeks Gestation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.71 | 20 to 42 Plus Weeks Gestation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.73 | 37 to 42 Plus Weeks Gestation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.75 | 37 to 38 Weeks Gestation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.76 | History of Atrial Ablation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.126 | Hospital Settings |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.143 | Observation Services |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.161 | All Primary and Secondary Cancer |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.164 | Admit Inpatient |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.171 | Opioid Use Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.173 | Sickle Cell Disease with and without Crisis SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.175 | Sickle Cell Disease with and without Crisis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.177 | Opioid Medication Assisted Treatment (MAT) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.179 | Cancer Related Pain SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.180 | Cancer Related Pain |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1114.14 | Medication drug class for allergen intolerance SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.12 | Healthcare Agent Ordinality |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.19 | Obligation or Prohibition Instruction Type Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.30 | Cardiopulmonary Resuscitation Order Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.31 | Cardiopulmonary Resuscitation Procedures Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.32 | Additional Portable Medical Order Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.33 | Initial Treatment Portable Medical Order Procedures Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.34 | Additional portable medical order Procedures Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.5 | Advance Directive Content Type SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.100 | Pathological M Stage M1c |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.101 | Pathological N Stage N3 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.102 | N Stage pN1a |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.103 | N Stage pN1b |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.105 | Pathological N Stage pN1mi |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.106 | Pathological N Stage N2b |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.107 | Pathological N Stage N2a |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.108 | Pathological N Stage N2 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.109 | Pathological N Stage N1b |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.110 | Pathological N Stage N1a |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.112 | Pathological N Stage N0 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.114 | Pathological T Stage T4d |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.115 | Pathological T Stage T4c |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.116 | Pathological T Stage T4b |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.117 | Pathological T Stage T4a |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.118 | Pathological T Stage T4 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.120 | N Stage N2C |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.121 | T Stage T3c |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.122 | T Stage T3b |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.123 | T Stage T3a |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.124 | Pathological T Stage T3 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.125 | T Stage T2c |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.126 | T Stage T2b |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.127 | T Stage T2a |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.128 | Pathological T Stage T2 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.129 | Pathological T Stage T1c |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.132 | Pathological T Stage T1b |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.135 | Pathological T Stage T1a |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.136 | Pathological T Stage T1 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.137 | Pathological T Stage T1mic |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.139 | Pathological T Stage T0 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.142 | Cancer Stage III |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.143 | Cancer Stage IIIA |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.144 | Cancer Stage IIIB |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.145 | Cancer Stage IIIC |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.146 | Cancer Stage IV |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.147 | Cancer Stage IVA |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.148 | Cancer Stage IVB |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.149 | Cancer Stage IVC |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.160 | ECOG Performance Status |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.162 | ECOG Performance Status |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.164 | Karnofsky Performance Status |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.185 | Breast Cancer |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.191 | Cancer Stage II |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.192 | Cancer Stage IIA |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.193 | Cancer Stage IIB |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.256 | Colorectal Cancer |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.280 | Cancer Stage IA |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.281 | Cancer Stage IB |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.286 | Cancer Stage IIC |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.292 | Negative Result |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.300 | Pathological N Stage N1C |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.365 | Hospice Care Referral or Admission |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.439 | T Category |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.440 | N Category |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.441 | M Category |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.442 | TNM Stage Group |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.539 | Fallopian Tube Cancer |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.547 | Cancer Stage 1C |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.555 | Gender Female |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.556 | Gender Male |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.557 | Pathological N Stage N3a |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.558 | Pathological N Stage N3b |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.95 | M Stage M0 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.97 | Pathological M Stage M1 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.98 | Pathological M Stage M1a |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.99 | Pathological M Stage M1b |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1121.6 | Most/Moderately Effective Contraceptive SNOMED Findings |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.11 | Sleep Apnea |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.12 | Toxic Megacolon in adults |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.13 | Septic Shock due to C. Diff |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.15 | Body Temperature |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.16 | Diarrhea Potentially due to CDI |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.17 | Abdominal Distension |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.18 | Vomiting potentially due to CDI |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.19 | Ileus due to infection |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.20 | Clostridium difficile infection |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.9 | Immunotherapy For Allergic Rhinitis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.1 | C2S Alcohol Use Disorders |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.11 | C2S Amphetamine Use Disorders |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.15 | C2S Cannabis Use DIsorders |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.18 | C2S Cocaine Use Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.22 | C2S Hallucinogens |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.27 | C2S HIV/AIDS Information Sensitivity |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.30 | C2S Inhalants |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.36 | C2S Mental Health Disorders |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.42 | C2S Opioids |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.43 | C2S Other Psychoactive Substance
Use Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.46 | C2S Sedative Hypnotic, or anxiolytic related disorders |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.51 | C2S Tobacco Use Disorders |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.58 | C2S Sensitive Categories |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.65 | Test C2S Alcohol Use Disorders |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.67 | Test C2S HIV/AIDS Information Sensitivity |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1012 | S. Typhi Infection (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1016 | S. Paratyphi Infection (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1021 | Dark Urine (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1022 | Acute Onset [Qualifier Value] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1024 | Acute Viral Hepatitis (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1029 | Listeriosis [Listeria species] (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1033 | Encephalitis [Unspecified Cause] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1035 | Indeterminate or Equivocal Lab Result Value |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1037 | Smoking Status [Current Nonsmoker] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1048 | Parkinson’s disease (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1050 | Parkinsonism [Secondary] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1071 | Drug Use [IV Evidence] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1072 | Miosis (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1077 | Poisoning or Overdose by Other Opioids (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1083 | Rash [Pustular Vesicular] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1084 | Salivary Gland Swelling [Unspecified Cause] (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1090 | Syphilis [Congenital] (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1091 | Cataracts [Nonspecific]/Congenital glaucoma [Unspecified Cause] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1092 | Congenital heart disease (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1093 | Hearing impairment (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1095 | Microcephaly (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1096 | Developmental delay (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.112 | Tetanus (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1124 | COVID_19 (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1143 | COVID_19 (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1145 | Resistant Lab Result Value |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.115 | Mumps (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1156 | Staphylococcus aureus (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1197 | Cervical Lymphadenitis (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1207 | CRE (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1210 | Enterobacter spp., E. coli, or Klebsiella spp. (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1212 | Enterobacteriaceae species [Carbapenem Resistant] (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1213 | Enterobacteriaceae [Carbapenemase Producing] (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1214 | Carbapenemase resistance mechanism (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1224 | Therapeutic Response to Medication [Improved] |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1225 | Altered Mental Status (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1230 | Eschar (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1231 | Hypotension (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1233 | Localized Edema (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1237 | Tachycardia (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1239 | RCKMS Conditions (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.124 | Poliomyelitis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1240 | Maternal Condition Puerperium (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1242 | Non pestis Yersiniosis Infection (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1244 | Blastomycosis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1246 | Blastomycosis (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1269 | Tuberculosis [Latent Infection] (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1274 | Histoplasmosis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1294 | Abscess [Liver, Lung, Spleen, Prostate, or Brain] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1295 | Seizure [Unspecified Cause] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.130 | Influenza (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1309 | RSV (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1314 | Wheezing (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1325 | Tobacco Use and Exposure (Social History) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1335 | Hospitalized [Inpatient] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1336 | Creutzfeldt Jakob Disease (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1337 | Variant Creutzfeldt Jakob Disease (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1349 | Cerebrospinal Fluid (Specimen Type) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.135 | Chronic Hepatitis B Virus Infection (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1350 | Endocervical (Specimen Type) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1351 | Tissue (Specimen Type) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1352 | Specimen from a Normally Sterile Site (Specimen Type)(SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1353 | Urethral Swab (Specimen Type) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1355 | Wound (Specimen Type) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.136 | Invasive Pneumococcal Disease (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1369 | Serum (Specimen Type) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1379 | Fish Poisoning (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1388 | Occupational Asthma (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1389 | Asthma (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1391 | Respiratory Condition, due to inhalation of chemicals, gases, fumes or vapors (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1393 | WRA (Occupational Exposure to Potential Asthma Inducing Risk Factor) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1405 | Cancer [Unspecified Skin Cancer, Benign Carcinoid Tumor, in situ Cervical Cancer, Intraepithelial Neoplasia, History Cancer, Complication of Cancer or Treatment] (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1407 | Cancer [Malignant Neoplasms] (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1418 | Alpha gal syndrome (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1422 | Ptosis of Eyelid [Unspecified Cause] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1424 | Constipation [Unspecified Cause] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1426 | Intubation [Respiratory Tract] (Procedure) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1430 | Infant Botulism (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1446 | Viral Hemorrhagic Fever [Suspected] (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1447 | MRSA (Disorders (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1449 | Staphylococcus aureus infection (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.145 | Varicella (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1463 | VRE (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1464 | VRE (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1468 | Enterococcus gallinarum or E. casseliflavus/E. flavescens (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1469 | Enterococcus faecium or E. faecalis (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1470 | Enterococcus species (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1471 | Amebiasis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1485 | Norovirus (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1487 | Clostridioides difficile infection (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1505 | Acanthamoeba Disease [Keratitis] (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1507 | Arsenic Exposure and Toxicity (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1513 | Urine (Specimen Type) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1516 | Cryptococcosis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1533 | Drug Overdose and Poisoning [Non opioid] [CNS Depressant] (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.154 | Hepatitis C Virus Infection (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1546 | Drug Overdose and Poisoning [Non opioid] (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1552 | Bacterial Meningitis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1553 | Fungal Meningitis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1554 | Parasitic Meningitis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1559 | Photophobia (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1562 | Bacteria [Causing Meningitis] (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1563 | Fungi [Causing Meningitis and Encephalitis] (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1564 | Viruses [Causing Meningitis] (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1580 | Animal Bite [Dog] (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1581 | Animal Bite [Mammal, Excluding Dogs] (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1582 | Animal Bite [Excluding Mammals] (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1584 | Animal Bite [Unspecified Animal] (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1605 | Vaccine Adverse Event (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1606 | Vaccinia disease or adverse event (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.161 | Vibriosis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1613 | Keratitis [Unspecified Cause] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1626 | Thrombocytopenic Purpura [Unspecified Cause] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1651 | Chagas Disease (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1661 | Cervical lymphadenopathy [Unspecified Cause] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1662 | Conjunctival injection (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1663 | Drying of lips (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1667 | Edema of hands or feet (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1679 | Pseudomonas aeruginosa (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1687 | NU_Gunshot Wound (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.169 | Gonorrhea [Neisseria gonorrhoeae] (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.170 | Chlamydia trachomatis Infection (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1700 | Encephalitis [Viral] (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1702 | Encephalitis [Parasitic] (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1712 | Bacteria [Causing Encephalitis] (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1714 | Parasites [Causing Encephalitis] (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1715 | Viruses [Causing Encephalitis] (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1716 | Drowning and Submersion (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1718 | Motor Vehicle Injury (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1720 | Enterovirus Infection [Non polio] (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1722 | Enterovirus Infection [Non polio] (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1739 | Head Injury (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1745 | Rotavirus Disease (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1748 | Chemical Pneumonitis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1755 | Vomitus (Specimen Type) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1758 | Asbestosis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1772 | Farmers Lung (Aspergillus fumigatus, Saccharopolyspora rectivirgula, or Thermoactinomyces vulgaris Antibody in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1773 | CLABSI (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1775 | Ophthalmia neonatorum (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1778 | Genital herpes (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1785 | Elevated liver enzyme (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1789 | Granuloma Inguinale (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1791 | Ulcer [Genital, Perineal, or Perianal Area] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1797 | Bronchial Wash (Specimen Type) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1800 | Nontuberculous Mycobacteria Infection, Pulmonary (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.181 | Coccidioidomycosis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1823 | Louseborne relapsing fever (Borrelia species in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1824 | Spirochetes (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1829 | Polyarthritis [Unspecified Cause] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1835 | Rheumatoid nodules (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1842 | Ventilator associated event (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1844 | Leishmaniasis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.185 | Brucellosis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1864 | Taeniasis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1866 | Taeniasis (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.187 | Dengue Virus Infection (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1878 | Surgical Site Infection (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1882 | Carbapenemase production (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1892 | Toxoplasmosis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1895 | Toxoplasmosis (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1923 | Coronary artery aneurysm (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1924 | Coronary artery dilatation (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1925 | Ectatic coronary artery (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1926 | Left ventricular ejection fraction [Decreased Level] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1928 | Shock (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1930 | Troponin [Elevated Level] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1931 | Oral mucosa Inflammation (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1935 | Strongyloidiasis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1941 | Strongyloidiasis (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1942 | Strongyloidiasis [Strongyloides stercoralis] (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1943 | Jamestown Canyon Virus Diseases (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1947 | Jamestown Canyon Virus Diseases (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1948 | Keystone Virus Diseases (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1949 | La Crosse Virus Diseases (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1950 | Snowshoe hare Virus Diseases (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1951 | Trivittatus Virus Diseases (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1959 | Keystone Virus Diseases (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1960 | La Crosse Virus Diseases (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1961 | Snowshoe hare Virus Diseases (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1962 | Trivittatus Virus Diseases (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1963 | Hepatitis C Virus Infection, Perinatal (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1964 | Encephalomyelitis (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1966 | Drug Overdose and Poisoning [Non opioid] [Muscle Relaxant] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1968 | Hepatitis D Virus Infection (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1973 | Hepatitis D Virus Infection (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1974 | Baylisascariasis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1975 | Baylisascariasis (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1978 | Larva Migrans (Neural, Ocular, or Visceral) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1980 | California Serogroup Virus Disease [Unspecified] (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1982 | California Serogroup Virus Disease [Unspecified] (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1987 | Flank Pain (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1988 | Bone Pain (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1989 | Abscess (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1991 | Focal Brain Lesions (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1992 | Pathologic Fractures [Unspecified Cause] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1994 | Granulomas (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1996 | Skin Lesions (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1998 | Angiostrongyliasis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1999 | Lymphocytic Choriomeningitis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2001 | Lymphocytic Choriomeningitis (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2007 | Eosinophilic meningitis (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2017 | Rash [Macular, Papular, Vesicular, Pustular, or Centrifugal] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.202 | Trichinellosis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2023 | Tick Paralysis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2024 | Bacillary angiomatosis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2025 | Animal Bite or Scratch [Cat] (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2027 | Bartonellosis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2029 | Bartonellosis (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2030 | Bartonella henselae infection (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2031 | Bartonella quintana infection (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2032 | Bartonella bacilliformis infection (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2036 | Bartonella henselae (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2037 | Bartonella quintana (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2038 | Bartonella bacilliformis (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.204 | Giardiasis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2052 | Echinococcosis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2054 | Cystic Echinococcosis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2056 | Alveolar Echinococcosis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2060 | Echinococcosis (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2061 | Genital Warts (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2062 | Pseudomembrane [Nose, pharynx, tonsils, or larynx] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2064 | Diphyllobothriasis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2066 | Diphyllobothriasis (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2068 | Angiostrongyliasis (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2069 | Pelvic Inflammatory Disease (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2070 | Pelvic Inflammatory Disease [nonGC and nonCT] (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2071 | Pelvic Inflammatory Disease [Unspecified] (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2075 | Lower Abdominal Tenderness (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2077 | Tenderness with motion of the cervix (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2078 | Adnexal Tenderness (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2079 | Uterine Tenderness (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2080 | Leukocytosis (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2082 | Purulent material in the peritoneal cavity (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2083 | Pelvic Abscess (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2087 | Nongonococcal Urethritis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2089 | Urethritis (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2091 | Urethral discharge (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2093 | Dysuria (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2096 | Cyanobacteria and Cyanotoxin Poisoning (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2098 | Rhinitis (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2101 | Pleuritis (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2105 | Methemoglobinemia (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2106 | Methemoglobinemia [Non Congenital] (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2110 | Anencephaly (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2112 | Fetal Anencephaly (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2114 | Cleft Lip Alone (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2116 | Fetal Cleft Lip (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2117 | Cleft Palate Alone (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2119 | Cleft Lip with Cleft Palate (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2121 | Fetal Spina Bifida (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2122 | Spina Bifida (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2124 | Down Syndrome (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2126 | Fetal Down Syndrome (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2129 | Bacteremia (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2131 | Gastroschisis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2133 | Fatal Familial Insomnia (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2135 | Gerstmann Straussler Scheinker Syndrome (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2137 | Prion Disease (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2140 | Phenylketonuria (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2145 | Tuberculosis [Suspected] (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2146 | Congenital Rubella Syndrome [Suspected] (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2147 | Limb Reduction (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2150 | Congenital Hearing Loss (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2153 | Primary Congenital Hypothyroidism (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2154 | Congenital Hypothyroidism [Unspecified] (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2163 | Dengue Virus Infection [Suspected] (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2164 | Mumps [Suspected] (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2165 | Pertussis [Suspected] (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2196 | Lung Tissue (Specimen Type) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2197 | Granuloma [Unspecified] (Finding by Microscopic Observation in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2202 | Abnormal Lung Sounds (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2204 | Anemia [Unspecified Cause] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2209 | Microangiopathic Changes (Schistocytes, Burr cells, or Helmet cells) (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2212 | Invasive Cronobacter Infection (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2214 | Necrotizing Enterocolitis (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2216 | Abscess [Brain] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2218 | Urinary Tract Infection (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2220 | Amniotic Fluid (Specimen Type) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2221 | Congenital Cytomegalovirus (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2231 | Congenital Cytomegalovirus Infection (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2233 | Cytomegalovirus Disease (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2241 | Stillbirth (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2247 | Extrapulmonary [NTM] (Specimen Type) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2250 | Lower Respiratory [Excluding Sputum] (Specimen Type) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2255 | Carbapenem Resistant Bacterial Infection [Carbapenemase Producing] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2256 | CP_CRE (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2259 | Neonatal Abstinence Syndrome (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.226 | Lyme Disease (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2261 | High Pitched Cry (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2262 | Inability to Console (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2264 | Hypertonia (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2266 | Tremors (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2268 | Myoclonus (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2270 | Poor Sleep (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2272 | Alterations in Feeding (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2274 | Excoriation (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2276 | Sneezing (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2278 | Nasal Congestion (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2280 | Yawning (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2281 | Cutaneous Mottling (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2282 | Sweating (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2284 | Feeding Intolerance (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2286 | Respiratory Distress or Nasal Flaring (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2289 | In Utero Substance Exposure (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2291 | Childbirth (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2295 | Opioids, Benzodiazepines, or Barbiturates (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2296 | NonOpioid, NonBenzodiazepine, or NonBarbiturate Substances (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2297 | Exposure or suspected exposure to harmful algae or algae toxins (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2305 | Gram_negative Diplococcus (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2307 | D_Transposition of the Great Arteries (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2308 | L_Transposition of the Great Arteries (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2309 | Transposition of the Great Arteries [Unspecified] (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2311 | Interrupted Aortic Arch (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2313 | Coarctation of the Aorta (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2315 | Ebstein Anomaly (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2317 | Pulmonary valve atresia (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2319 | Pulmonary valve stenosis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2321 | Fetal Pulmonary valve stenosis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2322 | Double Outlet Right Ventricle (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2324 | Hypoplastic left heart syndrome (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2326 | Single Ventricle (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2328 | Tetralogy of Fallot (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2330 | Truncus Arteriosus (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2332 | Atrioventricular septal defect (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2334 | Total Anomalous Pulmonary Venous Connection (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2336 | Tricuspid valve atresia (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2338 | Tricuspid valve stenosis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2340 | Fetal Tricuspid valve stenosis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2341 | Exposure to Measles (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2342 | Increased Risk for Exposure to Measles (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2349 | Consistent with Tuberculosis (Finding in Chest Xray Imaging Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2356 | Skin (Specimen Type) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2358 | Unspecified Tissue (Specimen Type) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2368 | Perinatal Hepatitis B (Maternal Hepatitis B Virus Infection) (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2369 | Necrotizing Fasciitis (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2371 | Renal Impairment [Acute or Unspecified] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2373 | Coagulopathy [Unspecified Cause] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2375 | Rash [Erythematous, Macular, or Desquamating of Unspecified Cause] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2377 | Soft Tissue Necrosis (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2381 | Specimen from a Nonsterile Site (Specimen Type) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.264 | Viral Hemorrhagic Fever (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.272 | Present or Positive Lab Result Value |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.287 | Varicella (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.300 | Meningococcal Disease (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.304 | Pesticide Related Illness (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.329 | Apnea (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.333 | Shigellosis (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.340 | Influenza (influenza A or B virus in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.341 | Campylobacteriosis (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.353 | Diarrhea (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.356 | HIV Infection (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.359 | Botulism (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.371 | Cryptosporidiosis (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.375 | Cyclosporiasis (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.386 | Vibriosis (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.395 | Syphilis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.40 | STEC Infection (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.408 | Hepatitis B Virus Infection (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.422 | Tuberculosis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.43 | Gonorrhea [Cervicitis Urethritis] (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.460 | HIV Infection or AIDS (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.48 | Salmonellosis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.494 | Ehrlichiosis (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.505 | Toxic Shock Syndrome (TSS) (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.516 | Brucellosis (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.534 | Smallpox (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.542 | Spotted Fever Rickettsiosis (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.580 | Arboviral Disease [Other] (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.6 | Diphtheria (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.606 | Tuberculosis (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.632 | Chlamydia trachomatis Infection [Secondary Sites Complications] (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.650 | Jaundice (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.660 | Hypertonia [Excluding Congenital Hypertonia] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.663 | Erythema Nodosum (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.664 | Congenital Zika Syndromes (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.666 | Guillain Barré syndrome (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.668 | Rash (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.672 | Arthralgia (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.674 | Conjunctivitis (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.676 | Pregnant (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.677 | Postpartum (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.679 | Hearing Loss (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.681 | Abdominal Pain (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.686 | Erythema Multiforme (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.692 | Eosinophilia (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.702 | Weight Loss (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.709 | Cough [Non Productive] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.711 | Wound Infection (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.714 | Sepsis [Septicemia] [Unspecified Organism] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.715 | Meningitis (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.718 | Cellulitis (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.719 | Myositis [Unspecified Cause] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.721 | Otitis Media (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.723 | Otitis Externa (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.727 | Acute Upper Respiratory Illness (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.733 | Perinatal Hepatitis B Virus Infection (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.750 | Chest Pain (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.758 | Muscle Spasms (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.763 | Parotitis [Unspecified Cause] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.765 | Aseptic Meningitis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.766 | Encephalitis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.777 | Mastitis (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.779 | Pancreatitis (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.789 | Purpura (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.79 | Campylobacteriosis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.793 | Novel Influenza A Virus Infection (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.794 | Sore Throat (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.795 | Influenza (influenza A virus in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.796 | Influenza (Novel influenza A virus in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.809 | Headache (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.810 | Backache (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.823 | Pneumoconiosis (Unspecified) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.836 | Lead in Blood (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.839 | Acid Fast Bacilli (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.86 | Hemolytic Uremic Syndrome (HUS) (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.864 | Nausea (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.865 | Confusion (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.867 | Dyspnea (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.869 | Loss of Consciousness (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.87 | Thrombotic Thrombocytopenic Purpura (TTP) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.875 | SARS (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.881 | Difficulty Breathing (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.895 | Rhinorrhea (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.907 | Arthritis [Unspecified Cause] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.91 | Cough (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.910 | Epididymitis [Unspecified Cause] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.914 | Osteomyelitis [Unspecified Cause] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.928 | Bleeding [Unspecified Cause] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.930 | ECG Abnormalities [Unspecified Cause] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.931 | Hematemesis [Unspecified Cause] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.934 | Hematuria [Unspecified Cause] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.935 | Hemoptysis (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.937 | Gastrointestinal Hemorrhage [Unspecified Cause] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.942 | Petechiae [Non Traumatic] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.952 | Thrombocytopenia [Unspecified Cause] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.956 | Sepsis [Septicemia] [Bacterial] [Unspecified Organism] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.957 | Regional Lymphadenitis [Including Bubo] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.96 | Salmonellosis [Salmonella Species and Subspecies] (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.969 | Proteinuria [Unspecified Cause] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.970 | Bulbar Weakness (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.976 | Dysphagia (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.978 | Impaired Respiration [Unspecified Cause] (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.979 | Botulism (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.98 | Shigellosis (Disorders) (SNOMED) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.999 | Chlamydia species (Organism or Substance in Lab Results) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.110 | Pressure Injury Stage 2, 3, 4 or Unstageable |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.112 | Pressure Injury Deep Tissue |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.113 | Pressure Injury Stage 2, 3, 4 or Unstageable |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.122 | Inpatient Falls |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.125 | Bleeding at Non Critical Site |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.143 | Bleeding at Critical Site |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.144 | Bleeding at Critical Site |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.146 | Bleeding at Non Critical Site |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.160 | Abdominal or Pelvic CT Scan with Contrast |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.163 | Ultrasound of Lower Extremities |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.165 | Ultrasound of Lower Extremities |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.171 | Inpatient Falls |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.188 | Extracorporeal Membrane Oxygenation (ECMO) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.191 | Intra Aortic Balloon Pump |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.11 | Bladder Cancer Staging Ta for Urology Care |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.12 | Bladder Cancer staging T1 for Urology Care |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.13 | Bladder Cancer staging Tis for Urology Care |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.15 | Carcinoma of urinary bladder, superficial |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.17 | High grade bladder cancer Ta for Urology Care |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.18 | Immunocompromised state for Urology Care |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.19 | Systemic chemotherapy for urology care |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.20 | Corticosteroids for patients receiving Urology Care |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.21 | Calcineurin inhibitors for patients receiving Urology Care |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.23 | Immunomodulators for patients undergoing Urology Care |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.24 | Monoclonal antibody for patient undergoing Urology Care |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.28 | Radiotherapy for patients undergoing Urology Care |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.29 | Plasmacytoid cell, morphologic abnormality for urology care |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.30 | Sarcomatoid, morphologic abnormality for Urology Care |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.31 | Micropapillary, morphologic abnormality, for Urology Care |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.39 | Mixed histology urothelial cell carcinoma for Urology Care |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.40 | Cystectomy for Urology Care |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.44 | Unavailability of Bacillus Calmette Guerin for urology care |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.55 | Cystectomy for Urology Care |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.56 | Active Tuberculosis for Urology Care |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.58 | Bladder Cancer Staging Tis for Urology Care |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.8 | Tuberculosis Diagnosis Prior to Urology Care |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.9 | Leukemia Diagnosis Prior to Urology Care |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.13 | Preventative Care Encounters During Which Diabetes Screening May Occur |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.16 | Intensive Lifestyle Interventions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.17 | Intensive lifestyle interventions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.23 | Office Visit Encounters Where Diabetes Screening May Occur |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.24 | Office Visit Encounters Where Diabetes Screening May Occur |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.25 | Reason for No Intensive Lifestyle Intervention |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.28 | Type 2 Diabetes Diagnoses |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.29 | Type 2 Diabetes Diagnoses |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.41 | Sickle Cell Disease with Vaso Occlusive Episode |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.42 | Sickle Cell Disease with Vaso Occlusive Episode |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.49 | Medication Therapy Management Services for Essential Hypertension |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.79 | Medication Therapy Management Services for Essential Hypertension |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.9 | Preventative Care Encounters During Which Diabetes Screening May Occur |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.50 | Urinary retention |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.52 | Urinary retention |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.66 | Morbid Obesity |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.67 | Morbid Obesity |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.1 | Pregnancy Status |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.109 | Sterilization SNOMED Findings |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.113 | Prenatal Care Specific Visits SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.114 | Prenatal Care Specific Visits |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.122 | Prenatal Care Visits SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.124 | Pregnancy Related Diagnoses SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.126 | Non Live Birth Diagnoses SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.133 | Pregnancy Related Diagnoses |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.134 | Female Sterilization SNOMED Provision Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.135 | General Prenatal Care Visits |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.137 | Non Live Birth Diagnoses |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.138 | IUD Surveillance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.139 | IUD Provision Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.140 | IUD Devices |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.141 | Contraceptive Patch SNOMED Devices |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.142 | Female Sterilization Provision Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.144 | Contraceptive Patch SNOMED Provision Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.145 | Contraceptive Patch SNOMED Findings |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.151 | Infecund Not for Contraceptive Reasons Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.152 | Live Birth Delivery Procedures SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.153 | Contraceptive Ring SNOMED Surveillance Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.154 | Contraceptive Ring SNOMED Provision Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.155 | Contraceptive Ring SNOMED Findings |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.161 | Contraceptive Implant SNOMED Devices |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.163 | Contraceptive Implant SNOMED Provision Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.164 | Contraceptive Implant SNOMED Findings |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.165 | Infecund Not for Contraceptive Reasons SNOMED Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.17 | Contraceptive Type |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.174 | Contraceptive Patch Devices |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.177 | Live Birth Delivery Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.178 | Contraceptive Ring Surveillance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.18 | Contraception Not Used Reason |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.181 | Injectable Contraceptive SNOMED Surveillance Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.182 | Injectable Contraceptive SNOMED Provision Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.183 | Injectable Contraceptive SNOMED Findings |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.189 | Oral Contraceptive Pill SNOMED Surveillance Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.190 | Oral Contraceptive Pill SNOMED Provision Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.191 | Oral Contraceptive Pill SNOMED Findings |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.192 | Contraceptive Implant SNOMED Surveillance Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.197 | Injectable Contraceptive Provision Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.198 | Injectable Contraceptive Surveillance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.199 | Oral Contraceptive Pill Provision Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.200 | Oral Contraceptive Pill Surveillance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.201 | Contraceptive Implant Devices |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.202 | Contraceptive Implant Provision Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.203 | Contraceptive Implant Surveillance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.209 | Yes and No Answers |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.21 | Contraceptive Provision Method |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.210 | Pap Smear Results |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.22 | Pregnancy Intention |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.24 | Clinical Provider Role |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.3 | Organism Detection |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.31 | English Proficiency |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.86 | Intrauterine Devices SNOMED Devices |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.87 | Intrauterine Devices SNOMED Findings |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.88 | Intrauterine Device SNOMED Provision Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.89 | Intrauterine Devices SNOMED Surveillance Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.96 | Infecund Not for Contraceptive Reasons SNOMED Findings |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.10 | ASN Screening Declined |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.15 | Intervention for Positive Transportation Insecurity Screen |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.16 | Intervention for Positive Food Insecurity Screen |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.19 | Intervention for Positive Food Insecurity Screen |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.2 | Intracranial or Intraspinal surgery |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.20 | Intervention for Positive Homelessness Screen |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.21 | Intervention for Positive Housing Instability Screen |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.27 | Mental Health Diagnosis without Substance Use Disorders |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.29 | Bed Assigned |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.3 | Malignant Intracranial Neoplasm Group |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.31 | Healthcare Agent & Power of Attorney Documentation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.34 | Advance Directive Documentation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.37 | Portable Medical Order(s) Documentation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.38 | Advance Care Planning Discussion Documentation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.42 | Healthcare Agent & Power of Attorney Documentation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.43 | Advance Directive Documentation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.45 | Advance Care Planning Documentation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.47 | Portable Medical Order(s) Documentation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.48 | Portable Medical Order(s) Documentation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.5 | Allergy to thrombolytics |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.50 | Intervention for Positive Utility Insecurity Screen |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.52 | Intervention for Positive Transportation Insecurity Screen |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.54 | Intervention for Positive Housing Instability Screen |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.56 | Intervention for Positive Homelessness Screen |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.6 | Thrombolytics Adverse Event |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.8 | Intervention for Positive Utility Insecurity Screen |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1176.58 | Food Insecurity Positive Finding |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.100 | Allergy or Intolerance to ACE Medication |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.101 | Allergy or Intolerance to ARB Medication |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.102 | Chronic Kidney Disease Stage 1 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.103 | Chronic Kidney Disease Stage 2 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.104 | Chronic Kidney Disease Stage 3 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.105 | Chronic Kidney Disease Stage 4 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.106 | Chronic Kidney Disease Stage 5 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.111 | AHA GWTG Chronic Kidney Disease Stage 2 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.115 | AHA GWTG Chronic Kidney Disease Stage 1 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.116 | AHA GWTG Chronic Kidney Disease Stage 3 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.117 | AHA GWTG Chronic Kidney Disease Stage 4 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.15 | Non Tobacco Smoking Product User |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.21 | Referral to cardiac rehab |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.22 | Cardiac Rehabilitation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.32 | Heart Transplant |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.33 | Heart Transplant |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.34 | Allergy to MRA Therapy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.40 | Cardiac Rehabilitation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.5 | Hypothyroidism |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.52 | Cardiac Pacer |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.53 | Cardiac Pacer |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.55 | Heart Transplant Complications |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.56 | Heart Transplant Complications |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.57 | Left Ventricular Assist Device Complications |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.58 | Left Ventricular Assist Device Complications |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.6 | Hypothyroidism |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.60 | Left Ventricular Assist Device Placement |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.61 | Left Ventricular Assist Device Placement |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.67 | Diastolic Heart Failure |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.68 | Diastolic Heart Failure |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.69 | Allergy to SGLT2 Inhibitors |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.70 | Intolerance to SGLT2 Inhibitors |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.71 | Intolerance to MRA Therapy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.74 | Mitral Stenosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.75 | Mitral Stenosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.77 | Mechanical Prosthetic Heart Valve |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.78 | Mechanical Prosthetic Heart Valve |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.8 | Anorexia Nervosa |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.83 | Systolic Heart Failure |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.84 | Systolic Heart Failure |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.9 | Anorexia Nervosa |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.96 | AHA GWTG Long COVID19 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.97 | AHA GWTG Long COVID19 SNOMEDCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.1 | Wound internal item and/or body structure visible value set (foundation metadata concept) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.11 | Wound exudate appearance value set (foundation metadata concept) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.12 | Wound exudate color value set (foundation metadata concept) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.13 | Exudate odor value set (foundation metadata concept) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.14 | Wound anatomic location value set (foundation metadata concept) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.16 | Skin temperature value set (foundation metadata concept) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.17 | Skin color enumerated value set (foundation metadata concept) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.18 | Skin turgor value set (foundation metadata concept) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.19 | Skin and mucous membrane integrity value set (foundation metadata concept) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.2 | Periwound condition value set (foundation metadata concept) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.20 | Skin moisture value set (foundation metadata concept) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.3 | Wound Type Etiology value set |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.4 | Wound episode value set (foundation metadata concept) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.6 | Wound bed appearance value set (foundation metadata concept) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.60 | Wound type reference set |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.7 | Wound bed color value set (foundation metadata concept) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.74 | Nonverbal pain indicators reference set |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.76 | Pain associated signs and symptoms reference set |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.77 | Pain body location reference set |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.8 | Wound edge description value set (foundation metadata concept) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.81 | Pain speed of onset reference set |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.9 | Presence absence value set (foundation metadata concept) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.2 | Common drug classes for allergy and intolerance documentation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.3 | Common dietary substances for allergy and intolerance documentation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.4 | Common environmental substances for allergy and intolerance documentation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.5 | Common refutations for substance causes for allergy and intolerance documentation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.7 | Common substances for allergy and intolerance documentation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.8 | Common substances for allergy and intolerance documentation including refutations |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.11 | NHSNCriterionOfDiagnosisCode(SNOMEDCT) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.13 | NHSNInfectionConditionCode(SNOMEDCT) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.15 | NHSNInfectionTypeCode(SNOMEDCT) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.17 | NHSNInfectionFirstReportedSource(SNOMEDCT) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.19 | NHSNLOS/MENDischargeDisposition(SNOMEDCT) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.23 | NHSNSameDayOutcomeMeasure(SNOMEDCT) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.25 | NHSNSignificantPathogenCode(SNOMEDCT) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.27 | NHSNSpinalFusionApproachCode(SNOMEDCT) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.29 | NHSNVascularAccessTypeCode(SNOMEDCT) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.31 | NHSNVascularSpecimenCollectionSite(SNOMEDCT) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.6 | NHSNPathogenCodeARO |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.74 | Enteral Medication Route |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.75 | Intravenous Medication Route |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.8 | NHSNRoleOfPerformerCode(SNOMEDCT) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.88 | Digestive, Intramuscular, Intravenous Route of Administration |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.91 | Long Term Care Discharge Disposition |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1139 | S4G Hyperlipidemia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1291 | S4G Cardiomyopathy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1292 | S4G Tricuspid valve disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1293 | S4G Pompe disease |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1294 | S4G Malignant hyperthermia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1295 | S4G Malignancy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1297 | S4G Intestinal polyp |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1298 | S4G Hamartoma |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1299 | S4G Diabetes mellitus |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1300 | S4G Muscular dystrophy and weakness |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1325 | S4G Hamartoma and S4G Intestinal Polyp |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1326 | S4G Malignancy and S4G Intestinal Polyp |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1358 | Beta lactam medicinal product SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4466 | Pharyngeal specimens |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4467 | Urogenital & Anorectal Specimens |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.788 | Social Determinants of Health Conditions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.789 | Social Determinants of Health Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.790 | Social Determinants of Health Service Requests |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.51 | VTE Symptoms |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.53 | Provider Types |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.60 | Screening Mammogram (SNOMEDCT) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.64 | Diagnostic Mammography (SNOMEDCT) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.67 | BI_RADS Categories 0, 4, and 5 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.68 | BI_RADS Categories 1, 2, and 3 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.115 | Kratom containing compounds |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.121 | Gastrointestinal bleeding episode and Risk of GI Bleeding 1 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.123 | Gastrointestinal bleeding episode and Risk of GI Bleeding |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.1 | Bronchiectasis Disorder SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.101 | Occupational Therapy Procedure |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.103 | Speech Language Therapy Procedure |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.105 | Intermittent Skilled Nursing Home Health Procedure |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.107 | Breathing Test Procedure During Sleep |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.11 | Interstitial Lung Disease SNOMEDCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.115 | Spine or Neck Disorder SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.117 | Spine or Neck Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.119 | Hypoventilation Disorder SNOMEDCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.12 | Interstitial Lung Disease |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.121 | Hypoventilation Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.122 | Respiratory Assist Device Qualifying Condition |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.134 | Sleep Related Symptom for Positive Airway Pressure Device Use Evaluation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.135 | Past Medical History Condition Related to Need for Positive Airway Pressure Device |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.136 | Home or Facility Care Location |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.137 | Fracture of Bone Disorder SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.139 | Fracture of Bone Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.14 | Cystic Fibrosis Lung Disease SNOMEDCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.140 | Severe Obesity Disorder SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.142 | Severe Obesity Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.143 | Transfer from Bed Impairment SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.145 | Transfer from Bed Impairment |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.146 | Ability to Safely Sit in Chair or Wheelchair Impairment SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.148 | Ability to Safely Sit in Chair or Wheelchair Impairment |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.149 | Fall or Fall Risk from Wheelchair or Stretcher SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.15 | Cystic Fibrosis Lung Disease |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.152 | Muscle, Tendon or Joint Contracture Disorder SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.154 | Muscle, Tendon or Joint Contracture Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.155 | Muscle Weakness or Myasthenia Gravis Disorder SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.158 | Myocardial Infarction Disorder SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.16 | Neoplasm of Lung or Trachea Disorder SNOMEDCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.160 | Myocardial Infarction Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.161 | Amputation Disorder SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.164 | Lower Extremity Deep Vein Thrombosis Disorder SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.167 | Spinal Cord Injury or Paralysis Disorder SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.169 | Spinal Cord Injury or Paralysis Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.170 | Demyelinating Disorder SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.172 | Demyelinating Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.173 | Grade 2, 3 or 4 Decubitus Ulcer on Buttock Disorder SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.176 | Wound Disorder SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.178 | Wound Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.179 | Danger to Self or Others Disorder SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.18 | Neoplasm of Lung or Trachea Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.181 | Danger to Self or Others Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.182 | Behavioral Disorder Related to Need for Non Emergency Ambulance Transfer SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.184 | Behavioral Disorder Related to Need for Non Emergency Ambulance Transfer |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.185 | Pain on Movement or Joint Pain Disorder SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.187 | Pain on Movement or Joint Pain Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.188 | Non Emergency Ambulance Transport Reason |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.189 | Osteoarthritis Disorder SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.19 | Secondary Erythrocytosis Disorder SNOMEDCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.191 | Osteoarthritis Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.194 | Non Emergency Ambulance Transport Qualifying Procedure |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.198 | Hepatic Medical History |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.21 | Secondary Erythrocytosis Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.23 | Acute or Chronic Heart Failure Disorder SNOMEDCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.24 | Acute or Chronic Heart Failure Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.25 | Home Oxygen Therapy Qualifying Condition |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.26 | Device Use Patient Activity Level |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.29 | Sleep Apnea or Breathing Related Sleep Disorder SNOMEDCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.3 | Bronchiectasis Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.31 | Sleep Apnea or Breathing Related Sleep Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.34 | Diabetes Mellitus Disorder SNOMEDCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.35 | Diabetes Mellitus Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.36 | Restrictive Lung Disease SNOMEDCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.38 | Restrictive Lung Disease |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.39 | Chest Wall Deformity Disorder SNOMEDCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.41 | Chest Wall Deformity Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.42 | Motor Neuron Disease or Spinal Muscular Atrophy Disorder SNOMEDCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.44 | Motor Neuron Disease or Spinal Muscular Atrophy Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.45 | Chronic Respiratory Failure Disorder SNOMEDCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.47 | Chronic Respiratory Failure Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.48 | Ventilator Therapy Qualifying Condition |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.5 | Chronic Obstructive Lung Disease SNOMEDCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.6 | Chronic Obstructive Lung Disease (COPD) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.64 | Urinary Incontinence Disorder SNOMEDCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.66 | Urinary Incontinence Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.67 | Chronic Urinary Retention Disorder SNOMEDCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.69 | Chronic Urinary Retention Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.70 | Urinary Incontinence or Chronic Urinary Retention Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.8 | Hypoxemia Disorder SNOMEDCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.81 | Organ Transplant History Significant to Immunosuppressive Therapy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.86 | Hyperglycemia or Hypoglycemia Disorder SNOMEDCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.88 | Hyperglycemia or Hypoglycemia Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.9 | Hypoxemia Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.90 | Organ Transplant Procedure Significant to Immunosuppressive Therapy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.91 | Pulmonary Hypertension Disorder SNOMEDCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.93 | Pulmonary Hypertension Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.95 | Physical Therapy Procedure SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.96 | Occupational Therapy Procedure SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.97 | Speech Language Therapy Procedure SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.99 | Physical Therapy Procedure |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.135 | Last Menstrual Period (LMP) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.149 | Abortion, All (SNOMED CT) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.150 | Abortion, All |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.156 | Abortion, Elective |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.165 | Abortion, Elective |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.167 | Abortion, Surgical Management |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.168 | Abortion, Surgical Management |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.170 | Abortion, Spontaneous / Miscarriage |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.171 | Abortion, Spontaneous / Miscarriage |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.173 | Contraception, Counseling |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.174 | Contraception, Counseling |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.180 | Contraception, Surveillance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.182 | Contraception, Surveillance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.187 | Infertility, Female |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.188 | Infertility, Female |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.190 | Infertility, Male |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.191 | Infertility, Male |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.192 | Infertility, All |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.194 | Gender Identity |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.195 | Intersex Surgery, History |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.196 | Intersex Surgery, Non specific |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.197 | Intersex Surgery, Female to Male |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.199 | Intersex Surgery, Female to Male |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.200 | Intersex Surgery, Male to Female Sex |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.202 | Intersex Surgery, Male to Female Sex |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.203 | Intersex Surgery, All |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.205 | Stillbirth |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.208 | Sexual Orientation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.100 | Sleep Apnea Disorders SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.102 | Sleep Apnea Disorders |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.103 | PostTraumatic Stress Disorder PTSD |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.105 | PostTraumatic Stress Disorder PTSD SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1203 | Medication Literacy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1213 | Elder and Child Abuse SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1229 | Education Level SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1281 | Elder and Child Abuse |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1375 | Tinnitus |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1377 | Brain Fog |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1378 | Depression Symptoms |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1379 | Mood Swings |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1380 | Anxiety |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1381 | Lightheadedness |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1382 | Stress |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1383 | Grief and Suffering |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1384 | Insomnia and Other Sleep Difficulties |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1385 | Impaired Sense of Taste |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1386 | Pink Eye Diagnosis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1388 | Pink Eye Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1392 | Lymphadenopathy Diagnosis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1394 | Lymphadenopathy Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1395 | Visual Changes |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1396 | Impaired Sense of Smell |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1398 | Fatigue |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1399 | Chills |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1400 | Fever |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1401 | Functional and Mobility Impairment |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1403 | Orthostatic Intolerance |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1405 | Cough |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1406 | Dyspnea |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1409 | Wheezing |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1413 | Sinonasal Congestion |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1414 | Respiratory Distress |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1415 | Edema |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1419 | Weight Changes |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1422 | Immunologic Changes |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1424 | Pain |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1425 | Arthralgia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1426 | Chest Pain |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1427 | Headache |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1428 | Myalgia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1429 | Back Pain |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1430 | Pain in Extremities |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1431 | Pain in Throat |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1432 | Palpitations |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1433 | Tachycardia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1434 | Bleeding |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1435 | Abdominal Pain |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1436 | Diarrhea |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1437 | Gastroesophageal Reflux |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1438 | Nausea |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1439 | Vomiting |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1440 | Constipation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1441 | Difficulty Swallowing |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1443 | Loss of Appetite |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1444 | Paresthesia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1445 | Rash |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1446 | Covid Toes (Toes and/or Fingers) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1447 | Itching |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1448 | Menstrual Cycle Irregularities |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1449 | Lower Urinary Tract Symptoms |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1450 | Urinary Incontinence |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1451 | Dizziness |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1453 | Hair Loss |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1455 | Disability Severity |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1456 | Hypercoagulability |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1457 | Post Exertional Malaise |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1458 | Chronic Pain |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1459 | Neurogenic Pain |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1460 | Impaired Hearing |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1461 | Parkinsonia Like Symptoms |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1462 | Bronchiectasis Diagnosis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1463 | Bronchiectasis Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1464 | Chronic obstructive pulmonary disease (COPD) Diagnosis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1466 | Chronic obstructive pulmonary disease (COPD) Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1467 | Interstitial lung disease Diagnosis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1469 | Interstitial lung disease Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1470 | Asthma Diagnosis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1472 | Asthma Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1473 | Fibromyalgia Diagnosis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1475 | Fibromyalgia Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1477 | Herpes zoster Diagnosis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1478 | Herpes zoster |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1479 | Pulmonary embolism Diagnosis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1481 | Pulmonary embolism Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1482 | Hypertension, Pulmonary Hypertension SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1484 | Hypertension, Pulmonary Hypertension |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1485 | Language and Speech Problems |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1486 | Postural tachycardia syndrome (POTS) Diagnosis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1488 | Postural tachycardia syndrome (POTS) Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1489 | Functional disorder of gastrointestinal tract Diagnosis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1491 | Functional disorder of gastrointestinal tract Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1492 | Autonomic dysfunction |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1496 | Mast Cell Activation Syndrome (MCAS) Diagnosis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1498 | Mast Cell Activation Syndrome (MCAS) Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1500 | Debility or Frailty SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1502 | Debility or Frailty |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1503 | Ehlers Danlos syndrome (EDS) Diagnosis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1505 | Ehlers Danlos syndrome (EDS) Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1506 | Malnutrition Diagnosis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1508 | Narcolepsy Diagnosis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1510 | Narcolepsy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1514 | Small Fiber Neuropathy Diagnosis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1516 | Small Fiber Neuropathy Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1517 | Malnutrition Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1518 | Neuropathy Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1519 | Multisystem Inflammatory Syndrome in Adults (MIS A) Diagnosis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1521 | Multisystem Inflammatory Syndrome in Adults (MIS A) Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1522 | Congestive heart failure Diagnosis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1524 | Congestive heart failure Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1526 | Cognitive disorder SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1527 | Post Acute Sequelae of Sars Cov 2 infection (PASC) SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1530 | Post Acute Sequelae of Sars Cov 2 infection (PASC) Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1531 | Hypertension, Persistent SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1532 | Acute Renal Failure Diagnosis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1534 | Acute Renal Failure Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1535 | Complication due to Diabetes Mellitus Diagnosis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1537 | Complication due to Diabetes Mellitus Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1538 | Coronary Revascularization History SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1540 | Coronary Revascularization History |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1541 | Heart Failure Diagnosis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1543 | Heart Failure Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1547 | Hypertension, Primary and Secondary Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1548 | Cerebrovascular Disease Diagnosis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1549 | Cerebrovascular Disease Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1550 | Migraine Diagnosis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1552 | Migraine Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1553 | Chronic Tension type Headache Diagnosis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1555 | Chronic Tension type Headache Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1556 | Low Back Pain SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1558 | Low Back Pain |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1559 | Metabolic Syndrome Diagnosis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1561 | Metabolic Syndrome Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1563 | Hypertension, Persistent |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1564 | Pregnancy SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1566 | Pregnancy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.157 | Chronic Kidney Disease All Stages (1 through 5) SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.159 | Chronic Kidney Disease All Stages (1 through 5) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1595 | Acute COVID 19 Diagnosis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1599 | Cardiomyopathy Diagnosis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1601 | Atherosclerotic Cardiovascular Disease SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1603 | Neuropathy Diagnosis SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1606 | Left Ventricular Hypertrophy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.22 | Alcohol Use Disorder SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.24 | Alcohol Use Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.25 | Peripheral Vascular Disease SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.27 | Peripheral Vascular Disease |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.28 | Hepatitis C Condition SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.30 | Hepatitis C Conditions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.31 | Diabetic Neuropathy SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.33 | Diabetic Neuropathy Conditions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.36 | Obesity Conditions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.37 | Obesity SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.4 | Chronic Kidney Disease Type or Cause SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.41 | Tuberculosis (Disorders) SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.417 | Prediabetes (Borderline Diabetes) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.419 | Prediabetes (Borderline Diabetes) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.420 | Maturity Onset Diabetes of the Young (MODY) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.43 | Tuberculosis Disorders |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.45 | Hypoalbuminemia Conditions SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.47 | Hypoalbuminemia Conditions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.48 | Hyperkalemia Conditions SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.481 | Diabetic Coma |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.482 | Diabetic Coma |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.491 | Diabetic Peripheral Angiopathy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.492 | Diabetic Peripheral Angiopathy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.496 | Cataract of the Eye |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.498 | Cataract of the Eye |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.499 | Rubeosis Iridis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.50 | Hyperkalemia Conditions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.501 | Rubeosis Iridis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.507 | Emotional Distress caused by Chronic Condition |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.508 | Emotional Distress caused by Chronic Condition |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.51 | Anemia Conditions SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.512 | Hypoglycemic Event |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.513 | Hypoglycemic Event |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.514 | Hypoglycemia Unawareness |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.516 | Hyperglycemic Hyperosmolar Nonketotic Syndrome HHNS |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.517 | Hyperglycemic Hyperosmolar Nonketotic Syndrome HHNS |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.519 | Ketoacidosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.520 | Ketoacidosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.522 | Diabetic Foot |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.523 | Diabetic Foot |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.525 | Diabetic Foot Ulcer |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.526 | Diabetic Foot Ulcer |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.529 | Charcot Foot |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.53 | Anemia Conditions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.531 | Charcot Foot |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.533 | Cellulitis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.535 | Diabetic Hand or Diabetic Cheiroarthropathy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.539 | Necrobiosis Lipoidica (Skin Lesions) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.540 | Necrobiosis Lipoidica (Skin Lesions) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.542 | Gangrene |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.543 | Gangrene |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.545 | Dupuytren's Contracture |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.546 | Dupuytren's Contracture |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.548 | Scleroderma or Thick Skin Syndrome |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.549 | Scleroderma or Thick Skin Syndrome |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.555 | Acanthosis Nigricans |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.556 | Acanthosis Nigricans |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.557 | Eruptive Xanthomatosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.559 | Periodontitis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.560 | Periodontitis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.562 | Amputated Limb (Not Traumatic) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.563 | Amputated Limb (Not Traumatic) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.565 | Hypertension, Essential or Primary SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.568 | Hypertension, Secondary SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.571 | Hypertension Stage |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.579 | Cardiomyopathy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.58 | Hypercalcemia Conditions SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.580 | NYHA Heart Failure Functional Classifications |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.581 | American Heart Association Heart Failure Stage |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.584 | Atherosclerotic Cardiovascular Disease |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.586 | Gout |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.587 | Psoriatic Arthritis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.588 | Reactive Arthritis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.591 | Cannabis Use |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.592 | Hearing Impairment |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.6 | Chronic Kidney Disease Type or Cause |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.60 | Hypercalcemia Conditions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.607 | Angina |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.608 | Angina |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.61 | Hypocalcemia Conditions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.610 | Unstable Angina |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.611 | Unstable Angina |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.613 | Ischemic Heart Disease |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.614 | Ischemic Heart Disease |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.615 | Left Ventricular Hypertrophy SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.618 | Stroke |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.620 | Transient Ischemic Attack |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.621 | Transient Ischemic Attack |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.626 | Aneurysm |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.627 | Aneurysm |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.63 | Hypocalcemia Conditions SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.635 | Aortic Disease |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.636 | Aortic Disease |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.638 | Carotid Stenosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.639 | Carotid Stenosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.64 | Hyperphosphatemia Conditions SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.641 | Intracranial Stenosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.642 | Intracranial Stenosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.644 | Pulmonary Edema |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.645 | Pulmonary Edema |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.647 | Osteoarthritis (Oa) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.648 | Osteoarthritis (Oa) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.650 | Rheumatoid Arthritis (Ra) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.651 | Rheumatoid Arthritis (Ra) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.653 | Infectious Arthritis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.654 | Infectious Arthritis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.656 | Temporomandibular Disorder Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.659 | Irritable Bowel Syndrome |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.66 | Hyperphosphatemia Conditions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.660 | Irritable Bowel Syndrome |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.662 | Neuropathic Pain (Neuralgia) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.663 | Neuropathic Pain (Neuralgia) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.665 | Neuromas |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.666 | Neuromas |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.668 | Phantom Pain |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.669 | Phantom Pain |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.67 | Hematuria Conditions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.671 | Entrapment Neuropathy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.672 | Entrapment Neuropathy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.674 | Myalgic Encephalomyelitis or Chronic Fatigue Syndrome |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.675 | Myalgic Encephalomyelitis or Chronic Fatigue Syndrome |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.677 | Psychotic Depression |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.678 | Psychotic Depression |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.680 | Post Partum Depression |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.681 | Post Partum Depression |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.683 | Seasonal Affective Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.684 | Seasonal Affective Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.686 | Psychological Trauma |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.687 | Psychological Trauma |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.689 | Grief or Loss |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.69 | Hematuria Conditions SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.690 | Grief or Loss |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.692 | Suicide Risk |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.693 | Suicide Risk |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.695 | Vaping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.696 | Vaping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.699 | Tobacco Use or Exposure |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.70 | Metabolic Acidosis Conditions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.701 | Binge Drinking |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.702 | Binge Drinking |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.705 | Drug Misuse |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.707 | Drug Misuse |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.709 | Sensory Status |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.714 | Lower Urinary Tract Symptoms (LUTS) From Benign Prostatic Hyperplasia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.715 | Lower Urinary Tract Symptoms (LUTS) From Benign Prostatic Hyperplasia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.717 | Urinary Incontinence |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.718 | Urinary Incontinence |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.72 | Metabolic Acidosis Conditions SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.720 | Urinary Urgency |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.721 | Urinary Urgency |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.723 | Urinary Frequency |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.724 | Urinary Frequency |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.726 | Nocturia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.727 | Nocturia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.729 | Pelvic Organ Prolapse |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.73 | Hyperlipidemia Conditions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.730 | Pelvic Organ Prolapse |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.732 | Erectile Dysfunction |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.733 | Erectile Dysfunction |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.735 | Interstitial Cystitis or Bladder Pain Syndrome |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.736 | Interstitial Cystitis or Bladder Pain Syndrome |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.738 | Recurrent Urinary Tract Infections |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.739 | Recurrent Urinary Tract Infections |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.741 | Hypertriglyceridemia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.742 | Hypertriglyceridemia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.744 | Hypothyroidism |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.745 | Hypothyroidism |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.747 | Menopause |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.748 | Menopause |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.75 | Hyperlipidemia Conditions SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.750 | Testicular Hypofunction |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.751 | Testicular Hypofunction |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.753 | Primary Aldosteronism |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.754 | Primary Aldosteronism |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.756 | Restless Leg Syndrome |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.757 | Restless Leg Syndrome |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.76 | Chronic Pain Conditions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.760 | Claudication |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.761 | Claudication |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.762 | Angioedema |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.764 | Angioedema |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.769 | Nonalcoholic Fatty Liver Disease |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.770 | Nonalcoholic Fatty Liver Disease |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.772 | Thalassemia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.773 | Thalassemia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.78 | Chronic Pain SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.79 | Arthritis Disorders SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.800 | Temporomandibular Disorder Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.81 | Arthritis Disorders |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.82 | Preeclampsia Disorders SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.84 | Preeclampsia Disorders |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.840 | Spinal Cord Compression |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.841 | Spinal Cord Compression |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.843 | Alcohol Use (Revised 2021) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.845 | Alcohol Use |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.85 | Hyperuricemia Conditions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.87 | Hyperuricemia Conditions SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.88 | Vitamin D Deficiency Conditions SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.90 | Vitamin D Deficiency Conditions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.91 | Alkaline Phosphatase Deficiency Conditions SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.93 | Alkaline Phosphatase Deficiency Conditions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.95 | Uremic Pruritus Conditions SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.96 | Uremic Pruritus Conditions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.97 | Insomnia Disorders |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.99 | Insomnia Disorders SCT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1225.5 | Glaucoma SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1226.1 | Scleritis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1226.3 | Scleritis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1228.6 | Outpatient Encounter Locations |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.60 | Guillain Barre Syndrome, diagnosis codes for AE reporting |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.61 | Febrile seizure, diagnosis codes for AE reporting |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.62 | Encephalomyelitis and encephalitis, diagnosis codes for AE reporting |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.63 | Disseminated Intravascular Coagulation, diagnosis codes for AE reporting |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.64 | Deep Vein Thrombosis, diagnosis codes for AE reporting |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.65 | Bells Palsy, diagnosis codes for AE reporting |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.66 | Appendicitis, diagnosis codes for AE reporting |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.67 | Anaphylaxis, diagnosis codes for AE reporting |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.68 | Acute Myocardial Infarction, diagnosis codes for AE reporting |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.69 | Multisystem Inflammatory Syndrome, SNOMED codes for AE reporting |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.7 | Anaphylaxis, SNOMED codes for AE reporting |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.70 | Multisystem Inflammatory Syndrome, diagnosis codes for AE reporting |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.8 | Appendicitis, SNOMED codes for AE reporting |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.167 | End Stage Renal Disease (ESRD)_HD_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.172 | End Stage Renal Disease (ESRD)_HD_Clinical Condition Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.173 | Systolic Blood Pressure_HD_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.176 | Systolic Blood Pressure_HD |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.177 | Diastolic Blood Pressure_HD_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.18 | Annual Physical SNOMED CN5 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.180 | Diastolic Blood Pressure_HD |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.181 | Remote Blood Pressure_HD_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.182 | Remote Blood Pressure_HD |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.184 | Acute Inpatient_CN_HD_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.186 | Acute Inpatient_HD_Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.188 | ED Visit_CN_HD_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.190 | Pregnancy_HD_Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.191 | Pregnancy_CN_HD_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.193 | ED Visit_HD_Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.194 | Lipid Panel_Event_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.198 | Lipid Panel_Event_Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.20 | Annual Physical CN5 |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.203 | Unknown Glucose_Event_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.204 | Unknown Glucose_Lab_Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.205 | Bone Marrow Transplant CN_HD_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.207 | Bone Marrow Transplant_HD_CN_Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.211 | Immunocompromising Conditions_HD_CN_Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.212 | Immunocompromising Conditions CN_HD_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.213 | Cerebrospinal Fluid Leak CN_HD_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.215 | Cerebrospinal Fluid Leak_HD_CN_Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.216 | Anatomic or Functional Asplenia CN_HD_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.219 | Anatomic or Functional Asplenia_HD_CN_Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.220 | Sickle cell Anemia and HB S Disease CN_HD_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.222 | Sickle cell Anemia and HB S Disease_HD_CN_Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.223 | Pneumococcal Vaccine CN_HD_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.227 | Pneumococcal Vaccine_HD_CN_Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.228 | Influenza Vaccine CN_HD_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.232 | Influenza Vaccine_HD_CN_Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.233 | Cochlear Implant CN_HD_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.237 | Cochlear Implant_HD_CN_Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.238 | Chemotherapy CN_HD_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.241 | Chemotherapy_HD_CN_Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.254 | Pregnancy Loss_HD_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.257 | Pregnancy Loss_HD_Clinical Condition Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.260 | Heart Failure (CHF)_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.265 | Heart Failure (CHF)_Clinical Condition Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.276 | LDL_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.280 | LDL_Lab_Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.303 | Sigmoidoscopy_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.304 | Sigmoidoscopy_Event_Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.308 | Colonoscopy_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.309 | Colonoscopy_Event_Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.313 | FOBT Lab_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.314 | FOBT Lab Test_Lab_Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.317 | Colorectal Cancer_HD_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.318 | Colorectal Cancer_HD_Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.321 | Absence of Cervix Diagnosis_HD_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.322 | Absence of Cervix Diagnosis_HD_Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.326 | Hysterectomy With No Residual Cervix_HD_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.327 | Hysterectomy With No Residual Cervix_HD_Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.331 | High Risk HPV Test_HD_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.332 | High Risk HPV Test_HD_Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.336 | Cervical Cytology_HD_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.337 | Cervical Cytology_HD_Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.340 | AFib (Atrial Fibrillation)_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.344 | AFib (Atrial Fibrillation)_Clinical Condition Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.357 | Coronary Artery Disease (CAD)_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.359 | Coronary Artery Disease (CAD)_Clinical Condition Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.360 | Allergy List_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.362 | Allergy List_Clinical Grouping Event |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.364 | Other Revascularization_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.366 | Other Revascularization_Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.367 | Ischemic Vascular Disease (IVD)_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.369 | Ischemic Vascular Disease (IVD)_Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.370 | Muscular Pain and Disease_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.372 | Muscular Pain and Disease_Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.373 | Cirrhosis_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.375 | Cirrhosis_Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.376 | IVF_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.378 | IVF_Grouping |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.402 | First Trimester_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.406 | First Trimester_Clinical Grouping Event |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.409 | Birth Event_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.413 | Birth Event_Clinical Grouping Event |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.414 | Obesity_Condition_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.417 | Obesity_Clinical Grouping Condition |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.429 | Vitals Body Height SnoMed |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.430 | Vitals Body Height |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.464 | Second Trimester_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.465 | Second Trimester_Clinical Grouping Event |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.466 | Third Trimester_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.468 | Third Trimester_Clinical Grouping Event |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.499 | Active Pregnancy_SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.500 | Active Pregnancy_Clinical Grouping Event |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.501 | Abnormal PSA Testing _SNOMED |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1237.12 | SNOMEDFindingValuesQualifierValue |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1237.13 | SNOMED Organism from LOINC Answer List |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1237.2 | SNOMED Organisms |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.1 | Mental Status Observation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.11 | Sexual Orientation Including nulls and Data Absent Reason |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.12 | Pregnancy Status Observation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.3 | Sex |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.8 | Medication Adherence |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1242.2 | Sickle Cell Disease |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1242.4 | Depression |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.1 | Food Insecurity Diagnoses SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.100 | Intimate Partner Violence Goals |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.101 | Less Than High School Education Diagnoses SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.103 | Less Than High School Education Diagnoses |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.106 | Transportation Insecurity Interventions SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.107 | Financial Insecurity Diagnoses SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.108 | Financial Insecurity Diagnoses |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.109 | Financial Insecurity Interventions SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.11 | Food Insecurity Service Requests |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.110 | Medical Cost Burden Goals SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.111 | Health Insurance Coverage Status Goals SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.112 | Health Literacy Diagnoses SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.114 | Health Literacy Goals SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.115 | Health Literacy Interventions SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.116 | Health Literacy Diagnoses |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.117 | Health Literacy Goals |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.118 | Health Literacy Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.119 | Health Literacy Service Requests |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.120 | Medical Cost Burden Goals |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.121 | Health Insurance Coverage Status Goals |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.122 | Medical Cost Burden Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.123 | Medical Cost Burden Service Requests |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.124 | Health Insurance Coverage Status Service Requests |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.125 | Health Insurance Coverage Status Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.137 | Cognitive disorder Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.14 | Homelessness Diagnoses SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.145 | Less Than High School Education Interventions SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.149 | Health Insurance Coverage Status Interventions SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.150 | Material Hardship Interventions SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.152 | Medical Cost Burden Diagnoses SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.153 | Medical Cost Burden Diagnoses |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.154 | Medical Cost Burden Interventions SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.158 | Homelessness Goals SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.159 | Homelessness Goals |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.16 | Food Insecurity Goals |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.160 | Housing Instability Goals SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.161 | Housing Instability Goals |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.162 | Transportation Insecurity Goals SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.163 | Transportation Insecurity Goals |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.164 | Veteran Status Interventions SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.17 | Food Insecurity Diagnoses |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.18 | Homelessness Diagnoses |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.19 | Homelessness Interventions SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.20 | Homelessness Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.21 | Homelessness Service Requests |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.213 | Health Insurance Coverage Status Diagnoses SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.214 | Veteran Status Goals |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.215 | Veteran Status Goals SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.219 | Digital Literacy Goals SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.22 | Housing Instability Diagnoses SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.220 | Digital Literacy Interventions SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.225 | Digital Literacy Goals |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.226 | Digital Literacy Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.227 | Digital Literacy Service Requests |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.229 | Digital Access Diagnoses SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.231 | Digital Access Diagnoses |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.232 | Digital Access Goals SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.233 | Digital Access Goals |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.234 | Digital Access Interventions SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.235 | Digital Access Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.236 | Digital Access Service Requests |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.24 | Housing Instability Diagnoses |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.241 | Utility Insecurity Diagnoses SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.243 | Utility Insecurity Diagnoses |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.244 | Utility Insecurity Goals SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.245 | Utility Insecurity Goals |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.246 | Utility Insecurity Interventions SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.247 | Utility Insecurity Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.25 | Transportation Insecurity Diagnoses SNOMED CT |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.252 | Utility Insecurity Service Requests |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.26 | Transportation Insecurity Diagnoses |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.27 | Transportation Insecurity Procedures |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1092 | Moderate or Severe |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1140 | Patient Reason for ACE Inhibitor or ARB Decline |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1141 | Psychoanalysis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1151 | Renal Failure Due to ACE Inhibitor |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1170 | Tobacco User |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1177 | Allergy to Beta Blocker Therapy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1178 | Intolerance to Beta Blocker Therapy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1187 | Group Psychotherapy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1189 | Tobacco Non User |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1193 | Cardiac Pacer |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1211 | Allergy to ACE Inhibitor or ARB |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1212 | Intolerance to ACE Inhibitor or ARB |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1240 | Annual Wellness Visit |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1241 | Acute and Subacute Iridocyclitis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1283 | Level of Severity of Retinopathy Findings |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1285 | Ophthalmological Services |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1320 | Macular Edema Findings Present |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1332 | Cognitive Assessment |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1409 | Burn Confined to Eye and Adnexa |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1410 | Cataract Secondary to Ocular Disorders |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1411 | Cataract Surgery |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1412 | Cataract Congenital |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1413 | Cataract Mature or Hypermature |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1414 | Cataract Posterior Polar |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1415 | Certain Types of Iridocyclitis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1416 | Chronic Iridocyclitis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1417 | Cloudy Cornea |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1418 | Corneal Edema |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1419 | Disorders of Cornea Including Corneal Opacity |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1423 | Glaucoma |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1424 | Hereditary Corneal Dystrophies |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1426 | Hypotony of Eye |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1427 | Injury to Optic Nerve and Pathways |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1428 | Central Corneal Ulcer |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1430 | Open Wound of Eyeball |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1432 | Pathologic Myopia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1433 | Posterior Lenticonus |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1438 | Retrolental Fibroplasias |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1443 | Traumatic Cataract |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1444 | Uveitis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1445 | Vascular Disorders of Iris and Ciliary Body |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1446 | Visual Field Defects |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1448 | Amblyopia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1450 | Choroidal Degenerations |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1451 | Choroidal Detachment |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1452 | Choroidal Hemorrhage and Rupture |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1453 | Degeneration of Macula and Posterior Pole |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1454 | Degenerative Disorders of Globe |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1455 | Diabetic Macular Edema |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1457 | Disorders of Optic Chiasm |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1458 | Disorders of Visual Cortex |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1459 | Disseminated Chorioretinitis and Disseminated Retinochoroiditis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1460 | Focal Chorioretinitis and Focal Retinochoroiditis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1461 | Glaucoma Associated with Congenital Anomalies and Dystrophies and Systemic Syndromes |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1462 | Hereditary Choroidal Dystrophies |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1463 | Hereditary Retinal Dystrophies |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1465 | Nystagmus and Other Irregular Eye Movements |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1466 | Optic Atrophy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1467 | Optic Neuritis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1468 | Other and Unspecified Forms of Chorioretinitis and Retinochoroiditis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1469 | Other Background Retinopathy and Retinal Vascular Changes |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1471 | Other Disorders of Optic Nerve |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1473 | Other Endophthalmitis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1475 | Prior Penetrating Keratoplasty |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1477 | Purulent Endophthalmitis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1478 | Retinal Detachment with Retinal Defect |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1479 | Retinal Vascular Occlusion |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1480 | Other Proliferative Retinopathy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1482 | Separation of Retinal Layers |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1483 | Visual Acuity 20/40 or Better |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1491 | Major Depressive Disorder Active |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1492 | Psych Visit Diagnostic Evaluation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1496 | Psych Visit Psychotherapy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1530 | Speech and Hearing Evaluation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1558 | Morgagnian Cataract |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1559 | Macular Scar of Posterior Polar |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1563 | Underweight |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1568 | Follow Up for Adult Depression |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1569 | Follow Up for Adolescent Depression |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1570 | Referral for Adolescent Depression |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1571 | Referral for Adult Depression |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1576 | Outpatient Encounters for Preventive Care |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1578 | Follow Up Within 4 Weeks |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1580 | Referral to Primary Care or Alternate Provider |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1581 | Lifestyle Recommendation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1582 | Patient Declined |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1583 | Referral or Counseling for Alcohol Consumption |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1584 | Hospice Care Ambulatory |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.319 | Prostate Cancer |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.326 | Primary Open Angle Glaucoma |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.327 | Diabetic Retinopathy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.353 | End Stage Renal Disease |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.362 | Asthma |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.366 | Arrhythmia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.367 | Atrioventricular Block |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.368 | Cardiac Pacer in Situ |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.369 | Coronary Artery Disease No MI |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.370 | Hypotension |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.371 | Cardiac Surgery |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.376 | Heart Failure |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.378 | Pregnancy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.398 | Prostate Cancer Treatment |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.399 | Salvage Therapy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.402 | Influenza Vaccine Administered |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.403 | Initial Myocardial Infarction |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.412 | Bradycardia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.451 | Pain Warranting Further Investigation for Prostate Cancer |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.471 | Bilateral Oophorectomy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.485 | Chemotherapy |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.509 | Tobacco Use Cessation Counseling |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1525 | Follow Up for Above Normal BMI |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1526 | Follow Up for Above Normal BMI |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1527 | Referrals Where Weight Assessment May Occur |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1528 | Follow Up for Below Normal BMI |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1551 | Follow Up for Below Normal BMI |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1578 | Palliative Care |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1579 | Palliative or Hospice Care |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1610 | Referrals Where Weight Assessment May Occur |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1751 | Encounter to Evaluate BMI |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1834 | Encounter to Document Medications |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1917 | Encounter to Document Medications |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.886 | Encounter to Evaluate BMI |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1475 | Referral to Primary Care or Alternate Provider |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1508 | Lifestyle Recommendation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1510 | Weight Reduction Recommended |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1511 | Dietary Recommendations |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1515 | Dietary Recommendations |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1518 | Recommendation to Increase Physical Activity |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1537 | Follow Up Within 4 Weeks |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1914 | Encounter to Screen for Depression |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1916 | Encounter to Screen for Depression |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1918 | Encounter to Screen for Blood Pressure |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1920 | Encounter to Screen for Blood Pressure |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.2387 | Overweight or Obese |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.2388 | Underweight |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.2395 | Finding of Hypertension |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.259 | Diagnosis of Hypertension |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.263 | Diagnosis of Hypertension |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.467 | Follow Up for Adolescent Depression |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.468 | Follow Up for Adult Depression |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.537 | Referral for Adolescent Depression |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.538 | Referral for Adult Depression |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.791 | Patient Declined |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.805 | Weight Reduction Recommended |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.810 | Recommendation to Increase Physical Activity |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.823 | Referral or Counseling for Alcohol Consumption |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.1250 | Major Surgical Procedure |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.1743 | General or Neuraxial Anesthesia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.1940 | Immunocompromised Conditions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.2262 | CABG Surgeries |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.2343 | Immunocompromised Conditions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.3011 | Acute Myocardial Infarction |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.3024 | Acute Myocardial Infarction |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.307 | Encounter Inpatient |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.335 | Bone Marrow Transplant |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.336 | Bone Marrow Transplant |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.694 | CABG Surgeries |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.737 | PCI |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.747 | Endotracheal Intubation |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.128 | Bipolar Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.246 | Personality Disorder Emotionally Labile |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.249 | Personality Disorder Emotionally Labile |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.254 | Dysthymia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.257 | Dysthymia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.262 | Deceased |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.269 | Hepatitis B |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.272 | Hepatitis B |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.273 | Live Birth or Delivery |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.275 | Live Birth or Delivery |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.278 | Delivery - Diagnosis |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.44 | Bipolar Disorder |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.82 | Delivery |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.11.721 | Deceased |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1001 | Strabismic Amblyopia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1003 | Refractive Amblyopia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1008 | Aphakia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1010 | Infantile and Juvenile Cataract |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1012 | Congenital Corneal or Anterior Segment Conditions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1014 | Eyelid or Orbital Conditions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1016 | Coloboma of Optic Disc |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1018 | Hemorrhage of Optic Nerve Sheath |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1020 | Optic Nerve Hypoplasia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1022 | Disorder of Visual Cortex Due to Underlying Condition |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1024 | Cortical Blindness |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1026 | Congenital Condition of Retina |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.3.1000 | Strabismic Amblyopia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.3.1001 | Refractive Amblyopia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.3.1005 | Aphakia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.3.1006 | Infantile and Juvenile Cataract |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.3.1007 | Congenital Corneal or Anterior Segment Conditions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.3.1008 | Eyelid or Orbital Conditions |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.3.1009 | Coloboma of Optic Disc |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.3.1010 | Hemorrhage of Optic Nerve Sheath |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.3.1011 | Optic Nerve Hypoplasia |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.3.1012 | Disorder of Visual Cortex Due to Underlying Condition |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.3.1013 | Cortical Blindness |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.3.1014 | Congenital Condition of Retina |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.6.2 | Allergy and Intolerance Type |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.6.8 | Severity |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.7.2 | Problem Type (SNOMEDCT) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.7.4 | Problem |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.8.9 | Body Site Value Set |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.28 | Procedure |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.60 | Social History Type |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.68 | Problem Status |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.24.7.14 | Clinically Important Bacteria and Fungi |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.24.7.281 | Bacterial Skin Commensals |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3180 | NHSNInsertionSiteCode |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3181 | NHSNRoleOfPerformerCode |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3194 | NHSNSignificantPathogenCode |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3195 | NHSNCriterionOfDiagnosisCode |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3196 | NHSNInfectionConditionCode |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3249 | NHSNSpecimenTypeCode |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3283 | NHSNOrganismASTCode |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3361 | NHSNRouteOfAdministrationAURPCode |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6007 | NHSNVascularAccessTypeCode |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6074 | NHSNStaphAureusTestResults |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7214 | NHSNSameDayOutcomeMeasure |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7215 | NHSNInfectionFirstReportedSource |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.113883.3.67.1.101.3.2444 | Major Depression Including Remission |
| http://fhir.ch/ig/ch-crl/ValueSet/nkrs-serumtumourmarkers | NKRS - Serum Tumour Markers |
| http://fhir.ch/ig/ch-crl/ValueSet/nkrs-treatmentgoal | NKRS - Treatment Goal |
| http://fhir.ch/ig/ch-crl/ValueSet/nkrs-whocnsgradingsystem | NKRS - WHO(CNS) Grading System |
| https://fhir.kbv.de/ValueSet/KBV_VS_MIO_DIGA_Problem_Type | Problemtyp |
| https://hins.or.kr/fhir/MyHealthWay/ValueSet/myhealthway-allergyintolerance-manifestation-codes | MyHealthWay AllergyIntolerance Manifestation Codes |
| https://hins.or.kr/fhir/MyHealthWay/ValueSet/myhealthway-snomedct-codes | MyHealthWay SNOMED CT Codes |
| https://www.alberta.ca/fhir/ValueSet/family-member-relationship-code | FamilyMemberRelationshipCode_AB |
| http://terminology.hl7.org.au/ValueSet/amt-mp-codes | AMT Medicinal Product and Substances |
| http://terminology.hl7.org.au/ValueSet/smoking-status | Smoking Status |
| https://gematik.de/fhir/terminology/ValueSet/epa-additional-dosage-instructions-snomed-ct-vs | EPA Additional Dosage Instructions SNOMED-CT® ValueSet |
| https://gematik.de/fhir/terminology/ValueSet/epa-allergy-intolerance-reaction-snomed-ct-vs | EPA Allergy Intolerance Reaction SNOMED-CT® ValueSet |
| https://gematik.de/fhir/terminology/ValueSet/epa-body-height-snomed-ct-vs | EPA Body Height SNOMED-CT® ValueSet |
| https://gematik.de/fhir/terminology/ValueSet/epa-body-weight-snomed-ct-vs | EPA Observation Body Weight SNOMED-CT® ValueSet |
| https://gematik.de/fhir/terminology/ValueSet/epa-drug-therapy-status-snomed-ct-vs | EPA Drug Therapy Status SNOMED-CT® ValueSet |
| https://gematik.de/fhir/terminology/ValueSet/epa-pregnancy-status-method-snomed-ct-vs | EPA Pregnancy Status Method SNOMED CT® ValueSet |
| https://gematik.de/fhir/terminology/ValueSet/epa-prn-medication-reason-snomed-ct-vs | EPA PRN Medication Reason SNOMED-CT® ValueSet |
| https://gematik.de/fhir/terminology/ValueSet/epa-route-of-administration-snomed-ct-vs | EPA Route of Administration SNOMED-CT® ValueSet |
| https://example.org/fhir/krcore/ValueSet/krcore-condition-codes | KR Core Condition Code |
| https://example.org/fhir/krcore/ValueSet/krcore-observation-labresult-codes | KR Core Lab Result Observation Codes |
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.
FHIR